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Leishmania mexicana iPGAM is a divalent metal-dependent phosphatase superfamily 
member in glycolytic pathway, which catalyses the interconversion 3- and 2PGA via a 
phosphoserine intermediate. It is a potential drug target for leishmaniasis because the 
parasite and human enzymes are not homologous. L. mexicana iPGAM shares 74% 
sequence identity with T brucei iPGAM, a drug target for sleeping sickness. Th 
iPGAM has recently been confirmed by RNAi experiments in which reduced levels of 
Th iPGAM caused the death of cultured parasites. The availability of the structure of 
Lm iPGAM provides a foundation for structure-based drug design studies that are 
currently in progress to develop novel drugs to tackle diseases caused by 
trypanosomatid parasites. 
Leishmania mexicana iPGAM is one of the rare cobalt enzymes have been well 
characterised crystallographically. Comparison with a well-characterised crystal 
structure of Bacillus stearothermophilus iPGAM shows that the active site 
architectures of both enzymes are very similar, although the sequence identity is only 
33%. Phylogeny by sequence gives clues about metal specificity of the presence of 
peptide insertion at Tyr210 of Lm iPGAM. Together with structural inspection shows 
that metal specificity of each enzyme depends on the active site volume, which 
corresponds to support the chemical nature of a particular metal. Cobalt requirement 
of Lm iPGAM, but not magnesium, manganese or zinc has been confirmed by the 
reactivation assays of the metal-free enzyme treated by EDTA, and removal unwanted 
salts by size exclusion chromatography. Substitutions of manganese or zinc in the 
active site cause the metal coordination geometries in the active site to change, and 
thus cause the loss of enzyme activity. Moreover, replacement of manganese or zinc 
instead of cobalt in the active site of Lm iPGAM can imitate a phosphoserine 
intermediate which can be seen from the movement of Ser75 to attach the phospho 
group of the substrate (or product). 
There are two metal sites located in the active site together with one molecule of the 
substrate or the product in the crystal structures of Lm iPGAM. A dissociation constant 
of Col bound Lm iPGAM is much lower than that of Co2. Kd of Co2 determined by 
activity assays is 9.1 M, whereas a crystallographic titration resulted 0.28mM. The 
higher Kd from the crystallographic titration is probably affected by the presence of 
citrate in the crystallising solution (200mM). In addition, the un-cleavable His-tag at 
the C-terminus can also be a competitive cobalt chelator albeit less strongly. A mixture 
of the substrate (3PGA) and the product (2PGA) is found occupy the same position in 
the active site. The substrate-bound or the product-bound structures can be 
distinguished by using the temperature factors and occupancies of the substrate and the 
product in the active site of each structure. The identification of higher relative 
amounts of each ligand in the crystal structures depends on the starting ligand in the 
co-crystallising conditions. 
Inhibitory study of Lm iPGAM has been carried out using the crystal structure of Lm 
iPGAM-3PGA-Co at 1.90A as a template. Inhibitory screening using 'DOCK' and 
3PGA-based compounds yield L-isoleucine as the first inhibitor-like compound. 
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1.1. Phosphoglycerate mutase from Leishmania mexicana and 
Trypanosoma brucei as drug targets 
Leishmaniasis, one of the diseases caused by trypanosomatid protozoan parasites, 
affects about 12 million people worldwide, and efficacious drugs and vaccines are 
not currently available. The parasites are transmitted by the bite of an insect vector, 
the phlebotomine sandfly. In humans, the disease occurs in at least four major forms; 
cutaneous, diffuse cutaneous, mucocutaneous and visceral (The World Health 
Organization, 2002). Current treatments include meglumine antimonate, sodium 
stibogluconate and amphotericine B, which can cause severe toxic side effects and 
even be fatal (Handman, 2001; Zhang et al., 2002). 
Human African trypanosomiasis or sleeping sickness is caused by Trypanosoma 
brucei, and the infection starts by transmission of the parasite through to the human 
blood system by the bite of an infected tsetse fly. The parasite proliferates in the 
bloodstream in the early stage of the disease, and then invades other tissues including 
the central nervous system, which will be permanently destroyed. Coma proceeds to 
death during this last stage. Sleeping sickness is an ancient and major fatal disease 
problem to 66 million people in 36 countries of sub-Saharan Africa, and 22 
developed countries in the world (The World Health Organization, 2002). 
Unfortunately, the treatment of sleeping sickness has always been unsatisfactory 
(Keiser et al., 2000). For attempts at chemotherapy, many compounds have been 
2 
screened to test their effectiveness against trypanosomes, but none has proved 
suitable (Keiser and Bun-i, 2000). Moreover vaccine development has proved 
difficult because of the rapid and intricate mechanism used by the parasite for 
evading the host's immune system (Verlinde et al., 2001). Research and development 
of drugs for the treatment of sleeping sickness has recently been reviewed 
(Burchmore et al., 2002). 
In Trypanosome and Leishmania species and other kinetoplastid organisms, part of 
the glycolytic pathway is compartmentalised in specialised peroxisomes, called 
glycosomes, which are not present in other eukaryotic organisms. The glycolytic 
pathway of Trypanosoma brucei has been revealed as shown in Figure 1.1.1. and is 
similar to those of other kinetoplastic organisms (Michels et al., 2000; Opperdoes 
and Michels, 2001; Hannaert et al., 2003). Bloodstream forms of trypanosomes 
exclusively obtain energy through glycolysis, and the inhibition of any of the 
glycolytic enzymes thus provides a potential therapeutic approach. Phosphoglycerate 
mutase is a particularly attractive target for the design of selective inhibitors because 
the parasite and human enzymes are not homologous (Fraser et al., 1999; Poonperm 
et al., 2003; Guerra et al., 2004). Furthermore, the suitability of this target has 
recently been confirmed by RNAi experiments in which reduced levels of iPGAM in 
T brucei caused the death of cultured parasites (Albert et al., 2005). Our work is part 
of an effort to provide 3-D crystal structures and identify potential structure-based 
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Figure 1.1.1. Glycolysis in the bloodstream-form trypanosome. Boxed metabolites are 
nutrients or end-products of metabolism. Enzymes: 1, hexokinase; 2, phosphoglucose 
isomerase; 3, phosphofructokiflaSe 4, aldolase; 5, triose-phosphate isomerase; 6, 
glyceraldehyde-3-phosphate dehydrogenase; 7, phosphoglycerate kinase; 8, glycerol-
3-phosphate dehydrogenase; 9, glycerol kinase; 10, adenylate kinase; 11, glycerol-3-
phosphate oxidase; 12, phosphoglycerate mutase; 13, enolase; 14, pyruvate kinase. 
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1.2. Phosphoglycerate mutase family and divalent metal-dependent 
alkaline phosphatase superfamily 
Phosphoglycerate mutase (PGAM) is an enzyme of the glycolytic pathway that 
catalyses the interconversion of 2- and 3- phosphoglycerates. A multiple sequence 
alignment using the program CLUSTALX (Thompson et al., 1994) of a total of 250 
sequences of phosphoglycerate mutases taken from the Swiss-Prot and TrEMBL 
databases (www.expasy.ch , 2002) shows two distinct types of PGAM; one is 
dependent on the cofactor 2,3-bisphosphoglycerate (dPGAM), and the other is 
cofactor-independent (iPGAM). dPGAM is found in archaea (van der Oost et al., 
2002) yeast (Rigden et al., 1998; Rigden et al., 1999), bacteria (Fraser et al., 1999; 
Rigden et al., 2002), and mammals, whereas iPGAM is found in archaea (van der 
Oost et al., 2002; Potters et al., 2003), bacteria (Galperin et al., 1998; Fraser et al., 
1999), plants (Gatehouse and Knowles, 1977; Breathnach and Knowles, 1977; 
Blättler and Knowles, 1980; Smith et al., 1986; Botha and Dennis, 1986; McAleese 
et al., 1987; Johnson and Price, 1988; de la Ossa et al., 1994) and the parasitic 
protozoa Leishmania mexicana (Poonperm et al., 2003; Guerra et al., 2004) and 
Trypanosoma brucei (Chevalier et al., 2000; Collet et al., 2001). A phylogenetic tree 
of all PGAMs is shown in Figure 1.2.1. The chain length of iPGAM is much larger 
than that of dPGAM, and there is no sequence similarity between iPGAM and 
dPGAM (Grafia et al., 1992; Graña et al., 1995; Chevalier et al., 2000). 
5 
JPGAMs from human, mammalian, 
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Figure 1.2.1. Phylogenetic tree shows the sequence relationship of iPGAMs from L. 
mexicana and T. brucei among 250 sequences of dPGAMs and iPGAMs from the 
Swiss- ProtITrEMBL databases. dPGAMs are in yellow shading, iPGAMs from 
archaea and cyanobacteria are in green; Bacillus stearothermophilus and other 
bacterial iPGAMs in cyan; and L. mexicana, T. brucei and plant iPGAMs are in pink 
shading. 
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There is significantly more information available for the dPGAM family compared 
with the iPGAM family. dPGAM from a variety of organisms has been well-studied, 
and is present in all vertebrates, most invertebrates and some fungi and bacteria. It is 
found in monomeric, dimeric and tetrameric combinations of identical subunits of 
about Mr 30kDa (Fothergill-Gilmore and Watson, 1989; Graña et al., 1995). A potent 
inhibitor for dPGAM is vanadate which has no effect on iPGAM (Fraser et al., 1999; 
Chevalier et al., 2000; Guerra et al., 2004). X-ray crystal structures of the yeast 
Saccharomyces cerevisae dPGAM at 2.3 and 2.12A resolution (Rigden et al., 1998; 
Rigden et al., 1999) and complexed with 3-phosphoglycerate (3PGA) at 1.7A 
(Crowhurst et al., 1999) have been reported. The catalytic mechanism of dPGAM 
involves the formation and hydrolysis of a phosphohistidine intermediate by a 
histidine residue near the N-terminus (Fothergill-Gilmore and Michels, 1993). The 
formation and hydrolysis of the phosphorylated form of S. cerevisiae dPGAM has 
been revealed by mass spectrometry (Nairn et al., 1995). Moreover, high resolution 
crystal structures of E. coli CIPGAM in an active form (Bond et al., 2001) and an 
inactive form with a visualized phosphohistidine intermediate in the enzyme-
vanadate complex have been obtained (Bond et al., 2002). 
By contrast, information on iPGAM is rather sparse. All iPGAMs characterised are 
monomers with a molecular mass of 55-75kDa (Fothergill-Gilmore and Watson, 
1989; Fothergill-Gilmore and Michels, 1993). It has been classified as a member of 
the metal-dependent alkaline phosphatase (A1kP) superfamily (Jedrzejas, 2000; 
Jedrzejas and Setlow, 2001), which comprises a wide range of enzymes catalysing 
the intramolecular transfer of phospho- (Kim and Wyckoff, 1991; Holtz and 
7 
Kantrowitz, 1999; Holtz et al., 1999) or suipho-groups (Bond et al., 1997; Lukatela 
et al., 1998) in a divalent metal-dependent reaction (Fraser et al., 1999; Galperin and 
Jedrzejas, 2001). This superfamily includes enzymes with diverse activities such as 
isomerase, hydrolase and putative lyase. Alkaline phosphatase enzymes are known to 
have phosphotransferase activity (Coleman, 1992), whereas iPGAM can function as 
a phosphatase in addition to its mutase reaction (Gatehouse and Knowles, 1977; 
Breathnach and Knowles, 1977; B!attler and Knowles, 1980). A comparison of the 
crystal structures of sulfatase (Bond et al., 1997; Lukatela et al., 1998), E. coli 
alkaline phosphatase (Kim and Wyckoff, 1991) and B. stearothermophilus iPGAM 
(Jedrzejas and Setlow, 2001) shows that residues involved in phosphate and sulphate 
binding are conserved, as are those involved in metal binding. The conservation of 
metal-binding residues in these enzymes indicates that they are all (divalent) metal 
dependent enzymes. A selection of enzymes in this superfamily is shown in Table 
1.2.1., together with their optimum pH working range and metal requirements. 
Table 1.2.1. Properties of enzymes of the alkaline phosphatase superfamily. This table is 
adapted from the published work of Galperin, M.Y. et al., (1998). iPGAMs from L. mexicana, 
T. bruce! and B. stearothermophilus are shown in the SWISS-PROT/TrEMBL codes as 
Q86N96, Q9NG18 and GPMI_BACST, respectively. n.d. is not done. 
SWISS-PROT / pH Metal 
TrEMBL code optimum requirements Enzyme 	No.) (EC 
Phosphoglycerate mutase Q86N96 (L. mexicana) 7.4-7.6 Co 
(EC 5.4.2.1) Q9NG18 (T. brucei) 7.4-7.6 Co 
GPMI_BACST (B. 8.0 Mn 
stearothermophilus) 
PMGIECOLI 7.7-9.5 Mn 
Phosphopentomutase (EC 5.4.2.7) DEOB_ECOLI 8.0-8.5 Mn or Co 
Alkaline phosphatase (EC 3.1.3.1) PPB_ECOLI 8.0-10.5 Zn + Mg 
Streptomycin-6-phosphatase STRK_STRGR n.d. n.d. 
(EC 3.1.3.39) 
Alkaline phosphodiesterase/ PCI_I{UMAN 8.0-9.0 Mn, Mg, or Ca 
nucleotide pyrophosphatase 
(EC 3.1.4.1/3.6.1.9) 
Phosphoglycerol transferase MDOB_ECOLI 8.9 Mn 
(BC 2.7.8.20) 
Ca2-ATPase - 8.0 Ca 
Phosphonopyruvate decarboxylased BCPC_STRHY n.d. Mg 
Phosphonoacetate hydrolase - 7.7-9.0 Zn, Mn, or Co 
(EC 3.11.1.2) 
Phosphonate monoesterase - 8.5-9.0 Mn 
Arylsulfatase (EC 3.1.6.1) ASLA_ECOLI n.d. n.d. 
Steroid sulfatase (EC 3.1.6.2) STS—HUMAN 6.0-7.5 n.d. 
N-acetylgalactosamine 6-sulfatase GA6S_HUMAN 3.5-4.0 n.d. 
(BC 3.1.6.4) 
Cerebroside sulfatase (EC 3.1.6.8) ARSA_HUMAN 4.8-6.2 Mg 
N-acetylgalactosamine 4-sulfatase ARSB_HUMAN n.d. Ca? 
(EC 3.1.6.12) 
Iduronate 2-sulfatase (EC 3.1.6.13) IDS _HUMAN 4.0-5.7 n.d. 
N-acetylglucosamine 6-sulfatase GL6S_HUMAN 3.9-5.7 n.d. 
(EC 3.1.6.14) 
N-sulfoglucosanhine sulfatase SPHM_HUMAN 3.9-4.1 n.d. 
(EC 3.10.1.1) 
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1.3. Cofactor-independent phosphoglycerate m utase (iPGAMs) 
A total of 134 sequences of cofactor-independent phosphoglycerate mutases from 
various sources were taken from the Swiss-Prot and TrEMBL databases 
(www.expasy.ch , 2002) and aligned by the program CLUSTALW (Thompson et al., 
1994). The alignment shows that Lm and Th iPGAMs cluster near to iPGAMs from 
plants. A phylogenetic tree of iPGAM from Lm and Th iPGAM, with some iPGAMs 
from archaea (van der Oost et al., 2002; Potters et al., 2003), plants (Gatehouse and 
Knowles, 1977; Breathnach and Knowles, 1977; Blättler and Knowles, 1980; Smith 
et al., 1986; Botha and Dennis, 1986; McAleese et al., 1987; Johnson and Price, 
1988; de la Ossa et al., 1994) and bacteria (Galperin et al., 1998; Fraser et al., 1999) 
is shown in Figure 1.3.1. The metal requirements of iPGAMs in some species are 
indicated where they have been characterised. 
Table 1.3.1. Sequence identity of divalent metal-dependent iPGAMs obtained from 
sequence alignment by CLUSTALW as mentioned in the phylogenetic tree (Figure 1.3.1.). 
T. brucei Zoo mays R. communis E. coil - C. perfringens B. stearothe B. subtiils M. Jannass S. soifataricus 
L.mexicana 	74 53 54 33 32 33 30 15 11 
T.brucei 53 54 34 34 34 32 9 10 
Zea mays 82 33 35 32 33 10 12 
R.communis 33 34 33 32 16 12 
E.coli 54 59 59 14 15 
C. 48 49 .13 14 
perfnngens 
B. siearother 80 10 9 
B. subtilis 13 9 
M. Jar,nass 44 
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Lm and Th iPGAM, requiring Co 
2+ for activity (see Section 5.7), showed high 
sequence identity to iPGAMs from plants (53-54% identity) rather than iPGAMs 
from bacteria (30-34%), all details are provided in Table 1.3.1. B. 
stearothermophilus and B. subtilis iPGAMs require I4n2 whereas Clostridium 
perfringens iPGAM requires Mn2  and/or Co 
2+  for activity (Chander et al., 1998; 
Chander et al., 1999). E. coli iPGAIVI has also been shown to contain Mn 2 (Fraser et 
al., 1999). On the other hand, archaea iPGAMs show only 9-15% sequence identity 
with Lm and Tb iPGAMs and may be reactivated fully by Mg 2 in the case of 
Methanococcusjannaschii (van der Oost et al., 2002) or by either Mn 2 and/or Co 
2+ 
 
in the case of Sulfolobus solfataricus (Potters et al., 2003). The multiple sequence 
alignment demonstrates that metal binding residues as found in the crystal structures 
of Bs iPGAM (green shading) are strongly conserved. Substrate binding residues 
(magenta shading) are conserved in all sequences except those from archaea M 
jannaschii and S. solfataricus (Figure 1.3.2.). Residues near the metal and ligand 
binding residues can be distinguished within two groups: Lm and Tb and plant 
iPGAMs (yellow shading), and bacteria iPGAMs (cyan shading). This observation 
suggests that the two groups of proteins probably differ from each other with respect 
to the detailed geometry of metal and ligand binding. 
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L mexlcana Co 
T brixel Co 
Zea mays Mg? 
R cnmunis Mg? 
E coil ipgam Mn 
C peri'ringens Co/Mn 
B stearotheimophilus Mn 
B subtilis Mn 
MJannaschll Mg 
S solfatailcus Co/Mn 
Figure 1.3.1. Phylogenetic tree of iPGAMs from representative species. The metal 
requirements are indicated. The following species are included: protozoa, 
Leishmania mexicana, Ttypanosoma brucei; plants Zea mays (Maize), Ricinus 
communis (Castor bean); bacteria, Escherichia co/i, Clostridium perfringens, Bacillus 
stearothermophilus, Bacillus subtiis; archaea, Methanococcus jannaschii and 
Sulfolobus solfataricus. 
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EEDPKVTDQYYPPFIVVDEQDKPLGTI EDGDAVLCVNF GDIVI  EMTRAF 293 
EEDANISDQYYPPFVIAGDDGRPIGTIEDGDAVI.CFTJC 	IEMSRAF 292 
AQ-PKANDQYLPPFVIVDDSGNAVGPVLDGDAVCTTI1 t LAKAL 297 
EE-PKANDQYLPPFVIVDENGKFVGPIVDGDH: 7 IrL- 	- LAKAL 294 
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H 	KT 	LPTVIE-EDGHV IKDGI IFJJIJIIJXPE RAI 271 
MARIDEN KATVIR-AEGQP 	EDGL IF R RAF TRAF 274 
	
KH IY 	L 	SNTF 271 
IY IPSVITKENGEP KIQDGDSV If. B IA SNTF 271 
ElK- --------------------- PLDDSE----  --- FF1 THE LNKL 195 
ESK- --------------------- PLEDSN ------- EAT TAE INTL 198 
CLUSTAL W (1.82) multiple sequence alignment 
LrnexlcandCo ----MSALLLKPHKDLPR-RTVLI 'LGIGPEDDYDAVHMASTPFMD 
T_brucei_Co MALTLAkHKTLPR-RKLVL\JV 'VGlGPRDEYDAVHVAKTPLMD 
Zea_ mays _Mg? MGSSGFSWTLPDHPKLPKGKSVAVVV 'WGEANPDQYNCI1-JVAQTPVMD 
R_communis_Mg? ---  GEFTWKLADHPKLPVCVTT:VV YJGEAKPDQYNCIHVAETPTMD 
C_perfringens_Co/Mn ---------------- :SKP 'FCISPNKECNAVAAANKPNYD 
E_coli_ipgam_Mn -------------- ML;SKP:: IV YGYREEQQDNAIFSAKTPVMD 
B_stearothermophilus_Mn ----------------- SKIP Hi L 'F'ALRDETYGNAVAQANKPNFD 
B_subtilis_Mn ----------------- SKP;::I 'FCLRNETVGNAVALAKKPNFD 
M_jannaschii_Mg ----------------IECFICV1F I JLGDRPNEK--GLTPLKEAKTP 
S_sol fataricus_Co/Mn ----------------MKQYKILLIV 	'LGDRPVSKLNGLTPLEAANKP 
Lmex i ca na_Co AHRR- DNRHFRCvRAHGTAVGLPTDADVr 	FH; INALGACRVALQGASL 
T_brucei_Co ALFN-DPKHFRSICAHGTAVGLPTDADVCr F'CHNALGAGRVVLQGASL 
Zea_mays_Mg? SLKNCAPEKWRLVKAHCTAVGLPSDDDMCN FPIUNALGAGRIFAQGAKL 
R_cornmunis_Mg? SFKKTAPERWRLIKAHGTAVCLPTEDDVCi EHJUNALGAGRIYAQGAKL 
C_pertringens_Co/Mn PIiIJ--Y 	TELQASGLEVGL EG 	<C.i i'NL IGAGRII Q T 
E_coli_ipgarn_Mn Al 	--l;l- TLIDASGLEVGL D 	MCi EHH 	LGAGRI Q T 
B_stearothermophilus_Mn RH JI.-V1TTLKACGEAVGL EG NC FVC}IL IGAGRI QS T 
B_subtilis_Mn P ,,; CI -- IPETLTASGEAVGL EG MCt FVC!IL IGAGRI QS T 
M_jannaschii_Mg Tl ICGLAIDIGIR -------------- DTAHL 
S_solfataricus_Co/Mn 
---- C--  
AITDLLKNSMIGLMDPISPGIIP ---- C-- -------------- DTSHL 
* 	* 	* 
L_mexicana_Co VDDAIKSGEIYTGEGYRYLHGAFSKEGSTLHLIGLLSDGG 	SRDNQIYS 
T_brucei_Co VDDALESGEIFTSEGYRYLHGAFSQPGRTLHLIGLLSDGG 	SRDNQVYQ 
Zea_mays_Mg? VDQALASGKIYDGDGFNYIKESFESG- -TLHLIGLLSDGG 	SRLDQLQL 
R_communi s_Mg? VDLALASGKIYEGEGFKYVKECFDKG- -TLHLIGLLSDGG 	SRLDQLQL 
C_perfringens_Co/Mn ITKEIKEGT F KALV 	DEAKENNTSLHLMGLLSNGG 	CHTnTKG 
E_col.i_ipgam_Mn LDVEIKD 	F PVLT DKAKNAGKAVHIMGLLSAGG 	CH[l)HIMA 
B_stearothermophilus_Mn INIAIREGE D ETFL 	HVKQHGTSLHLFGLLSDGG 	CH1HHLYA 
B_subtilis_Mri VNVAIREGE E QTFL 	ISNAKENNKALHLFGLLSDGG. CHINHLFA 
M_jannaschii_Mg AILGYNPYEVYTGR ------------------- GPLEAFCHCIHLEiGDI 
S_solfataricus_Co/Mn SIFGLDPHVYYRGR ------------------- GAFEALCACJIFLSHGDV 
L_mexicana_Co IIEHAVKDGAKRIRVHAL' 	;RD7 	i7SSFRFTDELEAVLAKVRQNGCDA 
T_brucei_Co ILKHAGANGAKRIRVHALC IRD7 	l'ITSFKFTDELEEVLAKLREGGCDA 
Zea_rnays_Mg? LLKGVSERGAKKIRVHIJJL7RDI I1;SSIGFVETLENDLLELRAKGVDA 
R_commun is_Mg? LLKGAAEHGAKRIRVHVL1;RDI ;TSVGFAETLEKDLENLREKGVDA 
C_er fringens_Co/Mn p LLE 	KKKGLQK 	H 	RD 	PISGKDFIVELENAMKEI 
E_coli_ipgam_Mn MVE ERGAEKI LH 	.1 .RD 	FSAESSLKKFEEKFAAL KG---- 
B_stearothermophilus_Mn LLR 	KEGVKR 	IHG H 	RD 	P.'TAPQYIKELQEKIKEY 	C---- 
B_subtilis_Mn LLK 	KKEGLTK 	IHG Ii7RD 	P;TAKTYINQLNDQIKEI 	17---- 
M_jannaschii_Ng AFRCNFATVDENFVVLDRI$R 117 iIIAE-ELEKEIDG-------- 
S_solfataricus_Co/Nn AFRGNFATVNNDLVVVDRI 	Ri- 	:GE-QLVKELNEKI -------K 
L_mexicana_Co AIASGG7R1Ii '1111 	DADWSIVERGWRAQVLGDA-RHFHSAKEAITTFR 
T_brucei_Co RIASCC IRMIVTC 	YEADWSIVERGWRAQVLGEG-RAFKSAREALTKFR 
Zea_mays_Mg? QIASCc;RMVFiRY 	117FF VYRCWDAQVLGEAPYKFKSALEAVKTLR 
R_commun is_Mg? QVASCI 7RY 	17 	11111 	CF RGWDAQVLGEAPYKFKSAVEAIKKLR 
C_perfringens_Co/Mn EIAl 	RY 	- 	R--DFRWIRVE1ACAMALGE E-KASSAVEAIEKS 
E_coli_ipgam_Mn RVAF RY 	- 	R--D: 'RW IRVEPAY!!,LTLAQjEFQADTAVAGLQAA 
B_stearothermophilus_Mn EIAT 	RY 	- 	R--Di RW:IRVEIAYI-.GMVYGE P-TYRDPLECIEDS 
B_subtilis_Mn EIAS RY 	- 	R--D;. RWRVEIAYIAMAYGE P-SYRSALDVVDDS 
M_jannaschii_Mg EIDCF 	 ::----- 	RH H HG EGLSCRVSDGDPHEEGVKVS 





C_perfri ngens_Co /Mn 
E_coli_ipgam_Mn 
B_stearothermophi lus_Mn 
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L_mexicana_Co 	 EDEDFNXFDRVR- -VPKVRYAGMNRY]7GDLGIPNNFLVPPPKLTRVSEEY 341 
T_brucei_Co EEEEFDKFNRVR- -LPKVRYAGMMRYDGDLGIPNNFLVPPPKLTRTSEEY 340 
Ze_mays_Mg? 	 EYADFDNFDRVR- -VPKIRYAGMLQYDGELKLPSRYLVSPPEIDRTSGEY 345 
R_communis_Mg? EYENFDTFDRVR--FPKIHYAGMLQYDGELYIPNLVSPpEIERTSGEy 342 
Cperfringens Co/Mn 	VDPEFKGFERKQ --- LHC QYDKTLE11D-VAIkPESYT LGEY 317 
E_coli_ipgam_Mn 	 VNADFDGFARKK--VVMTFVML EYAADIF3--Vk:PPASL FGEW 320 
B_stearothermophjlus_Mn TNEDFREFDRGPKHPKI-N PFVCI HFSETVFSi--VAFKPTNL 	1GEV 319 
B_subtilisMn 	 TNIKDFRDFDRGENYPKrJ:.'\JSITHFSETVDS --VFFFPINL VGEV 319 
M_jannaschii_Mg LKIVYEKLNNHP--------INEERRKKGLPPANIILPRGAGVVPKIEXF 237 
S_solfataricusCo/Mn 	TRKVFDVLNSSE -------- INKRRIEQGEKPANIILLRGAAHYVKLPPF 240 
L_mexicanaCo 	 LCGSGLNIFACSETQ G ITYF'WNGNRSGIKIDEKHETFKEVPSD-RVQF 390 
T_brucei_Co LIGSGCMIFALSETQ C '.TYFWNGNRSGKLSEERETFCEIPSD-RVQF 389 
Zea_mays_Mg? 	 LVKNCH- :FA,'.LSFT FG 'JTFF'WNGNRSGYFDATKEEYVEVPSDSGITF 395 
R_comrnunis_Mg? LVHNU 	 T"! FC 	IF'WNGNRSGZr-CPFTFVEIPSD\iCITF 392 
Cperfringens_Co/Mn 	VASKCI:QLRII.i EKY:H FFFNGVIQPIIII;--F1'RAIIASPKVZTY  365 
Ecolijpgam_Mn 	 MAKNI QLI 	EKY if PFFNG 	Ep:i--Il)Rr IrJSPKVP:Y 368 
B_stearothermophilus_Mn LSQH(I i QLRI .EKYH PFMSG ELI 
--HRI111JPPKV-
INSPKVVIY 367 
B_subtilis_Mn 	 LSQW QLRI 	EKYIHFFMSG 	EFI tRI •. i Y 367 
M_jannaschii_Mg SEKYN''J'JiI,iL'PIPPKMIG---------------LDV1EVLGATS 273 
S_solfataricus_Co/Mn 	SSYTKLKAAAVSATALIKGICRELG -------------- MNVITPSGATG 276 
* 
L_mexicana_Co 	 NEKPRMQSAAITEAAIEALKSGMYNVVRINFPNG 'JG GDLKATITGV 440 
T_brucei_Co NQKPLMKSKEITDAAVDAIKSGKYDMIRINYPNG 'G CDLKATITSL 439 
Zea_  mays _Mg? 	 NVAPrJPIVAIEIAEKARDALLSGKFDQVRVNLPNC MVG CDIEATVVAC 445 
R_communis_Mg? NV;i F 	EIAEKARDAILSGKFQQVRVNIPNGEVG GDVEATVVGC 442 
C_perfringens_Co/Mn 	FFE:SI-IEIVTDE INRLDQDKYDMI LNFANP /75 TGVQEAA 	I 415 
E_coli_ipgam_Mn 	 'iEPSS,ELTEK AAIKSGKYDTI CNYPNG 175 FGVMEAA V 418 
B_stearothermophilus_Mn 	FI'EIISi:,'EVTD 	KEIEADKYDAI LNYANP IF/C SCKLEPTI V 417 
B_subtilis_Mn 	 E:•IS!PIEIVKD VKEIEADKHDAI NFANP VG SGMVEPTI I 417 
M_jannaschii_Ng TPIJFSCL--  AK EALK--EYDFVLVNVKG EAS DGNYELKKEVL 319 
S_solfataricus_Co/Mn 	GIDTNYNAFI--AKAAIELLK--ENDFVFLHIKA * SDGLVEEKVIAI 322 
Lmex i cans_Co 	 EAVDESLAKLKDAVDSVNGVY IVTA 'NSDDMAQRDKKGKPMKDGNGNV 490 
T_brucei_Co EAVDQSLQRLKEAVDSVNGVFL IT Cl IS DDMVQRDKKGKPVRDAEGNL 489 
Zea_mays_Mg? 	 KAADEAVKIILDAVEQVGGIYL"iA ILPEDMVKRNKSGFPLLDKNL)Ri 495 
7 R_communis_Mg? KAADEAVKNTIDAIEQVGGIYVV[ P. PIJAEDMVKRf'F'VP :LP 	492 
C_perfringens_Co/Mn 	EAVDE LGK DKVLEKEGTLFJ I!. IIIPEVMIDYP - -----------C 454 
E_coli_ipgarn_Mn 	 EALDH EM KAVESVGGQLL1TA CNAEQMRDP/C -----------G 457 
B_stearothermophilus_Mn EAVDE LGK DAILAKGGIAIITA SIJADEVLTPF -----------C 455 
B_subtilis_Mn 	 EAVDE LGE DAILAKGGHAIIIISIADILITEP- -------------455 
M_jannaschii_Mg EKIDEMLAY FEHINKDEVYFVLTC SIP------- ----------- - 349 
S_solfataricus_Co/Mn 	ERIDRVIGAIIDNIGRDNLILMFTG SI F'--------------------352 
L_mexicana_Co 	 LPLTS TLSPVPVFIGGAGLDPRVA5ffiTDLPGLANVTATF1NLLCFEA 540 
T_brucei_Co MPLTS TLAPVLFLSEALVLI PVCKCGQTFRVR-PCNVTATFINLMGFEA 538 
Zea_  mays _Mg? 	 QILTS TLQPVPVAIGCI -'ILHP/7KFRNDIQTPGLANVAATVMNLHGFEA 545 
R_communis_Mg? QILTS TLQPVPIAIGIPF;iIP1PFRSDIPTGGLANVAATVIJLHGFEA 542 
C_perfringens_Co/Mri 	KPET TSF/PVPFLWVSE ---- !,EGKSLK 	KL IA T 	MGLEV 500 
E_coli_ipgarn_Mn 	 QAI-ii'FIII-PVPLIYV':--  ---- -KNVKAVE KLS I T SLMGMEI 501 
B_sterothermophi1us_Mn KPCI' TTIIPVPVIVT- ------}YGIKLR 	ILG L T DLLGLPQ 498 
B_subtilis_Mn 	 EPHT TTIJPVPVIVT- -----'FGITLRE ILG LA TL DLLGVEK 498 
M_jannaschii_Mg IEPIKI SADPIPIVIWC-FI.l-iDVTEFNEFACAKGALHWIKCEHVMKI 398 
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1/YE j  I LIEAVDN 556 
./EMTGTCLNK-- 512 
EMTGYP FIVE- 514 
FEMTGPS IVK-- 510 
7 ENTGTS IQK-- 510 
IT FGFNEKFGA- 411 
LLIIYSIIRAEKYGS- 414 
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Figure 1.3.2. Multiple sequence alignment of representative iPGAMs as in Figure 
1.3.1. The residue numbers of each sequence are shown at the end of each line. 
Green and pink shadings indicate conserved residues that are involved in metal and 
substrate binding. Yellow and cyan shadings indicate conservative residues in the 
trypanosomatid and plant 1PGAMs, and the bacterial iPGAMs, respectively. 
Symbols: (*) under the sequences indicates a position that is conserved (the same 
in all sequences); 
(:) and (.) indicate positions at which all sequences contain residues of very similar 
physicochemical character (:), or somewhat similar physicochemical character (.). 
As mentioned previously, Lm and Th iPGAMs have high sequence identity with 
plant iPGAMs, but the metal requirement of the plant enzymes is unclear. A study of 
iPGAM from wheat germ reported that the protein denatured by guadinine could be 
reactivated by Mn2 or Co 2+  (Smith et al., 1986). However, the experimental protocol 
did not clearly describe whether trace metals had been removed from the reaction 
mixture. Subsequent experiments showed that these two metals did not affect 
reactivation of the protein after treatment by EDTA and furthermore, Co 
2+  was found 
to inhibit enolase in the activity assay (Johnson and Price, 1988). These authors 
concluded that Mn2 or CO2  at 2mM were unable to reactivate the protein. It is also 
relevant to mention that Mg 2+  may satisfy the metal requirement of iPGAMs from 
wheat germ (Smith et al., 1986), Zea mays (maize) (Graña et al., 1989; de la Ossa et 
al., 1994) and castor plant, Ricinus communis (Botha and Dennis, 1986; Huang et al., 
1995) because the enzymes were active where no other metals were added to the 
assay mixture. These enzymes are therefore not likely to require Mn 2 or CO2t 
The activity of iPGAM is normally measured by coupling its reaction to those 
catalysed by enolase, pyruvate kinase and lactate dehydrogenase in the presence of 
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ADP and NADH, together with Mg 2+  (for enolase and pyruvate kinase activity) and 
K (for pyruvate kinase activity). The production of 2PGA from the substrate 3PGA 
by iPGAM can thus be detected readily by monitoring NADH oxidation rate at 
340nm. Unfortunately there is no convenient method to quantify the iPGAM reaction 
directly, as neither the substrate nor product is readily detected. The metal 
requirements of the coupling enzymes must therefore be considered in the 
reactivation experiments. 
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1.4. Metal discrimination by metalloenzymes 
Transition metals in the first row such as zinc, manganese and cobalt are essential 
cofactors in metalloenzymes that catalyse hydration or hydrolysis reactions (Galpenn 
et al., 1998). The role of the metal ion in these enzymes is to stabilise a highly 
reactive hydroxide ion, thereby ensuring that an activated nucleophile is available for 
catalysis at physiological pH. The positive charge of the metal ion can also serve as 
an electrophilic catalyst and stabilise developing negative charge(s) in the transition 
state of the catalytic mechanism. In a study of human carbonic anhydrase II, a zinc 
metalloenzyme, and rat liver arginase, a manganese metalloenzyme, the following 
functional relationship between these two metalloenzymes and the chemistry of 
metal-activated hydroxide were observed: (a) the protein environment of metal-
bound hydroxide modulates its activity; (b) a H-bond with metal-bound hydroxide 
holds it in the proper orientation for catalysis; (c) non-metal substrate-binding sites 
amino acids are implicated in the enzyme mechanism; (d) regeneration of metal-
bound hydroxide ion from a metal-bound water molecule requires proton transfer to 
bulk solvent mediated by a histidine proton shuttle (Christianson and Cox, 1999). 
The ligand composition of a specific protein-metal binding site with high affinity and 
specificity requires discrimination which optimises selectivity for the combination of 
the size, charge and chemical nature of the target metal ion (Christianson, 1997). 
Discrimination of ionic radii of transition metals is obviously different from those of 
the biologically important alkaline earth ions such as Mg 
2+  or Ca2 (0.65 and 0.99A). 
In aqueous solution, ionic radii for I\4n2 CO2 and Zn2 are 0.80, 0.72 and 0.74A, 
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respectively. Among the most prevalent divalent metal ions in biology, Zn 2 and 
Mn2  exhibit different ionic radii and chemical natures. The Mn 2 is considered as a 
hard metal and tends to prefer predominantly hard ligands in its coordination sphere 
such as the negatively charged carboxylate oxygen atoms of aspartate or glutamate, 
the polar oxygen atoms of asparagines, glutamine and solvent (as H20, 110 or 02.). 
A hard metal is characterised by low polarisibility which has a relatively small radius 
and a large charge. The nitrogen atoms of histidine imidazole group, considered as 
ligand of borderline hardness, are occasionally observed as metal ligands in 
manganese metalloenzymes, whereas cysteine and methionine sulphur atoms are 
considered as soft ligands and therefore not preferred for metal coordination of 
manganese metaloenzymes and are rarely found. 
In manganese metalloenzymes, metal coordination geometry is usually square 
pyramidal or trigonal bipyramidal for coordination number = 5; octahedral geometry 
is also observed with coordination number = 6. The Zn2  ion is characterised as a 
metal ion of borderline hardness and tends to complex with soft ligands in its protein 
coordination geometry (Christianson, 1997). In Zn 2 coordination occurring in 
metalloenzymes, the metal geometry is usually tetrahedral or distorted tetrahedral 
with coordination number = 4, while can sometimes can be raised to coordination 
number = 5 to stabilise a high-energy intermediate. Thus the specificity of the 
protein-metal binding site for one particular metal is dictated by ligand geometry and 
ligand composition, and also metal geometry that may deviate from regular 
octahedral geometry with coordination number = 6. 
In 
Recently the architecture of metal coordination groups in proteins has been analysed 
(Harding, 2004) and (Ruth Lyons and Harding, unpublished data) to investigate 
binding of cobalt, manganese and zinc compared to the theoretical metal-ligand 
binding (Cambridge Structural Database) (Cole et al., 2001; Allen, 2002; Allen and 
Motherwell, 2002) and in various protein crystal structures (PDB) (Berman et al., 
2000). The survey indicated that binding site geometry and metal coordination are 
important for the protein folding and the protein catalysis. Cobalt, manganese and 
zinc prefer similar amino acid donors such as histidine, serine, threonine and cysteine 
(Donella-Deana et al., 2003). Total coordination numbers (tcn) of these three metals 
are slightly different. Zinc and manganese have distinct coordination group 
properties. Zinc appears to have a much higher preference for tcn = 4 and a very low 
preference for tcn = 6, whereas manganese has a much higher preference for tcn = 6 
and much lower preference for tcn = 4. On the other hand, cobalt seems to have a 
distinct characteristic; it appears to be more flexible with the tcn 4, 5 and 6. 
Metal-to-donor (water, carboxylate, imidazole, phosphate and serine) distance is also 
a characteristic of each metal bound in protein structures. The mean distances for 
cobalt and zinc are very similar (Table 6.1.1.), while manganese-to-donor distances 
appear to be approximately 0.2A longer than that of cobalt and zinc (Orpen et al., 
1992; Harding, 1999; Harding, 2000; Harding, 2001). Metal substitution in the 
metal-native enzyme may cause either an increase or decrease in the protein activity 
because of changes in binding geometry. Zinc substituted by cobalt in zinc-
dipeptidase thermolysin was found to increase activity, whereas substitution by 
manganese and cadmium in the same protein resulted in loss of activity (Holland et 
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al., 1995). Unlike thermolysin, replacement of zinc by cobalt in E. coli alkaline 
phosphatase resulted in a decrease protein activity to only 30%, and again 
substitution by manganese and cadmium caused the protein to lose most of its 
activity (Coleman et al., 1983; Wilcox, 1996). 
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1.5. Catalytic mechanism of cofactor independent phosphoglycerate 
mutase (iPGAM) and the related enzyme, alkaline phosphatase 
(AlkP) 
All iPGAMs have been characterized as members of the alkaline phosphatase (A1kP) 
superfamily as mentioned previously. The mutase catalytic mechanism is very 
similar to that of AlkPs, involving the hydrolysis of phosphate monoester. In the 
presence of high concentration of a phosphate acceptor such as ethanolamine or Tris, 
AlkPs enzyme transfer the phosphate from the substrate to alcohol (R 1 OH in Figure 
1.5.1.) (Kim and Wyckoff, 1991). 
H20 	 ____ 
E.P 1 -.. 	 E + P I 
RIOH 
E + R 1 OP 	E.R 1 OP 	E-P 
/X _ 
R20H E.R2OP 	E + R2OP 
Figure 1.5.1. Schematic reaction of alkaline phosphatases which catalyze hydrolase 
and phosphotransferase reactions with a phosphomonoester substrate to produce an 
alcohol and an inorganic phosphate. E-P refers to a covalent phosphoseryl enzyme 
and E.R20P or E.P 1 represents the non-covalent phosphoseryl complexes. 
The mechanism of iPGAM catalysis has been studied with wheat germ iPGAM. 
These studies show that iPGAM catalyses an intramolecular phosphate transfer 
21 
(Gatehouse and Knowles, 1977; Breathnach and Knowles, 1977) involving the 
transient formation of an enzyme phosphate and free D-glyceric acid molecule which 
remains bound to the enzyme until it is rephosphorylated (Britton et al., 1971). The 
reaction of iPGAM is thus related to that of alkaline phosphatases. During catalysis, 
iPGAM catalyses the interconversion of 3- and 2-PGAs, with the formation of the 
covalent phosphoenzyme occurring at an early step, and with the D-glycerate acid 
stabilized by H-bonds from residues in the active site, see Figure 1.5.5. 
Reorientation of this D-glycerate acid causes replacement of an older phosphoester 
oxygen position by the hydroxyl group on the opposite side, while the carboxylate 
group is' stabilized by the positive groups from arginine side chains. A new re-
oriented D-glyceric acid is an alcohol mimic and is used as a phosphate acceptor in 
the last step of the reaction. 
An X-ray structure of B. stearothermophilus iPGAM complexed with 3PGA and two 
Mn2  ions has been solved at 1.9A resolution (Chander et al., 1999; Jedrzejas et al., 
2000b), and also with 2PGA and two Mn2  ions at 1.7A (Jedrzejas et al., 2000a) and 
IAA resolution (Rigden et al., 2003). iPGAM from B. stearothermophilus requires 
only Mn2  for activity, and is also very sensitive to pH (Chander et al., 1998; 
Chander et al., 1999). The catalytic mechanism of this enzyme appears to involve a 
phosphoserine intermediate similar to E. coli AIkP, as shown in Figure 1.5.1. Crystal 
structures of B. stearothermophilus iPGAM complexed with substrate (3PGA) or 
product (2PGA) are mostly identical and show only a substrate or a product bound in 
the active site. There is no indication of .a. substrate and product mixture because the 
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thermophilic protein was not able to drive catalysis during crystallisation at room 
temperature (Rigden et al., 2003). 
The protein structure of Bs iPGAM complexed with 3PGA and two Mn 2 ions, 
consists of 511 residues (57 kDa) and its active form structure contains two Mn 2 
ions (Jedrzejas et al., 2000b) as shown in Figure 1.5.2. It is a monomer with two 
distinct domains of approximately equal size connected to each other by two flexible 
loops. The active site is found buried in the middle between the two domains, and 
contains one substrate molecule, one ordered water molecule and two Mn 2 ions 
surrounded by 15 residues from both domains. The catalytic domains are named by 
the occurring of phosphatase and phospotransferase activity in the active site. Two 
Mn2  ions and the phospho group from 3PGA or 2PGA are located near to Ser62 in 
the phosphatase domain (domain A), whereas the glycerate part is stabilized by 
positively charged residues from the transferase domain (domain B). Both domains 
have central 13-sheets surrounded by cc-helices. The active site including conserved 
residues for metal and substrate binding, one molecule of 3PGA and two Mn 2 ions 
is shown in Figure 1.5.3. 
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Figure 1.5.2. Crystal structure of Bs 1PGAM complexed with 3PGA at 1.90A. 
C12 
Figure 1.5.3. Stereoview of the active site of Bs iPGAM complexed with 3PGA 
shows conserved residues for metal and substrate binding together with one 3PGA 
molecule and two Mn 2 ions. The coordinates were taken from the PDB, 1 EJJ. 
24 
Phosptwtransterase 
Domain 	 IPGM 
R 185 
R 153 	 R264 
D 54 	 R191 ",I 151, H12 
Wat1/ 
3PGA 










Figure 1.5.4. Superposition of the active sites of B. stearothermophilus iPGAM 
(green) and E. co/i AIkP (red) shows alignment of two catalytic metals (Mn in iPGAM 
and Zn in E. co/i AIkP), the conserved residues, catalytic water and 3PGA of iPGAM 
(Jedrzejas and Setlow, 2001). 
Superposition of E. co/i AIkP and Bs iPGAM crystal structures shows conserved 
metal-binding residues with the catalytic metals located in the same positions, Ser62 
and Arg261 of Bs iPGAM correspond to Ser102 and Arg166 of E. CO/I A1kP, and 
other conserved residues are located mostly in the same conformation in the active 
site. Moreover positively charged residues are found to stabilize the glycerate part of 
Bs iPGAM as shown in Figure 1.5.4. 
Site-specific mutagenesis studies of conserved metal binding residues in the active 
site of Bs iPGAM such as Aspl2Asn. Ser62Ala, Arg26lLeu. His407Asn mutants 
exhibited non-detectable (or very low levels) of PGAM activity at any pH and 
manganese concentration tested. Mutants His66Asn. His l23Asn and His462Asn 
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showed some PGAM activity between 0.3 and 3% of the maximum activity, and 
His445Asn retained 20% of the maximum activity (Jedrzejas et al., 2000b). The 
catalytic mechanism of Bs iPGAM (Figure 1.5.5.) was proposed based on the 
substrate-bound and product-bound crystal structures and the site-directed 
mutagenesis studies (Jedrzejas et al., 2000a; Jedrzejas et al., 2000b; Rigden et al., 
2003), integrated with sequence and structure comparison with E. coli A1kP (Kim 
and Wyckoff, 1991; Murphy et al., 1997; Stec et al., 1998; Holtz et al., 1999). The 
isomerization from 3- to 2PGA involves phosphorylation of Ser62 by 3PGA 
(phosphatase activity) followed by the reorientation of the remaining glycerate of 
3PGA and the transfer of the phospho group to the hydroxyl group of the 
repositioned D-glyceric acid instead of the old phosphoester oxygen (transferase 
activity). The active site ordered water molecule hydrolyzes the interaction of the 
product with Mn2  ion in the first site (Mnl) and frees up the active site for the next 
round of catalysis. Both Mn2 ions play essential roles in the catalytic process by 
coordinating ligands from the substrate and active-site residues to form the 
catalytically protein competent with precise coordination geometry (Jedrzejas, 2000; 
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Figure 1.5.5. Poposed catalytic mechanism of B. stearothermophilus iPGAM 
(Jedrzejas et al., 2000b). 
A phosphoserine intermediate is a major part of catalysis of enzymes in the alkaline 
phosphatase superfamily. The replacement of His331 by G1n331 of E. coli A1kP 
resulted in loss of 50% activity. This mutant also allowed the trapping of the 
covalently bound Ser102-phosphate intermediate in the crystal structure solved at 
2.3A (see next section). Although a crystallographic visualization of a trapped 
phosphoserine intermediate of iPGAM is not yet available, the formation of a 
phosphoserine intermediate of iPGAM from T brucei has been identified by mass 
spectrometry (Collet et al., 2001). The authors also conclude from kinetic results that 
the mutase reaction is unlikely to proceed via a phosphoserine intermediate, which 
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they suggest could only be the product of side reaction as it is only detected in very 
low amount. They suggest that a metaphosphate intermediate (Breatimach and 
Knowles, 1977) is more likely. 
Alkaline phosphatases, with optimal activity at pH values higher than 7.5, have low 
substrate specificity for phosphate monoesters, and a requirement for Zn 2 , and are 
found in both eukaryotes and prokaryotes. The crystal structure of E. coli AlkP 
consists of a homodimeric protein with two Zn 2 and one Mg2 ions in each 47 kDa 
subunit. The mechanism of E. coli A1kP has been shown to be similar to that of 
mammalian A1kP (Kim and Wyckoff, 1991), and a schematic reaction is shown in 
Figure 1.5.1. It has been noted that the AIkP mechanism involves nucleophilic attack 
by Serl02 on the phosphate monoester and is consistent with the observed retention 
of phosphorus stereochemistry, which suggests consecutive nucleophilic attacks by 
Serl02 and solvent, each occurring with inversion at the phosphorus (Blattler and 
Knowles, 1980). The two Zn2 ions of alkaline phosphatase are required for 
phosphatase activity, and the Mg 2 ion plays an auxiliary role, enhancing the 
catalytic activity. Although it has been reported that Mg 
2+  was necessary for a 
mammalian AlkP in order to achieve maximum activity in the presence of Zn 2 ion 
(Galperin et al., 1998), the catalytic role of magnesium in AlkPs is not understood. 
Cobalt substituted AlkP retains -30% activity, while cadmium and manganese 
sustain only very low levels of enzyme activity. In the case of substitution of zinc by 
cadmium in E. coli A1kP, the structure showed that cadmium required a larger space 
in the active site to form metal-ligand coordination. This caused the protein to lose its 
activity (Kim and Wyckoff, 1991). There is no crystallographic evidence to show 
either cobalt or manganese bound structures. However, the phosphorylated enzyme 
intermediate (E-P) can be obtained with all three of these metal-substituted forms, 
and spectroscopic data indicate an interaction of these metal ions with bound 
phosphate (Coleman et al., 1983). 
A reaction mechanism of AlkP has been proposed in which AIkP catalyses both 
hydrolase and phosphotransferase activity with a phosphomonoester substrate as 
shown in Figure 1.5.6. (Holtz and Kantrowitz, 1999; Holtz et al., 1999: Stec et al.. 
2000). The reaction proceeds via a phosphoserine intermediate where E-P refers to a 
covalent phosphoseryl enzyme and E'R 2OP or E-P represents the non-covalent 
phosphoseryl complexes with substrate or product. 
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Figure 1.5.6. Proposed mechanism of two-metal ion catalysis in the hydrolysis of 
phosphate monoester by AIkP (Holtz et al., 1999). 
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The crystal structure of a homodimer of E. Co/i A1kP complexed with inorganic 
phosphate which is a strong competitive inhibitor as well as a product has been 
solved and refined at 2.OA resolution. In addition, crystal structures of an inactive 
form of Cd-substituted enzyme complexed with inorganic phosphate and also the 
phosphate-free native enzyme have been solved at 2.5 and at 2.8A resolutions (Kim 
and Wyckoff. 1991). These crystal structures reveal Ser102, a nucleophilic conserved 
residue, together with two Zn ions and one Mg 2' bound in the active site. The 
native enzyme crystal structure with Zn 2 ions showed a non-covalent (Ser'P 102) 
phosphoenzyrne, whereas the Cd-substituted enzyme is predominantly the covalent 
phosphoenzyme (Ser-P 102) which is an inactive form, which causes loss of activity 
of the enzyme as mentioned previously. Both Zn 2 ions appear to be bridged by 
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Figure 1.5.7. Stereoview of the active site of E. co//AIkP shows a nucleophile Seri 02 
together with one inorganic phosphate, two Zn 2 and one Mg2*  ions. This figure was 
re-drawn using the coordinates taken from the PDB, 1ALK. 
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Although replacement of zinc by cobalt or manganese in E. coli A1kP resulted in a 
decrease of protein activity as mention earlier, crystal structures of the protein 
substituted with these metals are not been yet available. 
Furthermore, Arg166 is convincingly involved in the catalytic reaction by using its 
guanidinium group to interact with two oxygen atoms of the phosphate to maintain 
the phosphate position during catalysis. The hydrolysis of E-P involves both 
formation and dissociation of the non-covalent enzyme-phosphate complex (E-P). 
The E-P E•P1 equilibrium of the reaction has been studied by NMR spectroscopy, 
and showed that the hydrolysis of the covalent E-P intermediate is rate-limiting 
under acid conditions, whereas the hydrolysis of the non-covalent E-P complex is 
rate-limiting under alkaline conditions. Dissociation is rate-limiting in a pH-
dependent manner between pH 6 and 9. Below pH 6, dephosphorylation becomes 
rate-limiting (Holtz and Kantrowitz, 1999). 
Trapping and visualization of the covalent phosphoenzyme intermediate in a crystal 
structure at 2.3A resolution has been done successfully by using a His331Gln mutant 
of E. coil A1kP (Murphy et al., 1997). His331 is one of five donor ligands for zinc at 
metal site one (Znl). The replacement of His331 by G1n331 resulted in a mutant 
enzyme that has 50% of the activity of the wild-type enzyme. G1n33 1 in the mutant 
A1kP was not coordinated to Znl, but instead, its side chain pointed away from Znl 
too far to coordinate as shown in Figure 1.5.8. The coordination of Zn2 was slightly 
different from the wild-type structure, although Ser102 is a ligand of Zn2 in both 
structures. In the wild-type structure, Ser102 is not close enough to phosphate to 
form a covalent bond, but in the His331Gln mutant structure Ser102 and the 
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phosphate show a strong interaction with a distance of 1.6A apart between Ser 102 
OG and the phosphorus atom. There is continuous density in 12F0-FI and IF,,-Fl 
electron density maps between the two atoms, which is very similar to that of the Cd-
substituted crystal structure of an inactive enzyme solved by Kim and Wyckoff (Kim 






Figure 1.5.8. Stereoview of (a) I2F0-FI electron density map at 1.4o level for the 
mutant His331Gln enzyme (coloured atoms) presents Ser102-phosphate, two Zn 2 , 
one Mg2 , and Gln331 pointing away from Znl. This structure was superposed on the 
wild-type enzyme including inorganic phosphate, Pi (magenta) of E. co/i AlkP. (b) IF0 -
FI electron density map at 3.5a level of the mutant His331Gln enzyme shows the 
existence of G1n331 and the Serl02-phosphate (Ser-P). A putative Arg166 and a 
water molecule was located away from the phosphorus atom with a distance 3.4A 
(Murphy et al., 1997). 
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Crystal structures of E. coli A1kP mutants Serl02Ala, Serl02Leu and Serl02Cys 
have been characterized, and a decrease of four orders of magnitude in their activity 
relative to that of the wild-type enzyme has been measured for Sen O2Ala and 
Serl02Leu. By contrast, Serl02Cys shows 50% activity remaining which indicates 
that the cysteine side chain takes over the role of nucleophile (Stec et al., 1998). As 
mentioned previously, Argi 66 which is pointing toward two oxygens of the phospho 
group may play a major role in binding during catalysis by involving electrostatic 
stabilization of the phosphate. Mutations of Argl66Gln, Arg166Ser and Arg166Ala 
result in a substrate binding decrease over 50 fold of the mutant enzymes measured 
under the same conditions. This result indicates that Arg166 is essential for substrate 
binding by using its guanidinium group to stabilize the transition state and to interact 
directly with the substrate or product in the reaction (Holtz and Kantrowitz, 1999; 
Stec et al., 2000). 
Furthermore, a five-coordinate geometry resembling the proposed transition state in 
the enzyme catalytic reaction has been revealed in the pentavalent vanadium-enzyme 
complex crystal structure (V0 4 3 - E. coli A1kP crystal structure at 1.9A resolution) 
(Holtz and Kantrowitz, 1999; Holtz et al., 1999). Oxyanion pentavalent vanadium 
(V043 ) is isostructural and isoelectric with phosphate and is a competitive inhibitor 
of alkaline phosphatase, because it mimics the transition state in the enzyme-
catalysed reaction. Vanadate can form stable five-coordinate interactions with 
Ser102, the nucleophilic residue, and shows a trigonal bipyramidal geometry in the 
active site. One oxygen from vanadate takes the place of an ordered water in the 
active site, occurs in a position between those of the covalent intermediate E-P and 
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the non-covalent E-P complexes as shown in Figure 1.5.9. It can thus serve as a 
transition state analogue for both the acquisition of phosphate and its release in the 
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Figure 1.5.9. Stereoview of vanadate bound in the active site of E. co//AIkP. The omit 
electron density map is drawn in stereo at a contour level of 30. The vanadate ion is 
bound to the nucleophilic serine residue (Ser-102-VO 4 ) in a position intermediate 
between those of the covalent E-P intermediate and the non-covalent EP, complex. 
The free axial oxygen atom of the vanadate ion is 2.4A from the Znl site. 
34 
1. 6. Cobalt in biology 
Cobalt occurs in nature in two oxidation forms with distinctly different properties, 
cobaltic (Co 3 ) and cobaltous (Co 2 ) ions, and both of these are relevant for the use 
of cobalt in enzymes (Maret and Vallee, 1993). The cobaltic ion (Co 3 ) is 
paramagnetic and forms octahedral complexes that are relative inert kinetically. 
These properties of cobalt enable to be used as a spectroscopic probe in other 
metalloenzymes when particular questions could not be answered by spectroscopy of 
the native metal atoms. For example, Co 3+  bound porphyrin complexes in the deoxy 
form, allow metal sites to be studied by electron paramagnetic resonance (EPR) 
spectroscopy which is generally not possible for proteins when iron is bound in the 
Fe 2+  state (Yonetani et al., 1974). In structural studies, the Co 3+-bound
deoxymyoglobin crystal structure has been revealed at 1 .65A and appears to be an 
intermediate stage between Fe 2 -dependent deoxy- and oxymyoglobins (Brucker et 
al., 1996). CO 3  has also been used to trap the intermediate form of the Fe 3 -
dependent cytochrome c crystal structure to study protein folding (Tezcan et al., 
2002). Furthermore, it has been used to (a) study the transition between cobalt 
binding A-DNA and B-DNA forms by nuclear magnetic resonance (NIMIR) 
spectroscopy (Vargason et al., 2001; Ramakrishnan et al., 2003), and (b) to study the 
metal binding site of RNA by crystallographic substitution of native metals by such 
as Fe 2+  (Kieft and Tinoco, 1997) and Mg 2  (Colmenarejo and Tinoco, 1999; Rudisser 
and Tinoco, I, 2000) by Co 3+  to understand RNA folding and its functionality. 
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On the other hand, the cobaltous (Co 2 ) ion is diamagnetic and occurs in either low-
spin (S =,3) or high spin (S =%) (Maret and Vallee, 1993). The high spin CO2 
can be substituted for spectroscopically silent zinc when zinc is the native, 
catalytically active metal atom of enzymes. The substitution of zinc by cobalt is very 
informative because the enzymes retain their activity (Gomis-Ruth et al., 1994; 
Holland et al., 1995; Bouckaert et al., 1996; Iverson et al., 2000), and is an essential 
technique to study the structural basis of catalytic properties in zinc enzymes and the 
coordination environment of structural zinc site in proteins. Electronic absorption 
spectra of tetrahedral and octahedral geometries of CO2 complexes are readily 
interpreted, but not for the pentacoordinate structure. According to the smaller ligand 
field stabilisation complex with tetrahedral symmetry, absorption maxima occur at 
longer wavelengths with higher extinction coefficients than those of octahedral 
complexes. Information of ligand-to-metal charge transfer, a band in the near-
ultraviolet, is an order of magnitude higher in intensity than those of the d-d ligand 
field transition. It is used to identify cysteine ligands of the protein specifically and 
detect sulfhydryl coordination of substrate or inhibitor molecules. The crystal 
structures of enzymes in which zinc has been substituted by cobalt have been solved 
successfully, such as (a) lectin concanavalin A from Canavalia ensformis (jack 
bean) at 2.7A (Bouckaert et al., 1996), (b) zinc endopeptidase astacin from crayfish 
at 1.8A (Gomis-Ruth et al., 1994), (c) carbonic anhydrase from Methanosarcina 
thermophila at 1.95A (Iverson et al., 2000), and (d) thermolysin at 1.9A (Holland et 
al., 1995). 
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A comparison of CO2 and Zn2  ions, shows that their ionic radii are 0.72A and 
0.74A, and atomic numbers are 27 and 30, respectively. Accordingly, Co 2+  has a 
higher charge density resulting in lower association constants of bound ligands 
(Fraásto da Silva and Williams, 2001). Crystal structure analyses of small molecule-
metal complexes show differences in the coordination chemistry of cobalt and zinc 
that are too small to be seen in large protein structures (Maret and Vallee, 1993). 
However, it has been observed that, metal-ligand bond lengths decrease with 
decreasing coordination number, with cobalt-ligand bonds being shorter than those of 
zinc (Bonander et al., 1997). 
Table 1.6.1. Distances (A) between metals and ligation donor atoms, collected from a 
primary search in the Cambridge Structural Database. This table was taken from the work of 
Bonander (1997). 
Sulfur Nitrogen Oxygen 
Metal mEn ave max n'dn ave max nlin ave max 
Cu 2.21 2.30 2.57 1.92 2.04 2.20 1.89 2.23 2.70 
Cu 2.26 2.28 2.62 1.93 2.02 2.26 1.91 2.21 2.64 
N12 2.36 2.42 2.49 2.01 2.06 2.11 2.05 2.10 2.16 
CO2 2.23 2.35 2.46 1.95 2.02 2.14 1.90 1.98 2.16 
Zn24 2.29 2.40 2.53 2.06 2.17 2.34 1.94 2.19 2.52 
Characteristics of cobalt in nature are more informative and more convenient for 
biochemists than those of zinc as described above, but not many cobalt enzymes 
have been well characterised. This is probably a consequence of the lower abundance 
of cobalt in biological systems (Fraüsto da Silva and Williams, 2001) about 2-3 
orders magnitude lower than that of zinc, and is consistent with a concentration of 
cobalt in human serum of lp.g/L compared with lOOp.g/L of zinc. However, cobalt is 
one of the transition metals that is required as a cofactor for catalytic activity in 
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various enzymes (Kobayashi and Shimizu, 1999). Phosphoglycerate mutase from L. 
mexicana (Guerra et al., 2004) and T. brucei (Chevalier et al., 2000; Collet et al., 
2001) require Co 2+  for their activity, and other examples of cobalt proteins are 
described below: 
The well-known corrin-ring involved in the synthesis vitamin B12 is found in 
plants (Rodionov et al., 2003). 
The first reported enzyme involving non-corrin cobalt is aldehyde 
decarbonylase (Dennis and Kolattukudy, 1992). It functions in biosynthesis of 
hydrocarbons with the loss of CO from fatty aldehydes in plants. 
Xylose isomerase catalyses the reversible isomerisation of D-glucose and D-
fructose. This enzyme is used in industrial processes to produce high fructose corn 
syrup, and is activated by CO2+'  Mg2+ 	 2+ and Mn , but not by Ni•2+  , Ca 2+'  Ba2+  , Zn2+  
Cu2 and Hg2 . A crystal structure of xylose isomerase from Streptomyces diastaticus 
has been solved at 1.85A and shows two Co 2+  ions in the active site. The first site 
with octahedral geometry formed by EEDD residues stabilises the protein, whereas 
the second site, also with octahedral geometry coordinated by EHDDD and one 
water molecule is required for activity (Zhu et al., 2000). 
Hydration of nitrile to amide by a tight cobalt-containing nitrile hydratase from 
Rhodococcus rhodochrous is also a commercial biocatalytic enzyme in the kilo-ton 
productions of acrylamide and nicotinamide in Japan (Hourai et al., 2003). R. 
rhodochrous has been shown to have a cobalt transporter gene (nhlF) whose product 
Nh1F is responsible for cobalt uptake into the cell. Nh1F has a HxxxxxDH motif 
which has one more histidine residue at the N-terminus than that in HoxN, a nickel 
transporter in Alcaligenes eutrophus (Komeda et al., 1997). 
Moreover, CoaT, a member of the mercury transcriptional regulator (MerR) 
family in bacteria (Solioz and Vulpe, 1996; Brown et al., 2003) and a variant CPx-
type ATPase transporter for large metal ion in cyanobacterium Synechocustis PCC 
6083 have also been reported (Cavet et al., 2003). The Mer-like domain is present at 
the N-terminus, whereas the precorrin isomerase domain is located at the C-terminus 
with a CHC motif whose direct mutagenesis results show its responsibility for cobalt 
binding (Rutherford et al., 1999). 
Methionine aminopeptidase (MetAP) is a well-characterised cobalt-containing 
enzyme with two sub-families, MetAP type I (prokaryote) and type II (eukaryote). 
The latter has an extension of about 60aa at the N-terminus, and both forms are 
activated by Co 2 , Mn2 and Zn2 (Arfin et al., 1995; Keeling and Doolittle, 1996). 
The first crystal structure of MetAP type I from E.coli (eMetAP I) has been solved 
at 2.3A (Roderick and Matthews, 1993) and showed two Co 2+  ions in the active site. 
Both Co 2+  ions were located in trigonal bipyramidal geometry with DDHEE 
coordination. It has been reported that Kd values for both sites are 0.21tM and 
2.5mM, respectively, and also that inhibition occurred with Co 2+  excess of more than 
50 molar equivalent (D'souza et al., 2000). This perhaps suggests that the two 
binding sites of the enzyme require two different metals rather than both sites 
requiring only cobalt. The specificity of inhibition of eMetAP I by Co 2 , Mn2 , Ni2 
and Zn2 in vitro have also been characterised (Li et al., 2003), whereas the metal 
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required in vivo for active enzyme still awaits identification. Furthermore, a crystal 
structure of a human MetAP II, an anti-cancer drug target, complexed with an early 
anti-cancer drug fumagillin has also been solved at 1.8A. This shows a covalent bond 
between the nitrogen atom of His23 1 and the carbon of the spirocyclic epoxide of 
fumagillin, whereas the oxygen from the breaking of the epoxide is coordinated with 
the second site cobalt (Liu et al., 1998). 
Evidence from all these systems has shown that cobalt is as biologically relevant as 
manganese and zinc (Galperin et al., 1998; Fraásto da Silva and Williams, 2001). 
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1. 7. Crystal structure-based drug design 
A combination of scientific methods is required to find drugs as indicated in Figure 
1.7.1. In the pharmaceutical industry, the discovery of candidate drugs has typically 
begun with initial lead compounds, possessing activity by binding to a particular 
receptor or enzyme. These compounds are usually not yet suitable for human use, 
and are then progressed through a process of optimisation familiar for many decades 
of medicinal chemistry. But before a new drug can be developed, drug targets must 
be identified such as a cell surface receptor, an enzyme or other binding protein. 
Bioinformatics, consisting of databases and algorithms, becomes a tool for 
identification of protein families, for prediction of protein 3D structure, for 
identification of functionally important residues and so on. X-ray crystallography and 
other experimental structure determination methods can be used to obtain protein 
structures and binding sites on protein targets and to reveal modes of drug binding. 
In protein crystallography, it is necessary first of all to produce sufficient pure 
protein for growing good crystals, and then collecting X-ray diffraction data to solve 
the structure. A substrate or any ligand bound complex structure can be used to 
reveal the active site or favourable target point of the protein. Virtual screening of 
libraries is the computer-based evaluation of chemical structure against a model of 
biochemical 3D structure. The screening can be performed by docking each 
compound from a library to the crystal structure of the enzyme. A receptor model (a 
protein active site) may be used to evaluate molecules such as by predicting receptor 
binding quantitatively or qualitatively. The fundamental of QSAR is to take a set of 
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molecules, for which a biological response has been measured, and using statistical 
methods relate this measured activity to some description of their structure such as 
logP, a relationship between water accessible and water inaccessible parts of each 
molecule. The precise location of the active site of the protein can have a major 
impact on the quality of dockings. One approach to this problem is to use a pre-
generated set of favourable interaction points within the active site using programs 
such as GRID field (Goodford, 1985) and then to try to fit small molecules into this 
by the use of a docking program such as DOCK (Ewing et al., 2001). The aim is to 
evaluate and score each molecule in different docking conformations and 
orientations. 
The virtual library is defined as a set of chemical structures that theoretically could 
be made from defined reactions and starting materials. Very large databases of 
chemical compounds (from nature and syntheses) in private and public collections 
are most useful for the successful search for lead compounds. For instance, a 
collection of 107 compounds in the Chemical Abstract Databases and around 10 4 
compounds in the World Drug Index are available. However, it is essential to have 
the 3D structure of the receptor template to enable the design of tight binding ligands 
(Green, 2002). Furthermore, it is not possible to make and test all compounds against 
any drug target. Therefore virtual screening and combinatorial libraries have been 
utilised to direct the synthesis of biologically relevant molecules. The resulting 
candidate compounds are tested by high throughput screening (HTS) to detect their 
binding affinity. Drug-like leads will typically have affinity greater than 0.1DM, 
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Figure 1.7.1. Schematic of structure-based drug design by molecular docking and 
high throughput screening (HTS) to identify potential drug-like compounds (diagram 
provided by Lindsay Tulloch). 
X-ray crystallography and virtual screening can be combined and used for a high 
throughput analysis of proteinlligand complexes. This approach requires automation 
or manual data collection and analysis of a series of isomorphous crystals which are 
less concerned with interpretation of crystallographic phase determination, and more 
with calculation and interpretation of difference Fouriers in order to position ligands 
in an original defined crystal structure. Careful selection of a chemical library for 
soaking experiments, then efficient collection of X-ray data and interpretation of 
difference electron density maps, can enable the bound ligand to be recognised and 
its position in the complex to be defined (Blundell et al., 2002). To combat diseases, 
this technique is very powerful for structure-based drug design and is widely used in 
the world (Liu et al., 1998; Wu et al., 2001; Luo et al., 2003). 
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1.8. Aims and summary ofproject 
The overall aims of this project were to express, purify, crystallise and solve the 
crystal structures of phosphoglycerate mutase from 1'. brucei and L. mexicana, with a 
view to understanding the catalytic mechanism of the enzyme. A high-resolution 
crystal structure will be used as a template to identify potential inhibitors for 
structure-based, combinatorial chemistry (in collaboration with Chemistry 
Department, Edinburgh University). Enzyme activity assays against potential 
inhibitors will be used to evaluate drug-like compounds. 
The experimental design was to use the recombinant plasmid pET28a-Th iPGAM 
carried by E. coli strain BL2 1 (DE3)pLysS (from Prof. Paul A.M. Michels, Université 
Catholique de Louvain, Brussels, Belgium) as an expression system. Th iPGAM with 
a His-tag at the N-terminus contains 570 amino acid residues and was expressed in E. 
coli in LB media supplemented by sorbitol and betaine. The His-tag protein was 
purified by TALON affinity followed by size exclusion chromatography with a yield 
of'-3-4mg protein per litre cell cultures. Removal of glycerol and unwanted salts was 
necessary, and the protein was kept in a storage buffer containing 0.3mM 3PGA for 
protein stabilization. Initial conditions for Th iPGAM crystallisation were screened, 
and macro seeding with a cat's whisker have been studied and recommended in this 
report. 
The recombinant plasmid pET28a-Lm iPGAM carried by E. coli strain BL21 
(pDLmPGAM)pZLm37 encodes iPGAM with a 6His-tag at the C-terminus, and was 
also from Prof. Paul A.M. Michels, Université Catholique de Louvain, Brussels, 
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Belgium. This bacterial expression system was expressed in E. coli cells, and gave a 
yield of 20 mg of highly purified iPGAM per litre cell culture after TALON affinity 
chromatography. Crystals of the protein complexed with either 3- or 2PGA were 
obtained by the hanging drop method of vapour diffusion with PEG 4000 as the 
precipitating agent in the presence of cobalt chloride, and were shown to diffract 
synchrotron radiation to beyond 1.90A. The fully refined structure was used as a 
template for docking and database mining. The resulting candidate compounds were 
tested against the enzyme for inhibition of activity at 5mM (final concentration of 
inhibitor). 
The specific metal requirements and catalytic mechanism of the Lm iPGAM were 
elucidated. Individual metal reactivation assays after EDTA treatment, were used to 
characterise the dissociation constants of the metals (Co 2 , Zn2 and Mn2 ) from the 
enzyme. Metal substitutions in the crystal structures of the cobalt-dependent enzyme 
were characterised. Comparison of the crystal structure of Lm iPGAM with the well-
characterised structures of Bs iPGAM and E. coli A1kP, showed that they are all 
members of the divalent metal-dependent alkaline phosphatase superfamily. This 
provided the opportunity to propose a catalytic mechanism of Lm iPGAM. 
All crystallographic data sets are available in the CD in the pocket inside the back 
cover of the thesis. 
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CHAPTER 2 
MATERIALS AND METHODS 
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2 MATERIALS AND METHODS 
2.1. Materials 
2.1.1. ThiPGAMplasmid 
The recombinant plasmid pET28a-Th iPGAM carried by E. coli strain 
BL21(DE3)pLysS was from Prof. Paul A.M. Michels (Université Catholique de 
Louvain, Brussels, Belgium). The Th iPGAM gene was cloned in pET28a by 
creating an NdeI site at the position of the start codon. As a result, the sequence with 
tag (and including the initiator methionine) is: 
>Tb iPGAN with 6His-tag at N-terminus 
MGSSHHHHHH SSGLVPRGSH MALTLAAHKT LPRRKLVLVV LDGVGIGPRD EYDAVHVAKT 
PLMDALFNDP KHFRSICAHG TAVGLPTDAD MGNSEVGHNA LCAGRWLQG ASLVDDALES 
GEIFTSEGYR YLHGAFSQPG RTLHLIGLLS DGGVHSRDNQ VYQILKHAGA NGAKRIRVHA 
LYDGRDVPDK TSFKFTDELE EVLAKLREGG CDARIASGGG RMFVTMDRYE ADWSIVERGW 
PAQVLGEGRA FKSAREALTK FREEDANISD QYYPPFVIAG DDGRPIGTIE DGDAVLCFNF 
RGDRVIEMSR AFEEEEFDKF NRVRLPKVRY AGMMRYDGDL GIPNNFLVPP PKLTRTSEEY 
LIGSGCNIFA LISETQKFGHV TYFWNGNRSG KLSEERETFC EIPSDRVQFN QKPLMKSKEI 
TDAAVDAIKS GKYDMIRINY PNGDMVCHTG DLKATITSLE AVDQSLQRLK EAVDSVNGVF 
LITADHGNSD DMVQRDKKGK PVRDAECNLM PLTSHTLAPV LFLSEALVLI PVCKCCQTFR 
VRPCNVTATF INLMGFEAPS DYEPSLIEVA 
Tb iPGAM with the His-tag at the N-terminus contains 570 amino acid residues, with 
the calculated Mr 62,852 (including the initiator methionine) and theoretical p1 5.98 
(www.expasy.ch, 2002). The untagged Th iPGAM contains 550 amino acid residues. 
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2.1.2. Lm iPGAMplasmid 
The recombinant plasmid pET28a-Lm iPGAM (Guerra et al., 2004) carried by E. coli 
strain BL21 (pDLmPGAM)pZLm37 encodes iPGAM with a 6His-tag at the C-
terminus was from Prof. Paul A.M. Michels (Université Catholique de Louvain, 
Brussels, Belgium). The expressed Lm iPGAM contains 561 amino acid residues, 
with a calculated Mr 61,623 (excluding the initiator methionine and including the 
His-tag LEHHHHHH) and theoretical p1 5.26 (www.expasy.ch, 2002). The untagged 
Lm iPGAM contains 553 amino acid residues. 
>Lm 1PGAM with GHis-tag at C-terminus 
MSALLLKPHK DLPRRTVLIV VMDGLGIGPE DDYDAVHMAS TPFMDAHRPD NRHFRCVRAH 
GTAVGLPTDA DMGNSEVGHN ALGAGRVALQ GASLVDDAIK SGEIYTGEGY RYLHGAFSKE 
GSTLHLIGLL SDGGVHSRDN QIYSIIEHAV KDGAKRIRVH ALYDGPDVPD GSSFRFTDEL 
EAVLAKVRQN GCDAAIASGG GRMFVTMDRY DADWS IVERG WRAQVLGDAR HFHSAKEAIT 
TFREEDPKVT DQYYPPFIVV DEQDKPLGTI EDGDAVLCVN FRGDRVIEMT RAFEDEDFNK 
FDRVRVPKVR YAGMMRYDGD LGIPMNFLVP PPKLTRVSEE YLCGSGLNIF ACSETQKFGH 
VTYFWNGNRS GKIDEKHETF KEVPSDRVQF NEKPRMQSAA ITEAAIEALK SGMYNVVRIN 
FPNGDMVGHT GDLKATITGV EAVDESLAKL KDAVDSVNGV YIVTADHGNS DDMAQRDKKG 
KPMKDGNGNV LPLTSHTLSP VPVFIGGAGL DPRVAMRTDL PAAGLMWTA TFINLLGFEA 
PEDYEPSLIY VEKLEHHHHH H 
2.1.3. 	Growth media 
Sorbitol, betaine, NaCl, CoC12, kanamycin, chioramphenicol, lysozyme and 
protamine sulphate were from Sigma Chemicals; yeast extract and tryptone peptone 
were from Oxoid; IPTG, Agar no.1 and protease inhibitor mixture (Complete Tm  
mini, EDTA-free) were from Melford Labs, Difco Labs, and Roche respectively. 
2.1.4. SDS-PAGE 
Tris-HC1, ammonium persuiphate (APS), glycerol, bromophenol blue, and TEMED 
were from Sigma Chemicals; sodium dodecyl sulphate (SDS) and glycine were from 
BDH Biochemical; acrylamide/Bis acrylamide 30% stock solution was from Severn 
Biotech; and low molecular weight (LMW) markers was from Amersham Phamacia 
Biotech. 
	
2.1.5. 	Enzyme assays 
Triethanolamine (TEA), glycerol, KC1, NaOH, imidazole, MES, enolase, and 
pyruvate kinase were from Sigma Chemicals; NADH, LDH and 3PGA were from 
Roche; and sodium (meta) vanadate was from Fluka Chemicals. 
2.1.6. 	Protein purification, concentration and crystallisation 
PD-10 pre-packed columns and Sephacryl S-200 HR HiPrep 16/60 column were 
from Amersham Phamacia Biotech; TALON metal affinity resin was from Clontech; 
the column and a peristaltic pump system (Minipuls 2, Anachem) were connected to 
a 280nm UV detection system (ISCO) and a fraction collector (Pharmacia LKB 
RediFrac). Vivaspin concentrator tubes with PES 30,000 MWCO membrane were 
from Vivascience. 
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2.1.7. 	Protein crystallisation and data collection 
24-well Linbro plates were from Molecular Dimension Limited: fibre-cryo loops 
were from Hampton Research and the Structure Screen I kit was from Molecular 
Dimension, Oxford. PEG 4000, ammonium sulphate, ammonium acetate, tn-sodium 




2.2.1. Optimisation of Th iPGAM expression 
The optimum conditions for expression of Th iPGAM in E. coli were obtained by 
varying conditions such as different culture media, induction temperatures and times, 
isopropyl thio--D-galactoside (IPTG), CoC1 2 and betaine concentrations. The 
methods to analyse for Th iPGAM were both SDS-PAGE and activity assay. The 
results are shown in Chapter 3, Section 3.1. 
The recombinant plasmid pET28a-Tb PGAM was carried by E. coli strain 
BL21(DE3)pLysS, and has the T7 RNA polymerase gene under the control of the 
lacUV5 promoter for inducible expression by TPTG. Cells harbouring the 
recombinant plasmid were grown at 37°C in lOOml Luria-Bertani (LB) medium 
supplemented with and without 1M sorbitol, and with and without 1mM betaine 
(Blackwell and Horgan, 1991; Barth et al., 2000), various CoC1 2 concentrations, 
30p.g/ml kanamycin, and 34pgIml chioramphenicol. Various concentrations of IPTG 
were added when the cell culture reached an OD600 nm of approximately 0.6, and cells 
were grown at various temperatures and times. Cell pellets were collected by 
centrifugation, stored overnight at -20°C, and resuspended in lOml 100mM 
triethanolamine/HC1 (TEA) buffer pH 7.4 containing 10% glycerol and a tablet of 
protease inhibitor mixture. 20mg lysozyme was added to the cell extract for bacterial 
cell wall cleavage, incubated at room temperature for 10mm, and then sonicated by 
seven bursts of 30sec in an ice bath with 30sec rests in between. 
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After sonication, the lysate solution was centrifuged at 11 ,000xg, 4°C for 30mm, and 
the soluble cell fraction was collected. PGAM activities were measured by coupling 
the reaction to lactate dehydrogenase via enolase and pyruvate kinase, and following 
the decrease of NADH absorbance at 340nm (White, 1989; Chevalier et al., 2000; 
Collet et al., 2001). Protein concentration was estimated by Bradford assay. 12% 
SDS-PAGE was performed according to Laemmli with a BioRad mini gel system 
(Garfin, 1990). The relative expression of Th iPGAM and E. coli iPGAM (Fraser et 
al., 1999) to E. coli dPGAM was observed by using vanadate as a dPGAM inhibitor 
(Fraser et al., 1999; Chevalier et al., 2000; Guerra et al., 2004). Activity assays in the 
presence or absence of vanadate were done to measure the activity of iPGAMs from 
T. brucei and E. coli, and the total activity of both iPGAMs and dPGAM from T 
brucei. A higher relative ratio of the total activity of iPGAMs and the total activity of 
both iPGAMs and dPGAM from T brucei was representative of a larger amount of 
iPGAMs in each batch. The results are shown in Chapter 3, Section 3.1. 
2.2.2. 'Expression and purification of Th iPGAM 
To obtain about 10mg purified Th iPGAM, four litres of cell culture were grown. 
Frozen pellets from these cell cultures were defrosted and completely resuspended in 
20m1 lysis buffer of 100mM TEA buffer pH 8.0, containing 10% glycerol, 400mM 
KC1, and 2 tablets of protease inhibitor mixture. Lysozyme (40mg) was added to the 
cell extract, incubated at room temperature for 1 0mm, and then sonicated by seven 
bursts of 30sec in an ice bath with 30sec rests in between. After sonication, the lysate 
solution was centrifuged at 1 1,000xg, 4°C for 30mm, and the soluble cell fraction 
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was collected. Protamine sulphate 200mg was added to the soluble cell fraction for 
DNA precipitation, mixed gently on a circular rotor at 4°C for 30mm, and 
centrifuged at 1 1,000xg again at 4°C for 30mm. The soluble cell fraction was 
collected and filtered through a 0.45 p.m membrane. 
A 2m1 TALON resin in the column was prepared following the supplier's 
recommendation (lml resin per 5mg His-tagged protein), and the column and 
peristaltic pump system were connected to an 280nm UV detection system (ISCO) 
and a fraction collector (Pharmacia LKB RediFrac). The metal-affinity TALON 
column was used with 100mM imidazole in 100mM TEA buffer pH 8.0 containing 
10% glycerol and 400mM KC1 as eluent solution. The column was washed 
extensively with the same buffer lacking imidazole prior to elution. Weakly bound 
proteins were removed from the resin by using 10mM imidazole in the above buffer. 
Th iPGAM was prepared for crystallisation trials by removal of glycerol and 
imidazole salts by a PD-10 pre-packed size-exclusion column that was initially 
eluted in 20mM TEA buffer pH 7.4. However, most of the protein precipitated in this 
solution, and concentrations of NaCl and KC1 between 10 and 200mM were tested to 
stabilise protein. NaCl at 150miM in 20mM TEA buffer pH 7.4 was found to be 
suitable to prevent the precipitation of the protein, but the protein lost its activity in 
several days. The substrate 3-phosphoglycerate (3PGA) was then tested for its ability 
to stabilise the protein. A combination of 150mM NaCl and 0.3mM 3PGA in 20mM 
TEA buffer pH 7.4 was the best condition to maintain the protein activity. Thus the 
Th iPGAM fraction from TALON affinity chromatography was prepared for 
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crystallisation trials by removal of glycerol and imidazole salts by a PD-10 pre-
packed size exclusion column that was eluted in 20mM TEA buffer pH 7.4 
containing 150mM NaCl and 0.3mM 3PGA. This was followed by Sephacryl S-200 
HR size exclusion chromatography with the same buffer as eluent. The results are 
shown in Chapter 3, Section 3.1. 
Purified protein was concentrated and buffer exchanged to 20mM TEA buffer pH 7.4 
containing 50mM NaCl and 0.3mM 3PGA by a Vivaspin, 20ml concentrator tube 
with PES 30,000 MWCO membrane. The tube was centrifuged at 4,200xg at 4°C 
until the purified protein reached the desired volume and concentration. 
2.2.3. Th iPGAM characterisation by mass spectrometry and dynamic light 
scattering 
50.tl of protein (3mg/ml) was examined by Matrix Assisted Laser 
Desorption/Ionization - Time of Flight mass spectrometry (MALDI-TOF) with 
horseradish peroxidase HRP internal standard calibration, using a Voyager DE-STR 
(ABI) instrument. This analysis was done by Hannah Florence, EPIC group of the 
University of Edinburgh. 1 00tl Th iPGAM protein solution (1 mg/ml) in 20mM TEA 
buffer pH 7.4 containing 50mM NaCl and 0.3mM 3PGA was also investigated for 
molecular homogeneity by dynamic light scattering (Amare and Burley, 1997), using 
a DynaPro-801 instrument and DYNAMICS software. The result is shown in 
Chapter 3, Section 3.1. 
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2.2.4. Expression and purification of Lm iPGAM 
The expression system of Lm iPGAM was constructed by Daniel Guerra (Université 
Catholique de Louvain, Brussels, Belgium) and the optimisation of the Lm iPGAM 
expression and purification was done again by Daniel Guerra during a 2-month work 
visit to the University of Edinburgh supported by a travel grant from the COST B9 
Action of the European Commission. Details for optimum expression were as 
follows: Cells harbouring the recombinant plasmid were grown at 37°C in Luria-
Bertani (LB) medium containing 301igIml kanamycin, and expression was induced 
by the addition of IPTG (1 niM per litre cell culture) when the cell culture reached an 
0D600 of approximately 0.6. Cell growth was continued at 17°C for 20h. Cell pellets 
were collected by centrifugation at 4,200xg for 30mm, and then stored at -20°C. 
Buffers used in the protein purification from Daniel Guerra's work were modified 
later by the addition of lOp.M CoC1 2 . As the protein shares 74% sequence identity 
with Th iPGAM, the protein was presumed to require cobalt (Collet et al., 2001), and 
reactivation of the purified protein from the TALON affinity chromatography was 
then measured at various concentrations of cobalt. It was found that 1 0M gave 
about 50% of the maximum activity. To keep concentration of salts in the protein 
solution for crystallisation as low as possible, 10tM CoC1 2 was subsequently 
included in all buffers to stabilise the protein. (A dissociation constant of cobalt from 
Lm iPGAM of Kd 9.1±2.2p.M was identified later on by the reactivation of metal-free 
protein experiment; more details are discussed in Chapter 6, Section 6.4.) 
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Frozen pellets from 1 1 cell cultures were defrosted and completely resuspended in 
20m1 lysis buffer of 100mM tnethanolamine-HC1 (TEA) buffer pH 8.0, containing 
10% glycerol, 500mM NaCl, 10p.M CoC12, and 2 tablets of 'Complete, Mini, EDTA-
free' (Roche) protease inhibitor mixture. As discussed above, cobalt at 1 0j.tM was 
included throughout the purification and crystallisation because it is essential for 
optimal activity and stability. Lysozyme (Sigma) 40mg for bacterial cell wall 
cleavage was added to the cell culture that was incubated at room temperature for 
10mm, sonicated and centrifuged at 1 1,000xg for 30min at 4°C. Protamine sulphate 
(Sigma) 200mg was added to the soluble fraction that was then mixed gently on a 
circular rotor at 4°C for 30mm, and centrifuged the same as before. The supernatant 
was collected and filtered through a 0.45 p.m membrane. 
A metal-affinity TALON (Clontech) column (prepared the same as for Th iPGAM 
purification) was used with 50mM imidazole in 100mM TEA buffer pH 8.0 
containing 10% glycerol, 500mM NaCl and lOjiM CoC12 as eluting solution. The 
column was washed extensively with the same buffer lacking imidazole prior to 
elution, and weakly bound proteins were removed from the resin by using 10mM 
imidazole in the above buffer. Lm iPGAM was prepared for crystallisation trials by 
removal of glycerol and imidazole salts using a PD-10 pre-packed size exclusion 
column (Amersham Pharmacia Biotech) that was eluted by 20mM TEA buffer pH 
7.4 containing 50mM NaCl and 10pM CoC12. The sample was, then concentrated 
with a Vivaspin 20m1 centrifugal concentrator tube (Vivasciences) with a molecular 
weight cutoff of 30,000. 
56 
During protein production and purification, protein characterisation was monitored 
by SDS-PAGE. The protein molecular mass was confirmed by mass spectrometry. 
Bradford assays were used to identify protein concentration, and specific activity Of 
the protein was carried out by activity assays. The results are shown in Chapter 4, 
Section 4.1. 
2.2.5. 	Bradford: Standard curve and sample determination protocol 
Pipette 0-75p1 of 2mg/mi BSA standard solution or unknown sample into a cuvette, 
add deionised water to make up the total volume to 0.1 Oml. Add 1 .4m1 of the 
Coomassie Plus Protein Asay Reagent to the cuvette and mix well using a small 
piece of Parafilm to cover the cuvette and shake slowly. Set the spectrophotometer to 
595nm and zero the instrument with deionised water. Use 0. lml deionised water with 
1 .4m1 the Coomassie Plus reagent as blank. Subtract the absorbance of the blank 
from the readings of all samples tested. Plot a calibration curve of absorbance against 
BSA concentration. Calculate the protein concentration in each sample from the 
standard curve. This experiment was done at room temperature. 
2.2.6. Enzyme assays 
The activity of Th iPGAM or Lm iPGAM was measured at room temperature in a 1 
ml reaction mixture containing 1mM MgSO4, 20mM KCI, 1mM ADP, 0.4mM 
NADH, 0.1mM CoC12 , 1.5mM 3PGA, and auxiliary enzymes: 2 units (lunit = 1mol 
substrate converted per mm) of enolase (ENO), 4 units of pyruvate kinase (PYK), 
and 6 units of lactate dehydrogenase (LDH) in 0.1M triethanolamine (TEA) /HC1 
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(pH 7.4), by following decreasing absorbance of NADH (molar extinction coefficient 
6,250M 1 .cm') at 340nm. Because CO2 ion inhibits enolase in the coupled activity 
assays (Johnson and Price, 1988), twenty time excess units of enolase to that of the 
Lm iPGAM were used to maintain the coupling enzyme activity. Increased numbers 
of units of the other coupling enzymes were also included. The protein and mixture 
were added into a mini cuvette and incubated for ten min at room temperature. The 
reaction was started by the addition of 3PGA with a final concentration 1.5mM. 
Mixing was carried out by inverting the cuvette covered by Parafilm. The reaction 
was then monitored for 2min at 340nm in a Perkin Elmer UV/VIS Spectrometer 
Lambda. Each assay was carried out in triplicate at ambient room temperature and 
the slope of NADH oxidation (Aabsorbance/min) was analysed by the UVwinlab 
software and recorded as initial rate. 
2.2.7. Assays for metal reactivation of Lm iPGAM 
EDTA-treated protein was prepared by incubation of the protein with EDTA (mole 
ratio of Lm iPGAM:EDTA = 1:1,000) in 20mM TEA buffer pH 8.0 containing 
50mM NaCl for 12hr at 4°C followed by removal of metal-EDTA complexes and 
unwanted salts using a PD-10 gel filtration column (Amersham). The protein was 
stored in 20mM TEA buffer pH 7.4 containing 50mM NaCl. Trace metals in the 
protein solution were analysed by ICP-AES (induced-coupled plasma atomic 
emission spectrometry) and showed no detectable cobalt. The detection limit of this 
technique for cobalt is 0.Olppb (1 part per billion = 16nM cobalt). The ICP-AES 
analysis was done by Yanbo Shi, Chemistry Department, Edinburgh University. 
CoC12, MnC12, ZnC12 and NiC12 from Sigma Chemicals were dissolved in 20mM 
TEA buffer pH 7.4 containing 50mM NaCl and used for the metal reactivation of Lm 
iPGAM. Metal reactivation of the metal-free protein was measured at room 
temperature by using the same assay mixture as mentioned previously, but excluding 
0.1mM CoC12 . Individual metals were added at concentrations 0 to 4001iM into the 
solution of the metal-free protein and the assay mixture, .and incubated for (at least) 
fifteen minutes. The reaction was then started by the addition of 3PGA. No 
detectable activity of the protein was observed from the assays lacking additional 
metal in the assay solution (the assay solution always contains 1mM MgCl2)- 
Saturated curves were obtained from plots of the protein activity against individual 
metal concentration. Dissociation constants (Kd) of metal from Lm iPGAM were. 
calculated in the program SigmaPlot. 
2.2.8. 	Inhibitor solutions 
For activity assays, 50mM solutions of inhibitors were prepared in 0. 1M TEA buffer, 
pH 7.5±0.5. Compounds which were insoluble in this buffer were dissolved in 50% 
DMSO:50% buffer, giving the final lml reaction mixture a composition of 5% 
DMSO. The pH of all inhibitor solutions was adjusted to 7.5±0.5. For fluorescence 
experiments, 30mM inhibitor solutions were made up in 20mM TEA buffer, pH 7.4, 
containing lOp.M CoC12 and 50mM NaCl. pH was adjusted to 7.5±0.5. 
2.2.9. Preparation of 2PGA 
As 2PGA is no longer commercially available, it was prepared by incubating Lm 
iPGAM in 60mM 3PGA for 3h at room temperature. The equilibrated mixture was 
assumed to contain a mixture of 30mM 3PGA and 30mM 2PGA because the protein 
is able to catalyse reversibly. The solution was then boiled for 20mm, and 
centrifuged at 4,200xg for 20min at room temperature. The supernatant was stored as 
30mM 2PGA at 4°C. A separate equilibrium preparation control was centrifuged in a 
Vivaspin MWCO 10k tube, spun at 4,200xg, 20°C, for 50mm. The filtrate was stored 
as 30mM 2PGA at 4°C. 
2.2.10. Solvent effect testing on Lm iPGAM 
The effects of methanol, ethanol, DMSO and diethyl ether on all of the enzymes 
were evaluated using the pre-mentioned activity assays, substituting buffer for 
organic solvent to give final compositions of 5% and 10% in the reaction mix. Only 
DMSO gave non-specific inhibition on Lm iPGAM activity. 
2.2.11. IC50 Determination 
The standard assay was employed with increasing concentrations of ligand dissolved 
in 0.1M TEA pH7.5, or 50% DMSO pH 7.5. The concentration range used was 0.01, 
0.1, 0.3, 0.55, 1.0, 1.8, 3.2, 5.0, 7.5, 10.0, 15.0 and 20mM. SigmaPlot software was 
used to investigate IC 50 defined as the concentration of ligand to give 50% remaining 
activity of the protein. 
2.2.12. Fluorometric titration and absorption measurement 
Fluorometric titration and absorption spectrometry were done using FluoroMAX-3 
and DataMAX software (Jobin YVON Horiba) together with an Automated 
Fluorescence Data Processing (AFDP) (Hofmann and Wiodawer, 2002), and Perkin 
Elmer UV/VIS Spectrometer Lambda and UVwinlab software, respectively. Lm 
iPGAM protein concentration of 3MM, individual ligand concentration 0-2.0mM and 
20mM TEA buffer pH 7.4 containing 50mM NaCl and 10iM CoC12 were used for 
protein-ligand binding analysis. 
Potential ligands identified by activity assays were further studied using fluorescence 
at 25°C and 4°C. The excitation wavelength was set to 295rim. 20mM TEA buffer 
pH 7.5 containing 50mM NaCl and 109M CoC12 was used as a blank, while the 
protein used was at a concentration of 0.2mg/mi. The starting solution was incubated 
in the chamber for 10min prior to data collection. Upon ligand addition by syringe, a 
further 3min incubation was allowed before a 300-500nm scan was initiated. 
Titrations were carried out at 4°C and 25°C for each ligand. Each measurement was 
taken in triplicate and averaged. The spectral data were processed using an 
Automated Fluorescence Data Processing (AFDP) (Hoflnann and Wiodawer, 2002) 
program with data range 304-360nm and wavelength cutoff 305nm to give peak area 
values. 
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2.2.13. Protein crystallisation 
Varying concentrations of ammonium sulphate and PEG4000 in buffer solutions at 
different pH values in the range 4-9, and also the Structure Screen I kit from 
Molecular Dimensions were used for crystallisation screening to obtain crystals of 
both Th iPGAM and Lm iPGAM in 24-well Linbro plates by vapour diffusion using 
the hanging drop method (Ducruix and Giege, 1992) at 17°C. To obtain crystals of 
Lm iPGAM complexed with 3- or 2PGA, crystallisation drops contained equal 
volumes (1.5j.ii) of reservoir and enzyme solutions of (a) 5mg/ml Lm iPGAM, 
1.5mM 3PGA or 2PGA in 20mM TEA buffer pH 7.4 containing 50mM NaCl and 
10tM CoC12, or (b) 5mg/mi of Th iPGAM was stored in 20mM TEA buffer pH 7.4 
containing 50mM NaCl and 0.3mM 3PGA. 
2.2.14. X-ray data collection and data processing 
X-ray data collections were done using a CuK a rotating anode source mounted on a 
Nonius FR591 generator operating at 40kV and 1 lOmA connected to a MAR345 
area detector. Analysis of diffraction data sets was done by using the autoindexing 
procedure of Denzo and Scalepack of the HKL package (Otwinowski and Minor, 
1997). Crystal structures at higher resolution of Lm iPGAM-3PGA-Co and Lm 
iPGAM-2PGA-Co were obtained from data collections at the Daresbury SRS (station 
9.6, X = 0.870A and 14.2, 2 = 0.979A) with an ACD Q4 CCD. Each data set was 
processed with MOSFLM (Leslie, 1992) and scaled by the program Scala in the 
CCP4 program suite (Collaborative Computational Project Number 4, 1994). 
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2.2.15. Structure determination and structural analysis 
The molecular replacement (MOLREP) (Vagin and Teplyakov, 1997) was used to 
obtain the initial phases of the Lm iPGAM-3PGA-Co crystal structure using a 
published crystal structure of Bs iPGAM as a model. The automated building 
ARP/wARP (Lamzin and Wilson, 1993; Lamzin and Wilson, 1997) program was 
used for side chain tracing. The uncompleted model was inspected and built by the 
visual program 0 (Jones et al., 1991) and refined by Refmac5 of the CCP4 program 
suite. Superpositions of all mentioned crystal structures were done using the TOPP 
(Topology) program of the CCP4 program suite, and all crystal structure 
representations were drawn by BobScript, MolScript (Kraulis, 1991) and Raster3D 
(Merritt and Bacon, 1997). 
2.2.16. X-ray fluorescence and anomalous dispersion experiments 
Crystals of PGAM-3PGA-Co-Mn (10iM CoC1 2 and 6mM MnC12) and PGAM-
3PGA-Co-Zn (lOjtM CoC1 2 and 2mM ZnCl2) were obtained by the hanging drop 
technique as described previously with the addition of either Mn or Zn in the 
crystallising solution. These crystals were analysed by X-ray fluorescence and 
anomalous dispersion techniques to determine the possibility of substitution of J4 2 
Zn2 or Ni2 in the CO2 positions. High-energy X-ray available at beamline 1D29 
ESRF, Grenoble, France provided the opportunity to measure X-ray emission (The 
Rigaku Journal, 2001) from metals present in crystal samples which was done prior 
to data collection at each metal absorption edge. No attempt was made to wash 
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unbound metal ions from crystals prior to data collection. A blank spectrum was 
done by XRF of a crystallising solution instead of crystal sample. 
Prior to anomalous diffraction data collection, each crystal was scanned for an X-ray 
signal in order to determine the optimum energy/wavelength for measuring the 
diffraction data. At this energy the anomalous intensity differences will be the largest 
possible. X-ray diffraction data for each crystal was collected at the chosen 
wavelength for each metal at ESRF, station 1D29 with ADSC Q210 2D detector. 
Data sets were processed and scaled preserving the anomalous signal by MOSFLM 
and the CCP4 program suite (Collaborative Computational Project Number 4, 1994). 
All crystals belong to the same unit cell and unit cell dimensions as shown in Chapter 
6, Table 6.10.1. A single MTZ reflection file of the well-defined crystal structure of 
Lm iPGAM-3PGA solved at 1.90A resolution containing phase information was 
merged to an individual MTZ reflection file of each data set using the CAD program 
of the CCP4 program suite for the production of the file containing anomalous 
differences and phases of the solved crystal structure. An anomalous map of each 
data set was then calculated individually by the FFT program. Only anomalous 
differences of each data set collected at the relevant metal absorption edge provided 
the signal of metal occupied in the crystal structure. 
2.2.17. Docking, database mining and similarity searching 
The crystal structure of Lm iPGAM solved at 1.90A was used as a template for 
docking using DOCK 3.5. The protein active site was located in a 12.5A sphere 
using INSIGHT and the docking area chosen was filled with sphere clusters using 
SPHGEN. The enzyme was then prepared for scoring grids in SyByL and the 
docking programme could now be used to assess possible binding sites for molecules 
on the enzyme's chosen surfaces. DOCK 3.5 uses the Available Chemicals Database 
(ACD) containing approximately 250,000 compounds to carry out this mining 
process (Allen, 2002). 
In order to screen the results from the docking for similar compounds of 65% 
similarity to 3PGA based compounds, ISIS Base was utilised. These compounds 
were redrawn into ISIS Draw and assessed against other molecules by shape and 




CHARACTERISATION AND CRYSTALLISATION OF 
Trypanosoma brucei iPGAM 
3. EXPRESSION, PURIFICATION, CHARA CTERISA TION AND 
CRYSTALLISA TION OF Trypanosoma brucei iPGAM 
3.1. Optimisation of Tb iPGAM expression 
To optimise the protein expression system, E. coli cells harbouring the recombinant 
plasmid -Tb PGAM were grown in the presence or absence of 1.0mM betaine and/or 
IM sorbitol. Betaine has been proposed to stabilise protein folding within cells, and 
the sorbitol is present to help the betaine enter the E. coli cells (Blackwell and 
Horgan, 1991; Barth et al., 2000). Figure 3.1.1. shows that a combination of 
sorbitol/betaine (S/B) in LB media yielded a high fraction of Th iPGAM. 
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Figure 3.1.1. 	Comparison of total PGAM and iPGAM produced in different media 
a) LB+S/B, b) LB+S, c) LB+B, and d) LB at 33°C, 16h, IPTG 1mM. These results show 
that whereas total PGAM did not show much variation, the iPGAM produced in LB+S/B 
media was at the highest relative level. The total PGAM and iPGAM activities were 
described in Chapter 2, Section 2.2.1. 
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The optimised induction temperature. 33C. was used for the expression from the 
recombinant plasmid pET 1 8a-Th PGAM carried by E. coil strain BL21(DE3)pLysS 
in LB + S/B with various incubation times after IPTG induction. Figure 3.1.2. shows 
at least 14h of induction time is the most suitable to obtain maximum soluble protein 
(Figure 3.1.3.) with the highest Tb iPGAM activity relative to the total activity of 
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Figure 3.1.2. 	Comparison of the iPGAM/total PGAM ratio from cell extracts at 
different temperatures and times after IPTO (1mM) induction. It can be seen that the 
lowest temperature (at 18C) gives the lowest ratio, and this increased when the 
temperature was raised. At 33C, the ratio was relatively the highest and was quite 
stable when the growth time was longer than 14h. For temperatures higher than 33CC, 
the ratio was not only decreased again, but also fell dramatically when the growth time 
was longer than 14h. 
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Figure 3.1.3. 	SOS-PAGE of Tb iPGAM expression at 33C, 1mM IPTG, and 
various induction times; Lanes 1 and 9 were LMW markers, lane 2 was negative IPTG 
total cells, lanes 3 to 8 were positive IPTG total cells at different induction times, 3, 6, 
9,12, 14 and 16h respectively. Lanes 10 to 15 were cell extracts from the former total 
cells. Tb iPGAM could be seen at about 60kDa (arrowhead). The intensities of the 
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Figure 3.1.4. 	Comparison of total PGAM and iPGAM activities produced at 33CC 
and different times after IPTG induction, indicates that iPGAM is expressed in LB+S/B 
at high level at 14h after induction. 
The most suitable medium to be used for Tb iPGAM produced in E. co/i was 














3.2. Protein purification by TALON affinity chromatography 
After a cleared lysate solution was applied to the TALON affinity column, elution 
was performed with lysis buffer containing 100mM imidazole. Fractions of purified 
protein were collected and analysed for purity by 12C/  SDS-PAGE. Figure 3.2.1. 
shows purified protein with some contaminants at lower molecular weight lower than 








Figure 3.2.1. 	SDS-PAGE analysis of Tb iPGAM purified by TALON affinity 
chromatography. The optimum conditions were 100mM TEA buffer pH 8.0, 10% 
glycerol, 400mM KCI as equilibrating buffer, and 100mM imidazole in the above buffer 
as eluting buffer. Lanes 1 and 9 were markers, lanes 2 and 10 were cell extracts, 
lanes 3-8 were purified fractions, lanes 11-13 were fractions after elution with 200mM 
imidazole in the above buffer. 
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3.3. Sephacryl S-200 HR size exclusion chromatography 
From the TALON affinity chromatographic results, some molecules smaller than 60 
and 31kDa can be seen in SDS-PAGE (Figure 3.2.1.). One more separation step was 
used to obtain Tb iPGAM at higher purity. Sephacryl S-200 HR size exclusion 
chromatography was employed after buffer exchange with 20mM TEA buffer pH 
7.4, 150mM NaCl and 0.3mM 3PGA, which was also used as an eluting buffer in 
this separation. 0.3mM 3PGA was used to stabilise the protein as mentioned in 
Chapter 2, Section 2.2.2. 
30 	40 	50 	60 	70 80 
Fraction number 
Figure 3.3.1. 	Size exclusion chromatogram of Tb iPGAM by Sephacryl S-200 HR 
16/60 column, flow rate 0.5m1/min. 20mM TEA buffer pH 7.4, 150mM NaCl, 0.3mM 
3PGA was used as eluting buffer. SDS-PAGE indicated that Tb IPGAM eluted from the 
column in fractions 48-62. Fractions 48-54 were of high purity, whereas fractions 58-62 
contained small protein impurities as shown in Figure 3.3.2. 
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Figure 3.3.2. 	SDS-PAGE analysis of purified Tb iPGAM by Sehpacryl S-200 HR 
16/60, size exclusion chromatography. Lane 1 was molecular marker, lane 2 was Tb 
1PGAM sample after TALON purification, lanes 3-10 were size exclusion purified 
fractions, 48, 50, 52, 54, 56, 58, 60 and 62, respectively. 
Purified TI) iPGAM was characterised to have specific activity of tOO units per mg 
protein by Bradford and activity assays. 
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3.4. Dynamic light scattering characterisation 
Dynamic light scattering (DLS) is a technique for measuring the translational 
diffusion coefficient (DT) of moving macromolecules in solution (Amare and Burley, 
1997). The hydrodynamic radius (R H), estimated Mr for globular protein, and 
polydispersity value were obtained from the Stokes-Einstein equation, as shown 
below. 
Protein concentration 
Parameter 0.5mg/mi 1.0mg/mi 2.0mg/mi 
Diff. Coef. (nm) 366 405 357 
Rad. (nm) 4.0 3.6 4.0 
Polydispersity 1.8 0.9 1.5 
Estimated Mr 83k 64k 83k 
Baseline 1.006 1.000 1.009 
SOS error 4.427 3.218 1.721 
Bi-modal 98% 95% 91% 
The results show that a suitable Th iPGAM concentration for DLS measurment was 
1 .Omg/ml, and an estimated Mr 64k for Th iPGAM was obtained. The baseline value 
shows that Th iPGAM is a globular protein in the storage buffer, 20mM TEA buffer 
pH 7.4, 50mM NaCl, 0.3mM 3PGA, and also the 95% Bi-modal result indicated that 
Th iPGAM exists in a homogeneous form. The instrument manual recommends that 
a range of protein concentrations should be tested, and it can be seen that 0.5 and 
2.Omg/ml are not suitable because the technique was very sensitive to the analysed 
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protein concentration. At these concentrations, the protein is present in more than 
one form, as can be seen by the Polydispersity higher than one and the Estimated M r  far 
away from 64kDa. 
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3.5. Mass spectrometry 
The sample of Tb iPGAM (volume 50pi, 3mg/mi in 20mM TEA buffer pH 7.4, 
50mM NaCl, 0.3mM 3PGA) was investigated by mass spectrometry. The mass 
spectrogram of Tb iPGAM with horseradish peroxidase (HRP) the internal standard, 
revealed a major species in the sample (62,85813a), which agreed well with the mass 
calculated from the sequence (62, 852Da, Section 2.1.1.). 
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Figure 3.5.1. 	Mass spectrogram of Tb 1PGAM, was examined by Matrix Assisted 
Laser Desorption/Ionization - Time of Flight mass spectrometry (MALDI-TOF) with 
horseradish peroxidase HRP internal standard calibration, using a Voyager DE-STR 
(ABI) instrument. This analysis was done by Hannah Florence, EPIC group of the 
University of Edinburgh. 
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3.6. Tb iPGAM crystallisation 
Well formed orthorhombic crystals of Tb iPGAM complexed with 3PGA were 
grown in 24-well Linhro plates by vapour diffusion using the hanging drop method 
(Ducruix and Giege. 1992) at 17°C. Crystallisation drops contained equal volumes 
(1.51.tl) of reservoir and enzyme solutions (5mg/mi Tb iPGAM, 50mM NaCI and 
0.3mM 3PGA in 20mM TEA buffer pH 7.4). Crystals were obtained initially from a 
preliminary screen using the Structure Screen I kit from Molecular Dimensions: 
0.05M potassium dihydrogen phosphate with 20%w/v PEG8000 (measured pH is 
—6). Streak seeding with a cat's whisker was necessary to obtain well formed crystals 
suitable for X-ray diffraction (Ducruix and Giege. 1992) (Fig. 3.6.1.). 
Figure 3.6.1. 	Crystals from initial screening (left) and small crystals (right) 
obtained by a cat's whisker seeding of Tb iPGAM in 0.05M potassium dihydrogen 
phosphate with 20%w/v PEG8000 from Molecular Dimension screen kit I. 
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3.7. Summary and discussion 
Recombinant T brucei iPGAM was expressed in E. coli cells, as the enzyme with a 
20-residue extension including six His residues fused to its N-terminus. The best 
production yields were obtained under osmotic stress in the presence of sorbitol and 
betaine, and gave a relatively low yield of 3-4mg per litre cell culture. Many growth 
conditions were tested such as different growth media, induction temperatures and 
times, and IPTG, betaine and CoC12 concentrations. Purification for crystallisation 
trials was performed in four steps; (a) elimination of nucleic acids from lysate 
solution (b) immobilisation of His-tagged protein by TALON affinity 
chromatography (c) removal of glycerol and imidazole salts by PD-10 column size 
exclusion, and (d) Sephacryl S-200 HR gel filtration. Tb iPGAM could be purified to 
at least 95% homogeneity as assessed by SDS-PAGE, mass spectrometry, and 
dynamic light scattering. 
Although small crystals of Th iPGAM complexed with 3PGA in 0.05M potassium 
dihydrogen phosphate with 20%w/v PIEG8000 (pH -6) as the precipitating agent 
were obtained at 17°C, attempts to optimise the crystallising condition have not been 
successful. 
As crystal structures of Lm iPGAM have subsequently been obtained successfully by 
the method mentioned below, crystallisation of Th iPGAM could be attempted with 
the same strategy because these two proteins are conserved with high sequence 
identity (74%) (Guerra et al., 2004). In particular, it can be proposed that CoC12 
l0M is used instead of 0.3mM 3PGA for protein stabilisation. 
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4. EXPRESSION, PURIFICATION, CRYSTALLISATION AND 
CRYSTAL STRUCTURE DETERMINATION OF Leishmania 
mexicana iPGAM 
4.1. Lm iPGAM expression, purification and characterisation 
Details of Lm iPGAM expression and purification are mentioned in materials and 
methods. A metal-affinity TALON (Clontech) column was used with 50mM 
imidazole in 100mM TEA buffer pH 8.0 containing 10% glycerol, 500mM NaCl and 
10tM CoC12 as eluting solution. The purified protein was shown to be homogeneous 
by SDS-PAGE with a recovery of 20mg per litre of culture (Fig.4. 1.1.). 
kDa1 2 3 4 5 6 7 8 9 10 11 12 13 1415 
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Figure 4.1.1. 	SIDS-PAGE analysis of purified fractions from the TALON column. A 
12% gel was used and marker proteins (lanes 1, 5 and 7) were from a low-molecular-
weight calibration kit (Amersham Pharmacia Biotech). Lanes 2, 3 and 4: proteins not 
bound by TALON; lane 6: pre-eluted fraction withlO mM imidazole; lane 8: crude 
extract; lanes 9— 15: purified protein fractions eluted with 50mM imidazole. 









Lm iPGAM was prepared for crystallisation trials by removal of glycerol and 
imidazole salts using a PD-10 pre-packed size exclusion column (Amersham 
Pharmacia Biotech) that was eluted by 20mM TEA buffer pH 7.4 containing 50mM 
NaCl and 10DM CoC12. The sample was then concentrated with a Vivaspin 20m1 
centrifugal concentrator tube (Vivasciences) with a molecular weight cutoff of 
30,000. The Mr  of the purified Lm iPGAM was found to be 61,698 by MALDI-TOF 
mass spectrometry shown in Figure 4.1.2., compared to the calculated Mr from the 
sequence, 61,623 (see Section 2.1.2.), plus the mass of one cobalt to give a total of 
mass of 61,682. No attempt was made to remove the His-tag prior to crystallisation. 
Figure 4.1.2. MALDI-TOF mass spectrometry of Lm iPGAM. The M r of 61,698 
suggests that one cobalt ion is bound to the protein. This analysis was done by 
Hannah Florence, EPIC group of the University of Edinburgh. 
The purified Lm iPGAM was then checked for specific activity by enzyme assays 
and Bradford analysis, and found to be about 400units/mg protein. The Km of 3PGA 
was determined to be 0.18±0.01mM as shown in Figure 4.1.3., and was slightly 
lower than 0.27±0.02mM reported previously (Guerra et al., 2004). Since 2PGA is 
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Figure 4.1.3. Plot of determination of the Km  for 3PGA. 
4.2. Crystallisation of Lm iFGAM and data collection 
Well formed orthorhombic crystals of Lm iPGAM complexed with 3PGA and cobalt 
(Lm iPGAM-3PGA-Co) were grown in 24-well Linbro plates by vapour diffusion 
using the hanging drop method (Ducruix and Giege, 1992) at 17°C. Crystallisation 
drops contained equal volumes (1.5tl) of reservoir and enzyme solutions (Smg/ml 
Lm iPGAM, 1.5mM 3PGA, 50niM NaCl and lOjiM CoC12 in 20mM TEA buffer pH 
7.4). Crystals were obtained initially from a preliminary screen using the Structure 
Screen I kit from Molecular Dimensions. The best crystals were found with 0.40M 
ammonium acetate, 0.20M tn-sodium citrate dihydrate pH 5.6 and 30%(w/v) 
PEG4000 as the precipitating agent. In the optimised crystallisation conditions, the 
well solution consisted of 0.40M ammonium acetate, 0.20M tn-sodium citrate 
dihydrate pH 6.0 and 24%(w/v) PEG4000. Streak seeding with a cat's whisker was 
necessary to obtain well formed crystals suitable for X-ray diffraction (Ducruix and 
Giege, 1992) (Figure 4.2.1.). Quality crystals of Lm iPGAM complexed with 2PGA 
and cobalt (Lm iPGAM-2PGA-Co) were also grown from very similar crystallising 





Figure 4.2.1. 	Crystals from (a) the initial screening using The Molecular 
Dimension Screen I kit, (b) preliminary cat's whisker seeding and (c) well-formed 
orthorhombic crystals used for X-ray data collection. See text for details. 
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4.3. Preliminary crystallographic study 
A preliminary X-ray crystallographic study was done using Lm iPGAM complexed 
with 3PGA using a rotating anode X-ray generator. The crystal needed no further 
cryoprotection as the mother liquor contained 24% PEG4000, and was flash frozen in 
liquid nitrogen. X-ray data were collected at 100K in a nitrogen flow using a 
Cryostream Cooler (Cryosystem, Oxford, UK). The X-ray source and detection 
system comprised a CuKa rotating anode source mounted on a Nonius FR591 
generator operating at 40kV and 1 lOmA, connected to a MAR345 area detector. 
Each diffraction image was exposed for 30min with 1.00  oscillation range. Under 
these conditions, the crystal diffracted X-rays to beyond 2.25A. Analysis of the 
diffraction data using the auto-indexing procedure of Denzo (Otwinowski and Minor, 
1997) indicated an orthorhombic unit cell with dimensions a = 62.74, b = 72.20, c = 
129.73A. The intensity measurements confirmed the orthorhombic symmetry and the 
symmetric absences showed the space group to be P2 1 2 1 2 1 . A total of 28,662 unique 
reflections were processed with 97.8% completeness (Table 4.4.1.). The relative 
molecular volume, Vm , is 2.4A3/Da, and is consistent with one molecule of protein in 
the asymmetric unit and a solvent content of 48%. 
A model of B. stearothermophilus iPGAM, [PDB accession number 1EJJ] (Berman 
et al., 2000) was used to provide an initial solution by MOLREP (Vagin and 
Teplyakov, 1997). However, the solution was of relatively poor quality because the 
sequence identity of the model and Lm iPGAM is low (33% identity), and the 
connectivity of the electron density map was also not always apparent. An improved 
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search model was generated by threading the Lm iPGAM sequence onto the 
published Bs iPGAM structure by using 3dpssm (Kelley et al., 2000). After removal 
of poorly defined loops in the structure, the model gave a molecular replacement 
solution (Euleran angles a = 109.61, 3 = 31.89, y = 231.94, and translation function 
of Xfrac = 0.331, Yfrac = 0.425, Zfrac = 0.389) with R factor of 56.7% and 
correlation coefficient of 0.169 (Collaborative Computational Project Number 4, 
1994). A model structure was built manually using the program 0 (Jones et al., 
1991). The structure model at this stage consisted of 257 residues with complete side 
chain out of the possible total of 553 residues. The initial phases from molecular 
replacement were not good enough to allow the rest of the protein side chains to be 
built. Probably the sequence identity between the model (Bs iPGAM) and Lm 
iPGAM was too low and the resolution of the data set was only 2.25A, which was 
not good enough for an automated structure building program like ARP/wARP. 
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4.4. Crystal structure determination 
Well-formed orthorhombic crystals of Lm iPGAM-3PGA provided an opportunity to 
obtain a higher resolution structure. X-ray data were collected at the Daresbury 
Synchrotron Light Source, SRS station 14.2, X = 0.979A with an ACD Q4 CCD 
detector using a p  scan with the step size 1.00  and exposed for 60s each. The crystal 
to detector distance was 140mm, and the crystal diffracted beyond 1.90A. The data 
were processed using MOSFLM (Leslie, 1992). Initial phases of the first crystal 
structure, Lm iPGAM-3PGA were obtained by molecular replacement using the 
previous model. At high resolution 1.90A, the first rigid body refinement of Refmac 
(Collaborative Computational Project Number 4, 1994) provided R and R-free factors 
of 40.5% and 41.4%, and also connectivity of the electron density map was clearly 
apparent. The electron density map was then traced using an automated structural 
building program ARP/wARP (Lamzin and Wilson, 1993; Lamzin and Wilson, 
1997). 516 amino acid of the total 553 residues were fitted in electron density 
automatically with a connectivity index of 0.97. A new model was inspected and 
modelled manually using the program 0, and then was refined using a restrained 
refinement of Refmac. Statistics data for the crystals are shown in Table 4.4.1. 
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Table 4.4.1. Data collection details and statistics, and crystal structure parameters of Lm 
iPGAM-31PGA-Co and Lm iPGAM-2PGA-Co. 
Lm 1PGAM-3PGA Lm iPGAM-3PGA Lm iPGAM-2PGA 
Data collection 
X-ray source Rotating anode SRS station 14.2 SRS station 14.2 
Wavelength (A) 1.5418 0.979 0.979 
Resolution (A) 2.25 1.90 2.05 
Unit cell (A) 	a 62.75 62.46 63.58 
b 72.23 72.27 74.41 
c 129.74 129.68 131.59 
a = 15 = 7 (°) 90.00 90.00 90.00 
Unique reflections 28,496 43,943 37,258 
Multiplicity 9.2 4.1 3.1 
Completeness (%) 99.3 (99.5)' 98.7 (98.7) 97.0 (97.0) 
Rmcrgc (%)2 10.2 (45.8) 8.9(25.9) 10.6 (26.6) 
<licKi)> 21.9 (3.9) 5.7(2.4) 4.4(2.1) 
Refinement3 
R(%) 15.9 17.3 
R-free(%) 21.4 24.7 
Mean temperature factor B (A 2) 
Protein (overall) 15.2 14.0 
Col 6.7 4.9 
(100% occupancy) (100% occupancy) 
Co2 13.2 12.0 
(8.6% occupancy) (9.6% occupancy) 
3- or 2PGA 8.8 9.2 
(100% occupancy) (100% occupancy) 
Sodium 10.6 11.2 
All atoms used in refinement 4,773 4,753 
water 517 506 
Validation  
% of non-Gly non-Pro 
Most favoured 88.9 89.3 
Additional allowed 10.0 9.6 
Generously allowed 0.2 0.2 
Disallowed 0.9 0.9 
Refinement of ligand substitutions 5 
R(%) 15.9 17.3 
R-free(%) 21.5 24.6 
Mean temperature factor B (A 2) 
3PGA in 2PGA structure - 11.2 
2PGA in 3PGA structure 14.9 - 
Occupancy refinement6 
R (%) 16.5 16.7 
R-free (%) 23.8 25.6 
Averaged temperature factor B 
(A 2) for occupancy refinement 
Co2 9.3 9.3 
2- and 3PGA 8.7 8.0 
Occupancy (%) 
Col 100 100 
Co2 8.6 9.6 
3PGA 67.2 27.4 
2PGA 32.8 72.6 




h 1/hk! 	, 'hk/j 
where Ihkj is the intensity of a reflection and <I>uj.  
is the average of all observations of this reflection and its symmetry equivalent. 
3 Structure refinement was done by REFMAC. 
4Validation was done using PROCHECK. 
'More details are discussed in Section 5.4. 
—
'Occupancy refinement was done using SHELX97. 
4.5. Identification of 3PGA molecule, cobalt and sodium ions 
A 3PGA molecule was taken from the published structure of the Bs iPGAM, and was 
used to fit into the electron density map in the active site using the program 0. One 
cobalt ion was identified between the two domains using an IF,, - FI density map 
difference Fourier contoured at 35cr. The cobalt ion was located near the 3PGA 
molecule. Most of the cobalt coordinating residues gave distances around 2.OA and 
within the predicted range (Orpen et al., 1992). The model was then refined with 
individual B-factors. A total of 517 water molecules were added into IF0 - FI density 
maps contoured at 3cr using standard geometry criteria. 
A sodium ion was also identified at the edge of domain A using an IF,, - FI density 
map contoured at 4cr. The sodium ion is located in a hole with octahedral geometry 
and is coordinated with four carbonyl groups of the main chain and two water 
molecules. Most of the sodium-donor atom distances were within the prediction 
range of about 2.4A. Six coordinate octahedral geometry is a preferred form of 
sodium—ligand interactions (Harding, 2002). NaCl at high concentration was crucial 
for the Lm iPGAM purification by TALON resin, and was initially thought to 
minimise non-specific adsorption to the resin. However, it has been found that 
having at least 50mM NaCl in combination with CoC12 stabilises the Lm iPGAM for 
longer than a month (Guerra et al., 2004). Moreover, it has been noted that 50mM 
sodium phosphate buffer prevented the irreversible loss of activity in the last step of 
purification of iPGAM from Aspergillus nidulans (Johnson and Price, 1988). These 
results suggest that sodium plays a major role in protein folding and stability. 
The final model for the 3PGA complex consists of 552 residues and 517  water 
molecules. The final Rand R-free factors were 15.9% and 21.4%, respectively. The 
geometry of the structure was very well defined with more than 89% of the residues 
in the core region of the Ramachandran plot as shown in Figure 4.5. 1. Four residues 
(Ala 1 16, Thr206, Va1304 and 11e373) in the 3PGA-Co structure have been found in 
the disallowed region, three residues of Ala] 16, Va1304 and 1le373 are located in 
surface turning loops that may cause unusual conformations of these three residues. 
Thr206 is located in between Arg202 and Arg209, two residues involved in the 
substrate binding at the active site. This may also cause an unsual conformation of 
Thr206. All four residues are found fitting well in the I2Fo - FcI electron density 
map. 
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Figure 4.5.1. The Ramachandran plot of the 3PGA complex structure of Lm PGAM. 
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4.6. Determination of crystal  structure of Lm iPGAM-2PGA-Co 
High quality crystals of Lm iPGAM-2PGA-Co were also obtained by co-
crystallisation in 0.4M ammonium acetate, 0.2M tn-sodium citrate dihydrate pH 6.2, 
with 30%(w/v) PEG4000 as the precipitating agent. X-ray data of high quality crystal 
were collected at the Daresbury SRS station 14.2, X = 0.979A with an ACD Q4 CCD 
detector using a p  scan with the step size 0.5° and exposed for 60s each. The crystal 
to detector distance was 140mm, and the crystal diffracted beyond 2.05A. A total of 
37,258 unique reflections were processed with MOSFLM with 98.27% 
completeness, which indicated that the crystal belongs to orthorhombic space group 
P2 1 2 1 2 1 with the unit cell dimensions, a = 63.58, b = 74.41 and c = 131.59A. The Lm 
iPGAM-3PGA-Co structure (without ligand, Co and waters) was used as a model to 
obtain initial phases for the Lm iPGAM-2PGA-Co structure. Rigid body refinement 
using Refmac5 was done and the result gave initial R and R-free factors of 27.4% 
and 28.0%. 12F0 - FI and IF0 - FI maps were calculated, and a 2PGA molecule and 
one cobalt were fitted in the electron density map with the same procedure as used 
for the Lm iPGAM-3PGA-Co structure. The final structure including a 2PGA 
molecule, one cobalt ion, one sodium ion and a total of 506 waters showed R and R-
free factors, 17.3% and 24.7%, respectively. Statistics and crystal structure 
parameters are shown in Table 4.4.1. 
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4.7. Summary and discussion 
The recombinant plasmid pET28a-Lm iPGAM (Guerra et al., 2004) carried by E. 
coli strain BL21 (pDLmPGAM)pZLm37 encodes iPGAM with an eight residue 
6His-tag at the C-terminus. Cells harbouring the recombinant plasmid were grown at 
37°C in LB medium containing 30j.ig/ml kanamycin, and expression was induced by 
the addition of IPTG when the cell culture reached an 0D600 of approximately 0.6. 
Cell growth was continued at 17°C for 20h. Metal affinity chromatography by a 
TALON column followed by a PD-10 gel filtration column was used for protein 
purification and removal of unwanted salts. A high-yield (20mg/L cell culture) of 
protein in a storage buffer (20mM TEA buffer pH 7.4 containing 50mM NaCl and 
1 0M CoC12) was obtained for protein crystallisation. 
Crystals of the protein complexed with a substrate (3PGA) or a product (2PGA) in 
the presence of cobalt were obtained in a crystallising solution of 0.40M ammonium 
acetate, 0.20M tn-sodium citrate dihydrate pH 6.0 and 24-30%(w/v) PEG 4000. 
Streak seeding with a cat's whisker was necessary to obtain well formed crystals 
suitable for X-ray diffraction. The protein crystal structures were solved and refined 
at 1.90 and 2.05A, respectively, by the molecular replacement method. Each crystal 
structure consists of two domains connected by two flexible loops. The active site of 
the protein, with a substrate or a product and also two metal ions, was located in a 
buried position between the two domains. More details of the crystal structures will 
be described in the next chapter. 
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Although mass spectrometry and the initial crystal structure determination identified 
only one cobalt atom, the analogy with Bs iPGAM and the presence of a smaller 
electron density peak, suggested a second metal site. From subsequent work it 
appears that citrate in the crystallising medium has taken out most of the cobalt at the 
site M2 (but not at site Ml). This second site has therefore been included throughout 
the results sections, although with low occupancy. Further investigations of cobalt at 
site M2 are discussed in section 6.2. 
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CHAPTER 5 
THE STRUCTURE OF PHOSPHOGLYCERATE 
MUTASE FROM Leishmania mexicana 
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5. THE STRUCTURE OF PHOSPHOGL YCERA TE MUTASE 
FROM Leishmania mexicana 
5.1. Crystal structure of Lm iPGAM-3PGA-Co 
The crystal Structure of Lm iPGAM prepared by co-crystallisation with 3PGA and 
cobalt has been solved and refined at 1.90A. The structure is complete between 
residues 4-552, and has an overall globular shape with 17 -strandsand 19 a-helices 
folded into the phosphatase and transferase domains linked to each other by two 
loops (Figure 5.1.1). Folding of the protein starts from the phosphatase domain with 
residues Leu 4—A1a84 and then continues to the transferase domain linked by the first 
inter-domain loop (A1a84—Gly9l). The transferase domain encompasses residues 
Gly9 1—G1y3 13 and connects back to the rest of the phosphatase domain by the 
second inter-domain loop (G1y3 13—Ser338). The phosphatase domain contains seven 
parallel and two anti-parallel J3-strands surrounded by eight a-helices, whereas the 
transferase domain incorporates seven parallel and one anti-parallel 13-strand 
sandwiched between eight a-helices. 
CD PhO phatase domain 
, 	Transferase domain 
(a) 
(b) 
Figure 5.1.1. (a) Overall representation of the Lm iPGAM-3PGA-Co crystal structure 
with p-strands in yellow and x-helices in blue to form the phosphatase and transferase 
domains. The substrate 3PGA is shown in ball and stick fashion and two metal ions in 
the active site are indicated as pink balls, whereas a sodium ion is indicated as a 
green ball. (b) A stereoview of the C" trace of Lm iPGAM-3PGA monomer with 
sequential numbering of every 101h residue. 
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5.2. The active site of the protein 
The active site of Lm iPGAM-3PGA-Co or of Lm iPGAM-2PGA-Co comprises 16 
residues contributed by both domains that interact with 3PGA or 2PGA, and the two 
metal ions: Asp23, Ser75, Lys357, His360, Asp425, His429, Asp466, His467 and 
His496 from the phosphatase domain, and His136, Arg166, Asp167, Arg202, 
Arg209, Arg282 and Arg285 from the transferase domain. The molecule of ligand 
and the metal ion at site Ml fit well in the electron density map. Figure 5.2.1. shows 
a stereoview of the active site, and Figure 5.2.2. shows protein-ligand interactions. 
H-bond distances of protein-ligand interactions compared to those of Bs iPGAM are 
also shown in Table 5.2.1. Metal ions in the active site of the protein will be 





Figure 5.2.1. 	Stereoview of electron density contoured at 1.5cy shows the 
accommodation of 3PGA and the fully occupied cobalt at metal site one in the active 
site of Lm iPGAM-3PGA-Co. The cobalt at metal site two with 8% occupancy is 
invisible in this electron density map. 
209 	 P166 
46 
D23 
Figure 5.2.2. Protein-ligand interactions at the active site of Lm iPGAM-3PGA-Co. 
Table 5.2.1. H-bond distances of protein-ligand interactions compared to those of Bs 
iPGAM. Entries shown in red were not mentioned in (Jedrzejas et al., 2000b). 
Non-bonding distances of protein residues, substrate and waters in crystal structures of Lm 
iPGAM compare to Bs iPGAM-3PGA crystal structure (identical residues) 
Lm1PGAM BsiPGAM 
Substrate 3PGA 2PGA 3PGA 
Atom Atom (residue) A A Atom (residue) A 
01 NE(Arg 166) 2.89 3.03 NE(Arg 153) 3.17 
NH2 (Arg 285) 2.84 3.09 NH2 (Arg 264) 2.86 
0 (Wat 5. 1) 2.65 2.72 0 (inner Wat) 2.82 
02 NE2 (His 136) 2.83 2.96 NE2 (His 123) 2.69 
NE (Arg 285) 2.71 170 NE (Arg 254) 2.88 
NH2(Arg 202) 3.16 3.38 NH2(Arg 19 1) 3.36 
03 OD 	(Asp 167) 2.63 2.68 ODI (Asp 164) 2.75 
0D2 (Asp 167) 3.09 3.01 0D2 (Asp 164) 3.01 
NE2 (His 136) 3.21 3.32 NE-) (His 123) 3.13 
NH2 (Arg 202) 2.95 2.82 NH2 (Arg 185) 2.80 
OIP (ester) 0 (w 5)/0 (w I) 3.15 3.14 0 (inner wat) 3.39 
NE2 (His 429) 3.31 3.34 \(1 	I(i.4U7 
02P NE2 (His 467) 3.30 3.52 \I 	I 	1. 4 
OG (Ser 75) 3.26 3.36 OG (Ser 62) 2.79 
NZ (Lys 357) 2.89 2.93 r 	I 	s 
CID 	(Asp 425) 2.91 3.08 ( )1)1 (Asp 403) 30 
0D2 (Asp 425) 2.98 3.00 ()I 12 	Asp 4114 1 kw 
NE2 (His 496) 3.03 3.16 NF.2 dfi5 402 4 
03P OG (Ser 75) 3.54 3.77 OG (Ser 62) 179 
NH! (Arg 209) 2.96 3.14 NH! (Arg 19!) 3.11 
NH2 (Arg 282) 2.92 3.03 NH2 (Arg 261) 2.79 
NZ (Lys 357) 3.04 3.06 NZ (Lys 336) 2.63 
NE2 (His 360) 2.98 3.21 . . 
04P 	 N (Ser 75) 2.92 2.97 N (Ser 62) 2.99 
OG (Ser 75) 3.56 3.82 OG (Ser 62) 3.36 
NH 	(Arg 282) 2.85 3.05 NH 	(Arg 261) 2.79 
water 	NH2 (Arg 166) 3.15 3.20 NH2 (Arg 153) 2.79 
NH2 (Arg 209) 199 3.10 NH2 (Arg 19!) - 
OD! (Asp 425) 2.88 3.05 OD! (Asp 403) 3.05 
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5.3. Structure of 2FGA complex 
The crystal structure of Lm iPGAM co-crystallised with the product 2PGA and 
cobalt has also been refined (at 2.05A resolution) using the structure of the 3PGA 
complex as a model. R and R-free factors were refined to 17.3% and 24.6%. 
Superposition of both structures shows identity of their topologies. An r.m.s. fit for 
the comparable Ca atoms is LOA. The r.m.s. fit for C  and for side-chain atoms at the 
active site are 0.23 and 0.24A, respectively. As the structures of 3PGA and 2PGA are 
very similar Figure 5.3.1., it is not surprising that the protein complex structures with 
these two ligands do not show significantly different modes of protein—ligand 























Figure 5.3.1. The structures of 3PGA and 2PGA. 
Metal—ligand and H-bond distances surrounding the phosphoglycerate molecules 
from both structures were compared using Cruickshank's diffraction precision index, 
DPI (Blow, 2002), an estimated precision of coordinates obtained by structure 
refinement of protein diffraction data. This method gives an estimate of the standard 
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deviation of M-O or M-N bond lengths; the values given assume all atom sites are 
filly occupied. The equation used for calculation is shown below; 
tY(X,B avg ) = O.18[_!_ 
0.135' 
'4 niin 	5/2 " Rd min  
where VM = Matthews volume, d = crystal structure resolution (A), S = NsoivfNatoms, C 
= fraction of completeness of the intensity data and R = R-factor. Insignificant 
differences of the metal-ligand and protein—ligand interactions have been found. 
Attempts to distinguish between substrate (3PGA) or product (2PGA) bound to the 
crystal structures have also been carried out using the superposition of 12F0 - FI 
electron density maps contoured at 1.8a. Figure 5.3.2. (a)-(d) shows stereoviews of 
the superposition of both structures with the calculated electron density maps of Lm 
iPGAM-3PGA-Co. 3PGA is shown in atom-type colouring, and 2PGA in yellow. 
Figure 5.3.2.(e)-(h) shows stereoviews of the superposition of the 2PGA and 3PGA 
with the calculated electron density map of Lm iPGAM-2PGA-Co. In Figure 
5.3.2.(a)-(d), the model of the substrate fits in the electron density much better than 
the product bound model. In the same way, the model of the product-bound structure 
fits in the 2PGA electron density very well, especially for the bond between C2 and 
C3. Thus even at 1.90A resolution, it is not straightforward to distinguish between 
these two structures. The electron density contoured at 1.8(Y again suggests that it 
will be a mixture of 3PGA and 2PGA in individual crystal structure. At higher 
resolution it might be possible to distinguish them. It can be noted that the Bs 
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iPGAM structure at IAA resolution was sufficient to distinguish 3- and 2PGAs 
(Rigden et al., 2003). 
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Figure 5.3.2. Stereoview superposition of the binding site in different orientations of 
(a)-(d) Lm iPGAM-3PGA-Co (in atom-type colouring) and Lm iPGAM-2PGA-Co (in 
yellow) on the 12F0 - Fr I map contoured at 1.8cr 1.8 of Lm iPGAM-3PGA-Co; (e)-(h) Lm 
iPGAM-3PGA-Co (in atom-type colouring) and Lm iPGAM-2PGA-Co (in yellow) on 
the 12F0 - FI map contoured at 1 .8a of Lm iPGAM-213GA-Co. A 45 degree rotation 
in y-axis was made between images in the figure. 
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5.4. Substrate and product structures can be distinguished 
crystallograp hically 
The atoms of the substrate (3PGA) and the product (2PGA) in complex with Lm 
iPGAM adopt very similar positions (Figure 5.3.1.). The following procedure was 
used to determine whether the X-ray data were of sufficient quality to distinguish 
between the structures. The structures of Lm iPGAM-3PGA-Co and Lm iPGAM-
2PGA-Co were fully refined (Table 5.4.1.). The 3PGA molecule from the refined Lm 
iPGAM-3PGA-Co structure was then used to replace the 2PGA molecule from the 
refined Lm iPGAM-2PGA-Co structure and vice versa. As expected for such 
minimal differences in atomic positions of the substrate and product molecules, the R 
factors show no discrimination (Table 5:4.1.). However, the overall B-factor 
refinement of 3PGA and 2PGA in the different structures are consistent with the 
2PGA molecule fitting better in the Lm iPGAM-2PGA structure (overall B factor for 
2PGA is 9.5A2 compared with a value for 3PGA of 11.2A 
2)  while the 3PGA 
molecule refines with a lower B-factor in the Lm iPGAM-3PGA structure (overall B 
factors for 3PGA and 2PGA are 8.8A 2 and 14.9A2 respectively). The 2F0-FI 
electron density maps of the fully refined structures were calculated (Figure 5.4.1. (a)  
and 5.4.1(b)) and also show that, despite the close overlap of non-hydrogen atoms, 
the 2PGA molecule fits less well into the electron density calculated from the Lm 
iPGAM-3PGA-Co crystal data than the 3PGA molecule (Figure 5.4.1(a)) and vice 
versa (Figure 5.4.1 .(b)). In particular the bond between C2 and C3 of 2PGA fits well 
into the electron density of the Lm iPGAM-2PGA-Co structure while the C1-C2 bond 
of the 3PGA substrate molecule fits less well in the same density (Figure 5.4.1 .(b)). 
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Table 5.4.1. Comparison of statistics of refinement of the substrate and product bound 
crystal structures of Lm iPGAM. 
3PGA complex data set 2PGA complex data set 
Ligand in refinement 3PGA 2PGA 3PGA 2PGA 
R(c/) 15.9 15.9 17.3 17.3 
R-free (ek) 21.3 21.5 24.6 24.6 
B factors (A) 
Overall structure 15.1 16.4 14.2 14.1 
2PGA - 14.9 - 9.5 









Figure 5.4.1. Stereoview superposition of the active sites of Lm iPGAM-3PGA-Co (in 
atom-type colouring) and Lm iPGAM-2PGA-Co (in yellow) on the 12F0 - Fl map 
contoured at 11.5a of (a) Lm iPGAM-3PGA-Co. and (b) Lm IPGAM-2PGA-Co. 
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5.5. The active site probably contains a mixture of substrate and 
product 
There is a possibility that under crystallising conditions Lm iPGAM may still be 
enzymically active leading to a mixture of 3PGA and 2PGA in the active site. 
SFIELX97 (Sheidrick and Schneider, 1997) was used to calculate the partial 
occupancy of substrate and product. The fully refined structures of the 2PGA and 
3PGA were placed in the active site with initial occupancies set at 50%. The B 
factors of the 2PGA and 3PGA atoms were fixed at an average value for the B-
factors of the surrounding active site residues (Table 5.5.1.). In the Lm iPGAM-
3PGA-Co structure, the 3PGA and 2PGA occupancies refined to a values of 67.2% 
and 32.8% respectively. In the Lm iPGAM-2PGA-Co structure, the 3PGA and 2PGA 
occupancies refined to a values of 27.4% and 72.6% respectively (Table 5.5.1.). 
These occupancy results are quite consistent with the analysis of active site electron 
density discussed previously showing that though the active site is probably occupied 
by a mixture of substrate and product, the proportion of each depends on whether the 
protein was co-crystallised with 2PGA or 3PGA. Parameters and results of 2PGA 
and 3PGA occupancy refinement by SHELX97 in the Lm iPGAM-3PGA-Co and Lm 
iPGAM-2PGA-Co structures are shown in Table 5.5.1. 
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Table 5.5.1. Parameters and results of 2- and 3PGA occupancy refinement by SHELX97 in 
the Lm IPGAM-3PGA-Co and Lm iPGAM-2PGA-Co complex structures. 
Complex data set 3PGA 2PGA 3PGA (soaked in 2mM EDTA) 
Averaged B value of 8.4 8.3 23.8 
surrounding ligands 
R(%) 	. 16.5 17.3 17.8 
R-free (%) 23.8 25.1 24.4 
Occupancy (%) 
3PGA 67.2 27.4 47.2 
2PGA 32.8 72.6 52.8 
The presence of 2PGA and 3PGA in both Lm iPGAM-2PGA and Lm iPGAM-3PGA 
crystals suggests that the enzyme is indeed at least partially active under 
crystallisation conditions and that it can work both in the forward and backward 
direction depending on relative concentrations of product and substrate. Furthermore, 
the observation that the protein conformation is very similar for both substrate and 
product structures, suggests that the enzymic conversion from 3PGA to 2PGA does 
not require a major conformational change of the protein. 
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5.6. Metals at the active site 
The active site of Lin iPGAM-3PGA-Co or of Lin iPGAM-2PGACo comprises 16 
residues contributed by both domains that interact with 3PGA or 2PGA, and the two 
metal ions as mentioned in previously. The first metal site shows full occupancy with 
cobalt in the mother liquor at IO.iM. whereas the metal at site M2 has only 8C/ 
Metal-ligand interactions in the active site of Lin iPGAM-3PGA-Co are shown in 
Figure 5.6.1. Distances between the two metals were 4.23 and 4.54A for the 3PGA 
and 2PGA complex structures. All metal interacting distances are shown in Table 
5.6.1., and fall within expected ranges (Orpen et al., 1992). This variable occupancy 
is likely to be the consequence of the relative affinities of the two sites, together with 
the presence of 200mM buffering citrate chelator in the crystallising solution 
(Poonperm et al., 2003). 
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Figure 5.6.1. Cobalt coordination sites of Lm iPGAM-3PGA-Co with distorted 
octahedral geometry for Col and tetrahedral geometry for Co2, with three possible 
additional bonds indicated (cyan lines). 
Cobalt in site Ml is coordinated by six donor atoms: the phosphomonoester oxygen 
(01 P) and 02P from the phospho group of the 3PGA molecule, two oxygens of 
Asp425, and two nitrogens from NE2 (His429) and NE2 (His496). These provide 
four tight and two weaker interactions [O1P and OD1 (Asp425)] to form an 
octahedral geometry. A distorted tetrahedral geometry is formed by the cobalt in site 
M2 and four tight donors, OG (Ser75), 0D2 (Asp23), 0D2 (Asp466) and NE2 
(His467). There are three possible additional donors, 02P, 0131 (Asp23) and OD1 
(Asp466) with weaker interaction since their bond lengths are much longer than 2.5A 
(Figure 5.6.1. and Table 5.6.1.). This evidence is consistent with the observation that 
Col is much more tightly bound to the protein than Co2. 
Table 5.6.1. Metal - ligand coordination distances in Lm and Bs iPGAMs. Values shown in 
red were not mentioned in (Jedrzejas et al., 2000b). 
Metal - ligand and metal - metal distances in the active site (identical residues) 
Atom (residue Lm/Bs) Lm IPGAM-3PGA Lm iPGAM-2PGA 	Bs 1PGAM-3PGA 
Ml 	OIP (Pi) 2.55 2.58 2.56 
02P (Pi) 1.85 2.00 2.32 
OD I (Asp425/403) 2.66 2.78 2.61 
0D2 (Asp425/403) 2.01 2.05 2.03 
NE2(His429/407) 2.00 2.12 2.11 
NE2 (H1s496/462) 	 2.04 	 2.06 	 2.23 
M2 	02P (Pi) 2.89 3.27 3.13 
OG (Ser75/62) 2.12 2.22 2.15 
OD I (Asp23/12) 2.89 2.94 2.67 
0D2 (Asp23/12) 1.93 1.94 2.16 
NE2(His467/446) 1.81 1.82 2.16 
OD I (Asp466/445) 3.11 3.12 3.05 
0D2 (Asp466/445) 2.53 2.51 2.15 
Co(1) 	Co(2) 4.23 4.54 - 
Mn(I) 	Mn(2) - - 4.78 
112 
The metal at site two (Co2) shows a relatively low occupancy of 8% with a high 
temperature factor. The measured metal-ligand distances for this weakly occupied 
site are less precise (the two aspartate groups (Asp23 and Asp466) are more likely to 
have monodentate interaction with Co2). It has an ambiguous geometry since there 
are two possibilities for coordination number (OG:Ser75, 0D2:Asp23, 0D2:Asp466 
and NE2:His467): CN 4 that forms tetrahedral complexes, and CN 7 that has three 
additional, but less tight binding interactions. CN 7 is unusual for cobalt, and further 
studies are being undertaken to investigate the metal bound in this site. Metal-ligand 
and metal-metal distances at the active site of Lm jPGAM-3PGA structure compared 
to those of the published Bs iPGAM-3PGA structure (Jedrzejas et al., 2000b) are 
shown in Table 5.6.1. 
At metal site Ml, the coordinating ligand architecture is similar to that of EDTA 
(ethylenediaminetetraacetic acid), a powerful metal chelator, which uses the 
monodentate oxygens of four carboxylate groups (acidic hydrogens are red) and two 
amine groups with lone pair electrons (green dots) to bind strongly with a wide range 
of divalent metals at alkaline pH to form octahedral geometry. The structure of 
EDTA is shown in Figure 5.6.2. A dissociation constant of Co-EDTA in aqueous 
solution is 5x10 17  mole per litre (-log K16.3) (Bjerrum et al., 1964) and a 
concentration of EDTA with 1,000:1 mole ratio of EDTA:Lm iPGAM was used to 
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Figure 5.6.2. The 2D structure of EDTA (a) the structure of Co(EDTA).H0 complex 
with octahedral geometry (b), H 20 ligand (017) replaces an oxygen of the remaining 
carboxylic group (03). The complex structure was taken from the Cambridge 
Structural Database, Refcode CANZUS. 
Soaking of a Lin iPGAM-3PGA-Co crystal in the same crystallising solution used to 
produce the crystals, but also containing 2mM EDTA at 17°C for 70h was not 
capable of removing cobalt from metal site M 1. The structure of the crystal soaked in 
the presence of EDTA was refined at 2.25A with R and R-free factors of 17.4% and 
24.8 17c. Statistics and structure parameters are provided in Table 5.6.2. It is clear that 
metal site M I retained full occupancy. The coordinating ligand architecture of metal 
site Ml is similar to that of EDTA, a powerful metal chelator which uses four 
carboxylate groups (monodentate) and two amine groups with lone pair electrons to 
bind strongly with divalent metals at alkaline pH with octahedral geometry (Figure 
5.6.2.). The binding site of the protein at metal site M 1 to form the protein-Co 
complex (hidentate oxygens of carhoxylate:Asp425, two imidazole ring nitrogens of 
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His429 and His496, and two oxygens from the phospho group of the substrate) has 
much stronger binding than EDTA, because the metal chelate ring of the protein is 
enormously greater than that of EDTA (Bell, 1977). This means that EDTA chelation 
is probably not strong enough to remove cobalt from metal site Ml. These results 
suggest that metal binding site Ml is selective for cobalt and is stronger than that of 
site M2. 
Table 5.6.2. Statistics and structure parameters of the crystal structures of Lm 1PGAM-
3PGA-Co soaked in 2mM EDTA for 70h. 
Data collection 
Space group P2 1 2 1 2 1 
Unit cell (A) 	a 62.94 
b 72.44 
c 130.50 
Unique reflections 29,039 
Completeness (%) 99.7(99-9) 
Redundancy 3.7 
RmcTe '. '%) 11.7(53.6) 
Refinement 
Resolution (A) 2.25 
R(%) 17.4 
R-free (%) 24.8 
Mean temperature factor B (A2) 





All atoms used in refinement 4,510 
water 275 
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5.7. Leishmania mexicana iF GA M is a cobalt-dependent enzyme 
As mentioned earlier, Lm iPGAM is only reactivated fully by Co 
2+ (Guerra et al., 
2004), and a dissociation constant (Kd) of at least 9.1±2.2tM of CO2 binds the 
protein was determined from reactivation assays (Figure 5.7.1.). This value is likely 
to be an overestimate because the six histidine residues in the His-tag at the C-
terminus may also compete for cobalt binding, albeit less strongly. The Kd value 
reported here probably relates to metal binding at site M2 only because metal binding 
at this site is much weaker than that at metal site Ml as indicated by the low 
crystallographic occupancy. Moreover, metal site Ml is always fully occupied by 
cobalt even when the crystal was soaked in a crystallising solution containing high 
concentrations of EDTA. Tight binding of the Co 
2+  ion in metal site Ml by the 
phospho group of 3PGA or 2PGA and coordinating residues from the protein 
indicates that Col may play major roles both in catalysis and in protein folding. This 
is consistent with the observation that protein crystals have never been obtained in a 
crystallizing solution with an absence of ligand and Co 2 . 
The Co 2+  ion at metal site M2 coordinates the OG atom of Ser75 with distances of 
1.90 (3PGA structure) and 2.09A (2PGA structure), and indicates that the metal at 
this site could be an important aspect of the catalytic mechanism via a phosphoserine 
intermediate (Jedrzejas, 2000; Jedrzejas et al., 2000b; Collet et al., 2001; Jedrzejas 
and Setlow, 2001). Guerra et al., 2004 revealed that Lm iPGAM was fully active in 
the optimum pH range between 7.4 and 7.6 in both forward and backward reactions, 
but at pH 6 the protein activity was reduced to 50% (forward) and 10% (backward). 
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The lower activity is presumably a consequence of different protonation states of 
histidine and aspartate residues involved in metal coordination, and hence poorer 
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Figure 5.7.1. Cobalt reactivation profile of Lm IPGAM shows a Kd 9.1±2.2pM. The 
protein was treated by EDTA incubation (1:1,000 of protein:EDTA mole ratio) at 4°C 
for 12h followed by removal of unwanted salts using a PD-10 column. 
It is also relevant to mention that citrate in the crystallising solution may sequester 
cobalt from metal site M2 and thereby cause the loss of protein activity. The 
presence of high concentrations of citrate (200mM) in the crystallising solution may 
lower cobalt occupancy at metal site M2, as citrate acts as a competitive chelator. 
The dissociation constant of cobalt-citrate in aqueous solution is 25tM (-log K4.6, 
K=stability constant measured at 25°C) (Bjerrum et al., 1964; Bell, 1977). This 
suggests that most of the protein in the crystallising solution would be completely 
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inhibited by 200mM citrate. Thus crystals were formed by inactive protein with only 
poor cobalt occupancy at metal site M2. 
The activity of iPGAM is normally measured by coupling its reaction to those 
catalysed by enolase, pyruvate kinase and lactate dehydrogenase in the presence of 
ADP and NADH, together with Mg2  (for enolase and pyruvate kinase activity) and 
IC (for pyruvate kinase activity). The production of 2PGA from the substrate 3PGA 
by iPGAM can thus be detected readily by monitoring the NADH oxidation rate at 
340nm. Although the production of phosphoenol phosphate (PEP), the product of the 
conversion of 2-PGA by enolase, can be detected at 280nm (Guerra et al., 2004), this 
technique may not specific to measure metal effect of this enzyme because either 
Co 2+  ion or cobalt-bound Lm iPGAM absorb energy strongly at 280nm (see Section 
1.6. and Section 7.3.). Unfortunately there is no convenient method to quantify the 
iPGAM reaction directly, as neither the substrate nor product is readily detected. The 
metal requirements of the coupling enzymes must therefore be considered in the 
reactivation experiments. 
Co 2+  at high concentration in the assay solution can partially inhibit the coupling 
enzymes (enolase, pyruvate kinase and lactase dehydrogenase) as shown in Figure 
5.7.2.. Mn2  ion does not affect the coupling enzymes even at high concentration, 
whereas it does reduce the Lm iPGAM activity (Figure 5.7.3.). Zn2 does kill the 
coupling enzymes as shown in Figure 5.7.2.. Therefore we can deduce that Mn 2 
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Figure 5.7.2. Cobalt, manganese and zinc effects on the coupling enzymes (enolase, 
pyruvate kinase and lactase dehydrogenase). The activity assays were started by 
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Figure 5.7.3. Manganese or zinc titration into Lm 1PGAM with cobalt at 50pM. Both 
metals at concentrations higher than 40pM caused decrease of the protein activity to 
less than 60 and 20% for manganese and zinc, respectively. 
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Manganese is required for the activity of B. stearothermophilus iPGAM, but by 
contrast, reduces Lm iPGAM activity. It does not affect the coupling enzymes in the 
assay mixture up to 400p.M (Figure 5.7.2.). Lm iPGAM has maximum activity with 
CO2  at 50tM, and this was decreased to less than 60% when Mn 2 was present at 
concentrations higher than 40jtM (Figure 5.7.3.). Apparently both metals can bind at 
the active site, but only Co 2+  can confer activity. 
The competition of metal-ligand binding to the protein of cobalt and zinc, in general, 
the maximum activity of the protein (with cobalt 50p.M) is decreased to 25% in the 
presence of zinc higher than 40.tM (Figure 5.7.3.). There would be a possibility of 
inhibitory manner of zinc on Lm iPGAM. The activity of the coupling enzymes is 
higher than the maximum activity of Lm iPGAM when zinc 40.tM is present in the 
assay solution (Figure 5.7.2.), and that lowers Lm iPGAM activity (Figure 5.7.3.). It 
is relevant to mention that dissociation constants of cobalt and zinc with proteins are 
similar, but they are stronger than manganese (Bjerrum et al., 1964; Fraüsto da Silva 
and Williams, 2001). Also the similarity in coordination geometry of cobalt- and 
zinc-bound to proteins (Lyons, R. and Harding, M., unpublished data) may enable 
zinc to take the place of cobalt in the metal sites easier than Mn 2 . Since Lm iPGAM 
requires only cobalt for activity, any other metal replacement has a detrimental effect 
on the protein activity. 
Although metal-free Lm iPGAM can be reactivated only by Co 
2+ in vitro, the specific 
metal for the parasitic protein activity in vivo still remains unclear. However, he 
analysis of the cobalt content in T. brucei from infected blood, or cultured L. 
mexicana promastigotes using ICP-AES (induced coupled plasma—atomic emission 
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spectrometry) showed detectable cobalt in nano-molar (nM) concentration (Yanbo 
Shi, unpublished data). 
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5.8. Metal discrimination by iF GA Ms 
Multiple sequence alignment (discussed in Section 1.3.) and structural analysis can 
be used to distinguish how different iPGAMs can discriminate in favour of different 
metals. Inspection of the binding modes of 3PGA at the active sites of Bs and Lm 
iPGAM was made with superposition by the program TOP of the CCP4 program 
suite, and visualisation of these two structures simultaneously by the program 0. 
Comparison of these two structures showed that residues directly involved in metal 
and ligand binding were conserved and that most of the atoms were accommodated 
in the same spaces. Only four residues in each structure within a bA radius of the 
active site were found to be different. 
Pro422 and Gly424 in the Lm iPGAM structure are located near Asp425, one of the 
metal-binding residues at metal site Ml (Figure 5.8.1.). They occur in the 
phosphatase domain and the distances between the Ca  atom of Pro422 to Col and 
Co2 are 8.56 and 7.24A. The distances between Ca  atom of G1y424 to Col and Co2 
are 8.16 and 8.58A. These residues correspond to Ala400 and Pro402 of the Bs 
iPGAM structure in which Pro402 connects to Asp403, a metal-binding residue at 
metal site Ml. The distances of the Ca atom of Ala400 to Mnl and to Mn2 are 8.64 
and 7.26A, and the Ca  atom of Pro402 to Mnl and Mn2 are 8.54 and 8.77A. The 
rigid conformations of Pro422 in the Lm iPGAM and Pro402 in the Bs iPGAM cause 
the volume of the active site in the bacillus enzyme to be larger. It can be seen that 
the distances of the Ca  atoms to Mn2 in the Bs iPGAM are longer than those to Co2 








Figure 5.8.1. Structural basis of metal discrimination. A stereoview of portions of the 
active sites of Lm IPGAM (coloured atoms and green labels), and Bs IPGAM 
(magenta). The polypeptide backbone is shown in grey, and is the same between 
the two enzymes, with the striking exception of Tyr21 0 and Asp21 1 of Lm IPGAM 
that have no equivalent residues in Bs iPGAM because of a deletion at this position. 
H bond interactions involving His360 (Lm iPGAM) are shown by green dotted lines; 
these interactions are not observed in the Bs iPGAM structure. This Figure was 
made with the program TOP in CCP4 program suite (Collaborative Computational 
Project Number 4, 1994), Molscript (Kraulis, 1991) and Raster3D (Merritt and Bacon, 
1997). 
Another major difference involves Tyr210 of Lin iPGAM that is located near His360 
that in turn is H-bonded (2.95A) to the 03P of the phospho group of the substrate 
molecule (3PGA). The distance of the hydroxyl group of Tyr-2 10 to the ring nitrogen 
of (ND!) His360 is 2.60A. characteristic of a strong H-bond (Figure 5.8.1.). By 
contrast. there is no residue in the Bs iPGAM structure that forms a H-bond with 
His339, the residue corresponding to His360 of the Lin IPGAM structure. 
Consequently the imidazo!e ring of His339 in the Bs iPGAM structure is located 
perpendicular to that of His360 in the Lin iPGAM in the same space. Thus His339 
cannot participate in a protein—ligand interaction at the active site of the Bs iPGAM 
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structure because the distance between the imidazole nitrogen (NE2) of His339 and 
the 03P of the phospho group is 4.OA and the rigid orientation of the next residue 
Pro338 does not allow His339 to move freely in the space. These results show that 
the space in the active site of the Lm iPGAM is smaller than that of Bs iPGAM, as 
indicated by the distance of Col-Co2 (4.23A) in the leishmania enzyme being shorter 
than that of Mnl-Mn2 (4.78A) in the bacterial enzyme (Table 5.6.1.). Thus Co 
2+ is 
the preferred ion in the active site of the leishmania enzyme since Co 
2+  ions require 
less space to form the cobalt—coordination geometry at the active site. The average 
distance of metal-ligand coordination for cobalt complexes is 2.OA, (Orpen et al., 
1992) whereas manganese requires 2.2A. (Harding, 1999) 
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5.9. Comparisons of L. mexicana iPGAM to B. stearothermophilus 
iPGAM and E. coli alkaline phosphatase 
Superposition of the crystal structures of Lm jPGAM-3PGA at 1.90A (553aa) and Bs 
iPGAM-3PGA also at 1.90A (511 aa, 1EJJ) (Jedrzejas et al., 2000b) shows that their 
topologies are essentially identical, especially for the core of -strands and ct-helices 
(Figure 5.9.1.) even though their sequence identity is only 33% (Poonperm et al., 
2003; Guerra et al., 2004). The overall r.m.s. fit for comparable Ca atoms is 2.6A. 
The 3PGA molecule and two metal ions (Co 
2+ 2+ for Lm iPGAM or Mn for Bs 
iPGAM) are accommodated in the same region in the cleft between both domains. 
Superposition of the active sites of Lm iPGAM and Bs iPGAM shows highly similar 
active site architecture. However, there are also differences at the active site, 
including the conformation of His339 of Bs iPGAM, that appear to relate to metal 
discrimination (see earlier section). 
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Figure 5.9.1. Comparisons of Lm PGAM with Bs iPGAM (PDB accession number 
1EJJ). (a) Stereoview of superposition of Lm iPGAM-3PGA-Co (grey ribbon) with Bs 
iPGAM (blue ribbon). (b), Stereoview of superposition of the active sites of both 
structures (Lm iPGAM-3PGA-Co in grey, 1EJJ in atom-type colouring and residue 
numbers are indicated). 
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Superposition of the crystal structures of Lm iPGAM-3PGA at 1.90A (553aa) and E. 
co/i A1kP at 2.00A resolution (449aa, 1ALK) (Figure 5.9.2.) shows accommodation 
of the metals CO2 or Zn2  in similar environments of metal coordinating ligands. The 
overall r.m.s. fit for comparable Ca is 5.1A. Even though the overall sequence 
identity between these enzymes is very low, the conserved metal coordination cores 
of E. coli AIkP, Bs iPGAM and Lm iPGAM are mostly identical. In particular, 
Serl02, the residue in alkaline phosphatase (Kim and Wyckoff, 1991) that is 
phosphorylated during the reaction, is located in the same position as Ser62 of Bs 
iPGAM (Jedrzejas et al., 2000a; Jedrzejas et al., 2000b; Rigden et al., 2003) and 
Ser75 of Lm iPGAM. This residue is a part of a triad Asn-Ser-Glu apparent in all 
iPGAMs (Galperin et al., 1998; Galperin and Jedrzejas, 2001). Furthermore, two 
metal ions in each structure play a major role in the catalytic reaction. In addition, 
Arg166 of E. coli AlkP which is responsible for electrostatic stabilization of the 
phosphate is also identical to Arg261 of Bs iPGAM, and Arg282 of Lm iPGAM 
(Holtz and Kantrowitz, 1999; Stec et al., 2000). The catalytic mechanism of Bs 
iPGAM has been proposed (Jedrzejas et al., 2000a; Jedrzejas et al., 2000b) based on 
E. coli A1kP crystal structures (Kim and Wyckoff, 1991; Murphy et al., 1997; Stec et 
al., 1998; Holtz et al., 1999) and also site-specific mutagenesis of Bs iPGAM itself 
(Jedrzejas et al., 2000b). Mutation of Ser62 to A1a62 caused the protein to have 
undetectable activity, thus confirming that phosphorylation of this serine is likely to 
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Figure 5.9.2. Comparisons of Lm iPGAM with E. co/i AIkP. (a), Stereoview of 
superposition of Lm iPGAM-3PGA-Co (grey ribbon) with a monomer of E. coil alkali 
phosphatase (green ribbon, PDB accession number 1ALK). (b), Stereoview of 
superposition of the active sites of both structures (Lm iPGAM-3PGA-Co in grey, 1ALK 
in atom-type colouring and residue numbers are indicated). 
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5.10. Proposed mechanism of Lm iPGAM 
The mechanism of Lm iPGAM described here is based on that of Bs iPGAM 
(Jedrzejas et al., 2000a; Jedrzejas et al., 2000b) and of E. coli A1kP (Kim and 
Wyckoff, 1991; Stec et al., 1998; Holtz and Kantrowitz, 1999; Holtz et al., 1999; 
Stec et al., 2000). The conserved metal and ligand binding residues at the active site 
of these three enzymes are shown in Figure 5.10.1. In the reaction catalysed by Lm 
iPGAM, the formation of a phosphoserine intermediate is caused by the attack of the 
nucleophile Ser75 onto the phospho group of the substrate, with concomitant 
breakage of the phospho ester bond. The D-glycerate then adopts a new orientation 
by rotating around the glycerate axis to move the oxygen on C3 to the opposite side 
from its old position (Figure 5.3.1.). Dephosphorylation from the phosphoserine 
intermediate then transfers the phospho group back to the re-positioned D-glycerate, 
thus forming of the product 2PGA. Arg282 plays a crucial role by making H-bonds 
to two oxygens of the phospho group thus fixing its position during catalysis. The 
two metal sites are necessary to maintain active site geometry during catalysis. 
Moreover, the positive charge of the metal ion can serve as an electrophilic catalyst, 
stabilising the developing negative charge(s) in the transition state of the catalytic 












Figure 5.10.1. Comparison of the active site of phosphoglycerate mutase from L. 
mexicana and B. stearothermophilus and E. co/i AIkP shows conserved residues. 
Guerra et al. (Guerra et al., 2004) suggested that Lin iPGAM adopts different 
conformations, with and without bound substrate, during the catalytic reaction. 
Modification of histidine residues by diethyl pyrocarbonate (DEPC) in the presence 
of EDTA, and trypsin digestion followed by mass spectrometry analysis have shown 
that His 160. which is located in the transferase domain 25A away from Col and 20A 
away from the substrate, was protected in the presence of substrate and CO 2 
although it was modified in the apoenzyme. This means that EDTA is able to remove 
cobalt only from metal site M2 while leaving cobalt at site MI to coordinate the 
substrate and residues in the active site. Thus His 160 is always protected when the 
folding of the protein is stabilised. His 136 and His467 were also reportedly protected 
in the presence of the substrate, because they are involved in the substrate binding 
(Figure 5.2.5. and Table 5.2.1.). Moreover, His429 and His496. conserved metal 
binding site residues at metal site Ml, were protected in the presence of substrate and 
CO 2  but not Mn. whereas in the same conditions His467 in the second metal 
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binding site was only partially modified. This result suggested that the protein with 
bound substrate and metal adopts a different conformation, and only Co 
2+ could 
occupy both metal sites. In addition, Rigden et al. (Rigden et al., 2003) have studied 
Bs iPGAM crystal structures by molecular dynamic simulations and have suggested 
that the transferase domain acts during catalysis by slightly opening up the gateway 
to the active site between the two domains in which the D-glycerate is situated prior 
to dephosphorylation. 
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5.11. Summary and discussion 
The first crystal structures of phosphoglycerate mutase from Leishmania mexicana 
(Lm iPGAM) complexed with a substrate (3PGA) or with a product (2PGA) in the 
presence of low concentration of cobalt (101W) have been solved and refined at 1.90 
and 2.05A resolution, respectively. The model was completed with residues 4-552 
fitting in the electron density. Only the first three residues at the N-terminus and one 
amino acid with the 6-His tag at the C-terminus were disordered and not included 
into the model. The topologies of the two complex structures are mostly identical. 
Each crystal structure shows the protein folding into a globular shape and consisting 
of two distinct domains, phosphatase and transferase domains. They are defined by 
their roles in the catalytic reaction. During catalysis, phosphorylation occurs in the 
phosphatase domain, whereas reorientation of the D-glycerate takes place in the 
transferase domain. 
The active site of the protein is located between two domains. A substrate or a 
product together with two metal sites have been found to bind with 16 residues from 
both domains. The electron density map at 1.8a level of each structure shows -the 
possibility of a mixture of the substrate and product located in the same site. 
Comparisons of distances between metal-ligand and ligand—protein pairs have been 
made and mostly insignificant differences have been found. An exception is the 
distance between the two metal sites: 4.23A in the substrate structure and 4.54A in 
the product bound structure. Temperature factors and partial occupancies of 3PGA in 
the 2PGA structure, or 2PGA in the 3PGA structure have been used to identify 
132 
mixture of both compounds in each structure. This implies that the binding constants 
of 3PGA and 2PGA with the protein are similar. 
Two metal sites in the active site are important for the catalysis. The first metal site 
was found fully occupied by cobalt even at low concentration (1OM). It binds 
octahedrally with residues (Asp425, His429 and H496) from the transferase domain 
and glycerate part of the substrate or a product. On the other hand, the second metal 
site is ambiguously identified. It has very low occupancy (8% occupancy) or high 
temperature factor, and the coordinating geometry is not clear. This metal site is 
surrounded by Asp23, Asp466, His467 and Ser75, and a phosphate group from a 
substrate, with four short interatomic distances and three rather longer ones. 
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CHAPTER 6 
THE ROLE OF METALS IN Lm iPGAM 
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6. THE ROLE OF METALS INLm iPGAM 
6.1. Metal-ligand interactions 
A comparison of iPGAM sequences from different sources including bacteria, and 
plants, together with several members of the alkaline phosphatase superfamily, 
shows conserved residues in the active sites (Jedrzejas et al., 2000b; Guerra et al., 
2004). In particular, residues for metal binding are identical in Lm iPGAM and Bs 
iPGAM. Moreover, Lm iPGAM can be reactivated fully by cobalt after deactivation 
by EDTA, and the crystal structure shows that Co 
2+  ions are found at the active site 
(see Section 6.2). It is therefore clear that Lm iPGAM is a member of the metal-
dependent alkaline phosphatase superfamily (Jedrzejas, 2000; Galpenn and 
Jedrzejas, 2001; Jedrzejas and Setlow, 2001), and it is relevant to consider and 
compare the role of metals in various members of the superfamily. 
The structure of E. coli alkaline phosphatase contains two Zn 2 ions, whereas Bs 
iPGAM and Lm iPGAM structures contain Mn 2 and CO2 ions respectively. The 
criterion of metal coordination distances of carboxylate, imidazole and phosphate 
groups have been used to identify metals in crystal structures (Orpen et al., 1992; 
Harding, 2000; Harding, 2001). It is apparent from a survey of literature values that 
average Mn2 -ligand distances are approximately 0.2A larger than those of Zn 2 and 
Co 2+  as shown in Table 6.1.1.. This is the consequence of differences in ionic radii, 
polarisation and chemistry of these ions (Christianson, 1997; Christianson and Cox, 
1999; Fraásto da Silva and Williams, 2001). Mn2 can usually be clearly 
discriminated, but the similarity of distances of Zn 2 and CO2 to different donors 
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makes it difficult to distinguish between these two metals in protein crystal 
structures. Biochemical evidence shows that Lm iPGAM is reactivated fully only by 
Co2 , but not Mn2  after deactivation by EDTA, as mentioned previously. 
Table 6.1.1. Mean metal-to-donor distances and standard deviations (SD) for cobalt, zinc 
and manganese to water, carboxylate and imidazole. This survey was done by Ruth Lyons 
during a short training program of the Biochemistry Honours Project 2004, Edinburgh 
University. 
Mean dist (SD) [Al  
Co Zn Mn 
Metal 
(0.72) (0.74) (0.80) 
(ionic radii) [A] 
M - water 2.09 (0.04) 2.06(o.09) 2.19 (0.04) 
M - carboxylate 2.08 (0.03) 2.00 (0.07) 2.15 (0.07) 
M - imidazole 2.03 (0.10) 2.00 (0.02) 2.19 (0.08) 
Metal coordination geometry is also important for the metal selectivity of enzymes 
during catalysis. Aspartate and histidine residues in the proteins are common ligands 
found coordinating to all three metals Zn 2 , Mn2 and Co2 , but the preferred 
coordination number (CN) of these metals shows differences (Harding, 2001). CN 4 
is most preferred by Zn2 , with lower preference for CN 5 and 6. This is not the case 
for Mn2  which prefers CN 6. Co 
2+  is found in a broad range of CN 4, 5 and 6 
(Lyons, R. and Harding M., unpublished results). In the crystal structure of E. coli 
AlkP, it has been reported that metal site Ml (Znl) appears to have a pseudo tngonal 
bipyramidal geometry. Znl is penta-coordinated by two imidazole nitrogen atoms, 
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bidentate carboxyl oxygens and one of the phosphate oxygens with an average Znl-
ligand distance of 2.07A. At metal site two, Zn2 is coordinated by four ligands 
consisting of one imidazole nitrogen, two monodentate carboxyl oxygens and one of 
the phosphate oxygens to form a tetrahedral geometry. The average Zn2-ligand 
distance is 2.00A. A putative catalytic nucleophile Ser102 is found to be disordered 
and not bound to Zn2 as shown in Figure 6.1.1. (a) (Kim and Wyckoff, 1991). 
Both Mn2 ions in the structure of Bs iPGAMs coordinate with five donors to form 
distorted square pyramidal geometry shown in Figure 6.1.1(b). The average Mn-
ligand distances are 2.17 and 2.37A for Mnl-ligand and Mn2-ligand, respectively. 
On the other hand, Co 2+  ions found in the Lm iPGAM have been revealed in two 
different geometries. Col is coordinated octahedrally by four tight binding ligands 
with an average Col -ligand distance of 1.97A, and two less strongly bound ligands 
with an average distance 2.60A. Co2 seems to have tetrahedral coordination with the 
four strongly bound ligands with an average distance Co2-ligand of 2.09A. However, 
there are also three less strong binding ligands. An average distance of the last three 
less strong bonds is 2.96A. It can be seen that the coordination architecture of metal 
site M2 seems to provide an opportunity for changing metal coordination geometry 
during catalysis (Holtz and Kantrowitz, 1999; Holtz et al., 1999; Stec et al., 2000). 
Thus metal site M2 may play an important role during catalysis, especially for 02P 
from the phosphate group when the group moves towards metal site M2 and serine to 
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Figure 6.1.1. Stereoviews of bound substrate and metal coordination at the active sites of 
(a) zinc in E. co/i AIkP, (b) manganese in Bs iPGAM and (c) cobalt in Lm iPGAM. The active 
site of Lm IPGAM shows distorted octahedral geometry for Col (bond length of Co-
NE2:His429 and Co-NE2:His496 are 2.00 and 2.04A), and tetrahedral geometry for Co2 with 
four pink lines. Longer, less strong bonds are shown with cyan lines. 
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6.2 Cobalt at the active site of Lm iPGAM 
Structures of Bs iPGAM complexed with 3PGA and 2PGA have been reported 
(Jedrzejas et al., 2000a; Jedrzejas et al., 2000b). The presence of two manganese ions 
in both structures plays a major role for the activity of Bs iPGAM, which is 
extremely dependent on pH. By contrast, it has been noted that only CO2 could fully 
reactivate EDTA-treated iPGAM from T. brucei (that has 74% sequence identity to 
Lm iPGAM); Mn2  restored activity to only about 10%. The sequence identity of Lm 
iPGAM and Bs iPGAM is low (30%), but the active sites of both structures are 
conserved, and are located in corresponding positions in the cleft between the two 
domains. A sequence alignment of iPGAM from L. mexicana and B. 
stearothermophilus with corresponding secondary structures is shown in Figure 
6.2.1. 
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Figure 6.2.1. Sequence alignment of L. mexicana and B. stearothermophilus iPGAMs with corresponding secondary structures. Residue 
numbering is according to the L. mexicana FOAM (TrEMBL code 086N96). The box around S75 indicates a putative phosphoserine residue: 
circles and squares show metal-coordinating residues for metal site Ml and metal site M2 of both enzymes. This figure was prepared with 
ALSCRIPT (Barton, 1993). 
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Initial inspection of the Lm iPGAM-3PGA-Co structure indicated that metal site M2 
was unoccupied. However, it is unlikely that solvent or water molecules would fit 
into this metal pocket or the interaction with the ligand atoms would be too short. 
The structure suggested that cobalt at metal site M2 may be partly occupied in the 
crystal structure. This hypothesis was confirmed by growing Lm iPGAM-3PGA-Co 
crystals at higher concentration of cobalt chloride with a reservoir solution 0.5mM. 
Well-formed orthorhombic crystals were obtained in the same conditions as Lm 
iPGAM-3PGA-Co. Crystals at this higher concentration of cobalt diffracted X-rays 
at SRS (station 14.2). The crystal structure was solved and refined at 2.00A, and the 
well defined structure at 1.90A of Lm iPGAM-3PGA-Co was used as a model. The 
2F0 - FI and IF,, - FI maps were calculated and used for the location of cobalt at 
metal site M2. Obvious electron density was apparent in the expected metal site M2 
position with IF,, - FI density map contoured at a 4a level. All parameters and 
statistical details of this structure are shown in Table 6.2.1. 
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Table 6.2.1. Crystal parameters, X-ray diffraction and refinement statistics (by REFMAC5). Occupancy refinement of metal site Ml and M2, and 2-and 3PGA 
(by SHELX97). 
1 2 3 4 5 6 7 8 9 10 
X-ray source SRS 14.2' SRS 9.6 SRS 9.6 Rot-anode' SRS 14.2 SRS 14.2 SRS 14.2 SRS 9.6 SRS 14.2 SRS 9.6 
Wavelength (A) 0.979 0.8700 0.8700 1.5418 0.979 0.979 0.979 0.8700 0.979 0.8700 
Substrate 3PGA 3PGA 3PGA 3PGA 3PGA 2PGA 3PGA 3PGA 
3PGA 3PGA 
Cobalt concentration (mM) 0.01 0.1 0.5 2.0 4.0 0.01 0.01 0.01 0.01 
0.01 
Other metal/compound (mM) - - - - - - Zn 0.5mM Mn 1mM Ni 4mM 
EDTA2mM 
Data collection 
pace group P2 1 2 1 2 1 P22,2i P2,2,2, P211__11_2, P2,2,2, P2,2 1 2, P2 1 2 1 2, 
P2 1 2 1 2 1 
Unit cell J)a_ 62.46 62.60 62.45 62.64 62.75 63.58 62.26 62.78 62.73 6194 
b 72.27 71.97 72.12 72.14 72.11 74.41 72.28 72.11 72.25 72.44 
c 129.68 129.26 129.76 129.97 129.95 131.59 129.68 129.89 129.54 130.50 
No of unique reflections 34,857 38,398 ,765 32,870 37,258 37,838 47,235 
29,790 29,039 
5.7 (2.4) 13.2 (2.0) 11.5 (2.7) 4.4 (2.1) 8.0 (1.7) 6.7 (2.0) 7.2 (2.1) 10.8 (2.4) 
_41_. 2.9 3.9 3.5 3.6 3.6 2.9 3.7 
11.7(74.7) 10.5(42.5) 10.6 (26.61 6.6(2) 8.0 (25.7) 13.5 (48.9)__i 1.7 (53.6) 
Resolution (A) 1.90 2.10 2.00 2.25 2.00 2.05 2.00 1.90 2.20 2.25 
Completeness (%) 98.7 (98.7) 99.2 99.8 (99.8) 99.6 (99.6) 99.6 (99.8) 98.5 (98.5) 98.9 99.0 97.1 (97.5) 99.7 (99.9) 
Refinement 
15.9 15.6 15.7 17.5 16.4 17.3 16.7 16.2 16.5 17.4 
20.9 26.3 21.4 24.6 _ 20.5 24.7 24.8 
Water molecules   517 438 471 294 401 506 399 573 392 275 
Me urefactorJ  
Protein (overall) 15.1 18.8 15.6 32.8 17.8 14.1 20.9 16.4 23.5 28.1 
Cobalt (1)   6.7 7.5 6.7 24.8 6.0 5.2 110 13.4 14.2 22.5 
Cobalt (2) 7 57.0 284 17.8 118.1 21.1 2.0 106.5 85.3 
2-or3PGA  8.8 14.4 11.6 30.2 23.9 9.5 18.5 18.2 19.2 23.9 
r.m.s. deviation from ideal values________  
Bond _eg1A) 0.024 0.029 0.026 0.040 0.032 0.035 0.027 0.021 0.036 0.033 
L9472.135 1.876 ..... 2.362 2.369 2.111 1.853 2.565 2.454 
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r.m.s. isotropic thermal factor 
restraints (A 2) 
Protein main chain bonds 1.193 1.323 1.180 1.537 1.506 
1.353 1.314 1.135 1.396 1.359 
 
Protein main chain angles 2 2.297 2.079 2.556 2.468 
2.199 2.192 1.978 2.338 2.375 
Protein side chain bonds 3.234 3.742 3.399 3.900 4.095 
5.107 3.265 3.187 3.665 4.076 
Protein side chain angles 5.154 6.002 5.517 6.039 6.341 
7.311 5.093 5.200 5.670 6.180 
Validation (PROCHECK) 
. % of non-Gly non-Pro 
Most favoured 88.9 90.0 89.3 87.8 89.1 
. 89.3 88.0 90.4 89.2 89.2 
Additional allowed 10.0 8.8 9.6 10.7 9.6 
9.6 10.9 8.3 9.5 9.5 
Generously allowed 0.2 0.4 0.2 0.6 0.4 
0.2 0.2 0.4 0.4 0.4 
Disallowed 0.9 0.9 0.9 0.9 0.9 
0.9 0.9 0.9 0.9 0.9 
DPI (A) 0.13 0.21 0.16 0.36 0.16 0.21 
0.16 0.13 0.32 0.35 
Occupancy Refinement6 
n.d. nd, 12.6 8.3 15.3 12.1 n.d. 18.5  Averaged 	) from surrounding (A 8.6 n.d. 
ligands for PGA refinement 
Averaged B (A2) from surrounding 9.5 14.2 13.1 26.6 12.7 
9.3 15.7 14.3 20.7 19.5 
M2 for M2 refinement 
R (%) 16.5 n.d. n.d. nd. 
16.1 17.3 17.7 16.6 nd. 17.8 
R(%) 23.8 n.d. n.d. nd. 23.5 
25.6 25.0 22.7 n.d. 24.4 - 
2PGA 32.8 nd. nd. n.d. 35.0 
72.6 35.5 39.6 n.d. 47.2 
3PGA 67.2 n.d. n.d. n.d. 65.0 
27.4 64.5 60.4 ii.d. 52.8 
Co(1) 100 100 100 100 100 
100 41,78 43 .68 100 100 
- 58 .3 8 56.48 - nd. 
- 
!A I1\ R5 16.3 19.2 43.2 -37.0 8.3 64.3 35.6 23.5 
13.3 
'Diffraction data were collected at the Daresbury SRS (station 9.6, ? = 0.870A, and 14.2, ? = 0.979A) with an ACD Q4 CCD detector and data were processed using MOSFLM. 
2Diffraction data were collected using a CUK a  rotating anode source mounted on a Nonious FR592 generator connected to a MAR345 area detector. 
3The crystal of Lm iPGAM-3PGA-Co obtained from the crystallising solution with 10tM CoC1 2 
 was soaked in the mother liquor containing 2mM EDTA for 72hours. 
4Values in parentheses refer to the highest resolution shell. 
5Rmergc = 	hiI'hk!,i - 	
where I,,.,,, is the intensity of a reflection and <I>,,,, is the average of all observations of this reflection and its symmetry equivalent 
60ccupancy refinement was done by SHELX97. 
7n.d. is not detected. 
'Metal occupancy was estimated by iW anomalous peak heights at metal sit Ml (Table 6.10.1.). 
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6.3. Dissociation constant of Co2 at metal site M2 by crystallographic 
titration 
The metal reactivation of Lm iPGAM experiment showed that the protein could be 
reactivated fully by cobalt but not other metals. The Lm iPGAM crystal structures 
show two metal ions bound at the active site in which the metal site Ml is much 
more tightly bound compared with metal site M2. Cobalt at high concentrations (0.1, 
0.5, 2.0 and 4.0mM) was added into the crystallising solution in order to observe 
higher cobalt occupancy in the metal site M2. Well-formed orthorhombic crystals 
were obtained in the same conditions as for Lm iPGAM-3PGA with cobalt at lOiM. 
Crystals at higher concentrations of cobalt were used for data collection at the SRS 
(station 14.2) and with the in-house rotating anode. Data were collected to beyond 
1.90-2.25A resolution, and the crystals grown with different concentrations of cobalt 
were refined individually. The 1 2F,, - FI and IF,, - Fl maps were calculated and used 
to inspect cobalt at metal site M2 (Co2). Clear electron density was apparent in the 
expected Co2, and occupancy refinement of cobalt at the metal site M2 was done 
using the program SHELX97. The cobalt occupancy at M2 and all parameters and 
statistical details of the structures are shown in Table 6.2.1. There were no electron 
density peaks (12F0 - FI contoured at 1() corresponding to a cobalt occupancy less 

















Figure 6.3.1. Comparison of electron density in different structures with increasing 
concentrations of cobalt (a) 0.01, (b) 0.1, (c) 0.5, (d) 2.0 and (e) 4.0mM. Cobalt 
occupancies in each structure are shown in Table 6.2.1., and presented graphically in 
Figure 6.3.2. 
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As described previously, .a high concentration of a chelator citrate buffering system 
(200mM) in the crystallising solution may affect the protein—cobalt binding ability. 
The 12F0 - FI electron density maps around Co2 with different concentrations of 
cobalt show partially occupied cobalt which reached 40% occupancy, whereas that of 
Col shows 100% occupancy at every concentration. A plot of percent occupancy of 
cobalt at metal site M2 against concentration of cobalt in mlvi resulted in a saturated 
curve. A Kd value of 0.28m1v1 was obtained for the dissociation constant of cobalt 
bound to protein at the metal site M2 (Figure 6.3.2.). This over estimated Kd value is 
caused by the presence of high concentrations of citrate (200mM) in the crystallising 
solution, and also un-cleaved His-tag at C-terminus of the protein may lower cobalt 
occupancy at metal site M2, as citrate and His-tag act as competitive chelators. 
Citrate in the crystallising solution may sequester cobalt from metal site M2 and 
thereby cause the loss of protein activity (see Section 7.1. and 7.2.). 
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0 	1 	2 	3 	4 	5 
Figure 6.3.2. Occupancy of two metal sites a varying cobalt concentration as shown in 
Figure 6.3.1. (a) 0.01, (b) 0.1, (c) 0.5, (d) 2.0 and (e) 4.0mM. 
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6.4. Mn, Zn and Ni substitution of Co in the Lm iPGAM-3PGA crystal 
structures 
In order to observe metal coordination in the active site, manganese (1.0mM), zinc 
(0.5mM) and nickel (4.0mM) were added into the crystallising solution. Well formed 
orthorhombic crystals were obtained. The crystals diffracted synchrotron radiation at 
SRS 9.6 and SRS 14.2 to beyond 1.90, 2.00 and 2.20A for manganese, zinc, and 
nickel respectively. Each data set was processed and scaled by MOSFLM and the 
CCP4 program suite. All crystal structures were fully refined by REFMAC5, and 
metal occupancy refinement at metal site M2 was done by SHELX97. Parameter 
statistics of the crystal structures are shown in Table 6.2.1., and metal occupancies 
for each crystal structure are presented in Figure 6.4.1. Metal coordinating distances 
(Table 6.4.1.) and H-bond lengths of protein—ligand interactions (Table 6.4.2.) were 
observed from the refined REFMAC5 based structures. For making comparison of 
distances, Cruickshank's diffraction precission index, DPI (Blow, 2002) was used as 
an extimate of the standard deviation of M-O or M-N bond lengths; the values given 
assume all atom sites are fully occupied. Precision of coordinates obtained by 
structure refinement of protein diffraction data, was used to analyse the differences at 
the active site. The equation (DPI = cJ(x,Bavg)) used for calculation is shown below; 
-1/2 
	5/2 Vm 
0(x, Bavg ) = 0.18[_ 
1+s 	C 
-- O.135d] 	
Rdmin L  
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where VM = Matthews volume, d = crystal structure resolution (A), s = NsojvlNatoms, 
C = fraction of completeness of the intensity data and R = R factor. The results are 






0 	1 	2 	3 	4 	5 
Metal conc. (mM) 
Figure 6.4.1. Comparison of metal occupancy in metal site M2 in crystal structures. 
The curved line represents M2 occupancy for cobalt in crystal structures (closed 
circles). A red triangle is zinc at 0.5mM, a pink circle is manganese at 1mM and an 
green triangle is nickel at 4mM, all three crystals were obtained from a crystallising 












Table 6.4.1. Metal ligand interaction distances (A) (from REFMAC5 based structures) 
2 3 4 5 6 7 8 
9 








Ni 4.0 mM 





O1P(Pi) 2.55 2.40 2.43 2.42 2.29 
2.58 1.95 2.14 2.44 
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Table 6.4.2. Comparison of distances (A) non bonding interactions in the active site of Lm iPGAM-
3PGA and Lm iPGAM-2PGA (from REFMAC5 based structures) 
Substrate 3PGA 3PGA 3PGA 3PGA 3PGA 2PGA 3PGA 3PGA 3PGA 
Co conc (MM) 0.01 0.10 0.50 2.00 4.00 0.01 0.01 
0.01 0.01 
0.5mM 1.0mM 4.0mM 
Other metal ZnCl2 MnCl2 NO2 
Atom! Atom/ residue 
residue 
01 NE(Arl66) 2.89 3.00 2.97 3.02  
3.25 3.10  
NH2 2.84_ 
0 (Wat5, 8,1) 2.65 2.70 2.60 2.70 2.61 2.72 2.70 2.39 
2.74 
02 NE2 (His 136) 2.83 2.69 2.74 2.81 2.90 2.96 
2.92 2.78 2.89 
2.80 2.51 
NH2(Arg202) 3.16 3.24 3.21 3.48 3.26 3.38 3.10 3.34 
3.25 
1 
03 OD1(Asp167) 2..3 . 2.67 2.56 2.61 
2.68 2.69 2.66 2.50 
OD2Ap16? 09 8 3.12 
2.99_ 
NE2 (His 136) 3.21 3.23 3.14 3.38 3.27 3.32 3.08 3.15 
3.26 
NH2 (Arg202) 2.95 2.93 2.96 2.98 3.00 2.82 2.88 2.86 
2.89 
O1P 0 (w5)/0 (w 1) 3.15 2.91 3.07 3.18 3.16 3.14 
2.93 2.92 3.04 
(ester)  
NE2(His429) 3.31 3.23 3.27 3.44 3.19 3.34 3.14 
3.32 3.42 
02P NE2(His467) 3.30 3.34 3.42 3.47 3.41 3.52 
3.18 2.94 3.31 
. ..P9r75) 26 3 3.12 
NZ(&yS351) 29 2.94 21 
2.65 2.73 2.93 2.72 2.82 3.04 
0D1As425) . 299 3.:00.. 2.99  3.18 2?. 
 2.99 
NE2 (His496) 3.03 3.10 3.20 3.14 3.17 3.16 3.65 
3.29 2.99 
03P OG(Ser75) %,  3.64 3.12 3.63 
3.77 3.20 3.07 3.08. 
NH1(AO .2 
_N2 .22 2.86 ..8
. 3.12 2.83 3.03 2.81  3.02 
NZ (Ly 04 3.26 . 3 :26 .3 . 06 p2....  3.04 3.03 
NE2 (His360) 2.98 3.03 3.07 2.99 3.00 3.21 2.92 
2.81 2.91 
04P N (Ser7) .... 296 2.94 2.63 2.89 
2.97 2.80 2.79 2.73 
3.56 3.66 3.56 3.11 3.46 3.82 3.15 2.88 
3.18 
NH1 (Arg282) 2.85 2.77 2.78 2.73 2.81 3.05 
2.74 2.96 2.69 
Inner NH2(Arg166) 3.15 3.17 3.17 3.23 3.19 




2.99 3.•0 2963.03 2.91 31 2.9H 3.02287 
ODI (As25) 2.88 2.93 3.01 2.94 2.99 3.05 
2.93 2.76 .., 2.89 
Outer OD  (Asp 167) 2.74 2.78 2.66 
- 2.73 2.62 2.79 2.70 2.67 
water -. 
N (His496) 3.19 3.01 3.03 - 3.07 3.27 3.01 
2.97 3.03 
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6.5. Co-Mn crystal structure 
Previous results indicated that manganese inhibits Lm iPGAM at concentrations 
higher than 401tM in the presence of 50.LM Co as shown in Figure 5.7.3.. Crystals of 
Lm iPGAM-3PGA in the presence of 1 0M CoC12 and 1.0mM MnC1 2 were grown in 
0.40M ammonium acetate, 0.20M tn-sodium citrate dihydrate pH 6.0-6.2 and 24-
26%(w/v) PEG4000. Streak seeding with a cat's whisker was necessary to obtain 
well formed crystals suitable for X-ray diffraction. The crystal diffracted beyond 
1.90A, and the structure was solved, and fully refined by REFMAC5. 2- and 3PGA 
occupancy at ligand binding site, and metal occupancy at metal site M2 was refined 
by SHELX97 as previously described. 
Structure analysis was done using the program 0 (Jones et al., 1991) for the overall 
structure and the active site. Metal-ligand (Table 6.4.1.) and protein-ligand 
interaction (Table 6.4.2.) distances were measured. DPI numbers were calculated and 
used in comparisons with the crystal structures of both Lm iPGAM-3PGA-Co and 
Lm iPGAM-2PGA-CO. Data analysis, structure refinement parameters and validation 
details are presented in Table 6.2.1. A stereoviews of electron density at the active 






Figure 6.5.1. Stereo view of a 12F0 - Fj electron density, contoured at 10 level, for 
the active site of Lm iPGAM-3PGA-Co-Mn crystal structure. 
Geometric changes at the metal binding sites when crystals are co-
crystallised in the presence of 1mM Mn: 
As mentioned previously, the measured metal-ligand distances in the active site 
(Table 6.4.1.) show significant differences between the cobalt and manganese 
structures using the DPI number as a criterion of standard deviation (Figure 
6.5.2.). At the active site, O1P the ester oxygen of the substrate and 
OD1:Asp425 moved closer to the metal at site Ml, and 02P of the substrate 
and 0D2:Asp466 made closer interactions with the metal at site M2. whereas 
the distances of other metal-ligand pairs did not change significantly (Figure 
6.5.2.). This caused the coordination geometry in both sites to change. At metal 
site Ml, five tight interaction bonds (pink dashed lines in Figure 6.5.3.(b)) and 
one weaker bond (cyan dashed line in Figure 6.5.3.(b)) were seen instead of 
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four tight bonds (pink dotted lines in Figure 6.5.3.(a)) and two weaker tight 
bonds (cyan dashed lines in Figure 6.5.3.(a)). 02P moved closer to metal at site 
M2 significantly and caused five tight interaction bonds instead of four. These 
subtle changes gave both metal sites a trigonal-bipyramidal geometry which is 
one of the most favoured for manganese. A comparison of metal geometries is 
shown in Figure 6.5.3. 
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Figure 6.5.2. Comparison of metal—ligand distances in the active sites of Lm iPGAM-
3PGA-Co (.), Lm iPGAM-2PGA-Co (:) and Lm iPGAM-3PGA-Co-Mn (.). All crystals 
were grown in the presence of 10pM CoCl 2 . The Lm iPGAM-3PGA-Co-Mn crystal was 
grown in the presence of cobalt as mentioned above and 1mM MnCl 2 . Error bars 
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Figure 6.5.3. Comparison of metal geometry at the active sites of Lm PGAM-3PGA-
Co (left) and Lm iPGAM-3PGA-Co-Mn (right). Cyan dashed lines represent strong 
bond interactions and blue dashed lines represent weaker bonds. Trigonal bipyramidal 
geometry of manganese is shown. 
Superposition of a well defined Lni iPGAM-3PGA-Co structure and the new crystal 
structure of Lin iPGAM-3PGA-Co-Mn was done using the TOPP program in the 
CCP4 program suite. It can he seen that the active sites are very similar, with the 
exception of Ser75 that moves toward the phospho group of the substrate (Figure 
6.5.4.). As described above the effect of these two metals is to attract OIP at metal 
site Ml and release 02P at metal site M2. A stronger interaction between the metal 
at site M2 and oxygen from Ser75 (1.93A instead of 2.12A) is also observed as 
shown in Figure 6.5.3. This is consistent with the catalytic mechanism in which the 
phospho group of the substrate moves towards Ser75 to form a phosphoserine 





Figure 6.5.4. Superposition of the Lm iPGAM-3PGA-Co structure (with coloured 
atoms, cobalt in pink) and Lm 1PGAM-3PGA-Co-Mn structure (in grey, manganese in 
cyan) shows the conformation of Ser75 in the Lm iPGAM-3PGA-Co-Mn crystal 
structure pointing upward to the phospho group of the substrate. 
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6.6. Co-Zn crystal structure 
Crystals of Lm jPGAM-3PGA in the presence of CoC12 1 0iM and ZnC1 2 0.5mM 
were grown in 0.40M ammonium acetate, 0.20M tn-sodium citrate dihydrate pH 6.0-
6.2 and 24-26%(w/v) PEG4000. Streak seeding with a cat's whisker was necessary to 
obtain well formed crystals suitable for X-ray diffraction. The crystal diffracted X-
rays beyond 2.00A, and the structure was solved, and fully refined by REFMAC5. 
The 2- and 3PGA occupancy at ligand binding site, and metal occupancy at metal 
site M2 was refined by SHELX97 as described previously. The program 0 was used 
for overall structure and the active site inspection. Metal-ligand and protein-ligand 
interaction distances are presented in Table 6.4.1. and Table 6.4.2. DPI numbers 
were calculated and used in comparisons of the crystal structures with both Lm 
iPGAM-3PGA-Co and Lm iPGAM-2PGA-Co. Data analysis, structure refinement 
parameters and validation details are presented in Table 6.2.1. A stereoview of 





Figure 6.6.1. Stereoview of a 12F0 - FI electron density map, contoured at the 1G 
level, for the active site of Lm iPGAM-3PGA-Co-Zn crystal structure. 
Geometric changes at the metal binding sites when crystals are co-
crystallised in the presence of zinc 0.5mM: 
Measured metal-ligand distances in the active site are given in Table 6.4.1. 
Significant differences using DPI number as a criterion of standard deviation can be 
found in Figure 6.6.2. At the active site, oi p the ester oxygen of the substrate moved 
closer to the metal at site Ml. 02P moved away from metal site Ml but moved 
closer to metal site M2 instead. Introduction of zinc resulted in a close interaction 
between 02P of the substrate and 0D2:Asp466 with metal at site M2. However, the 
distances of other metal-ligand pairs are not affected (Figure 6.6.2.) and are similar 
to those in the Lin jPGAM-3PGA-Co crystal. The differences caused the metal 
geometry in both sites to change. 
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Figure 6.6.2. Comparison of metal—ligand distances in the active sites of Lm iPGAM-
3PGA-Co (.), Lm PGAM-2PGA-Co (c) and Lm iPGAM-3PGA-Co-Zn (A). Error bars 
correspond to the DPI values for the relevant structures as given in Table 6.2.1. 
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(a) 	 (b) 
Figure 6.6.3. Comparison of metal geometry in the active sites of Lm PGAM-3PGA-
Co (left) and Lm iPGAM-3PGA-Co-Zn (right). Pink dashed lines represent strong bond 
interactions and cyan dashed lines represent weaker bonds. 
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At metal site Ml, the four tight interaction bonds (pink dashed lines in Figure 
6.6.3.(b)) form tetrahedral geometry. There are also two weaker bonds (cyan dashed 
lines in Figure 6.6.3.(b)) which is different from the coordination found in the Lm 
iPGAM-3PGA-Co crystal structure (Figure 6.6.3.(a)). The 02P moved from metal 
site Ml significantly closer to the metal at M2 and caused five tight interaction bonds 
instead of four, and formed trigonal-bipyramidal geometry (Figure 6.6.3.(b)). In 
general for zinc coordination, five coordination (metal site M2) is less preferred than 
four coordination (metal site Ml). This could mean that at metal site Ml, zinc 
coordinates with O1P much better than cobalt, and zinc causes 02P to interact more 
strongly at metal site M2 similar to manganese. As mentioned previously, manganese 
inhibits the protein and the intermediate of the reaction was trapped as can be seen in 
the crystal structure of Lm iPGAM-3PGA-Co-Mn. The metal coordination at metal 
site M2 found in the zinc complex Lm iPGAM-3PGA-Co-Zfl can also be regarded as 
an "intermediate" in the catalytic pathway. During catalysis, metal site Ml 
coordinates with 01P of D-glycerate, whereas metal site M2 pulls out the phosphor 
group for phosphoserine formation with Ser75 (Figure 6.6.4.), and an "intermediate" 
can be trapped when either manganese or zinc are present. The distortion of the 
active site when complexed with manganese or zinc may therefore explain the 
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Figure 6.6.4. Superposition of crystal structures of Lm iPGAM-3PGA-Co (with 
coloured atoms, cobalt in pink) and Lm iPGAM-3PGA-Co-Zn (in grey). The 
conformation of Ser75 in the Lm iPGAM-3PGA-Co-Zn crystal structure points upward 
to the phospho group of the substrate. 
Superposition of the crystal structure of Lin iPGAM-3PGA-Co-Zn with the Lin 
iPGAM-3PGA-Co structure was done using the TOPP program in the CCP4 program 
suite. The conformation of Ser75 moves toward the phospho group of the substrate 
as shown in Figure 6.6.5. As described above these two metals bind stronger to OIP 
at metal site M I and release 02P to metal site M2. A strong interaction between the 
metal at M2 and oxygen from Ser75 is also observed. At the same time, the phospho 
group of the ligand molecule moves towards Ser75 to mimic a phosphoserine 
intermediate. The structure of Lin iPGAM with zinc is therefore suggestive of a 
trapped intermediate. 
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6.7. Co-Ni crystal structure 
Crystals of Lm jPGAM-3PGA in the presence of 1OM CoC12 and 4.0mM NiC1 2 
were grown in 0.40M ammonium acetate, 0.20M tri-sodium citrate dihydrate pH 6.0-
6.2 and 24-26%(w/v) PEG4000. Streak seeding with a cat's whisker was necessary to 
obtain well formed crystals suitable for X-ray diffraction. The crystal diffracted X-
rays beyond 2.20A. The structure was solved, and fully refined by REFMAC5. Metal 
occupancy at metal site M2 was refined by SHELX97 as described previously. 
Structure analysis was done using the program 0 for overall structure and active site 
inspection, and for measurement of metal-ligand (Table 6.4,1.) and protein-ligand 
interaction distances (Table 6.4.2.). DPI numbers were calculated and used to make 
comparisons between the crystal structures of both Lm jPGAM-3PGA-Co and Lm 
iPGAM-2PGA-CO. Data analysis, structure refinement parameters and validation 
details are presented in Table 6.2.1. A stereoview of electron density at the active site 
of the Lm iPGAM-3PGA-Co-Ni is shown in Figure 6.7.1. 
Analysis of the Lm iPGAM-3PGA-Co-Ni crystal structure at the active site resulted 
in insignificant differences to the initial cobalt containing crystal structures as shown 
in Figure 6.7.2. Although the crystal was grown in 4.0mM NiC12, occupancy of metal 
at site M2 is low (23.5%) compared to 19.2% of cobalt at 0.5mM (Table 6.2.1.). This 
suggests that not only is nickel not required for the protein activity (Guerra et al., 




Figure 6.7.1. Stereoview of a 12F0 - FI electron density contoured at lo level of the 
active site of Lm iPGAM-3PGA-Co-NI crystal structure. 
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Figure 6.7.2. Comparison of metal—ligand distances in the active site of Lm IPGAM-
3PGA-Co (.), Lm iPGAM-2PGA-Co () and Lm iPGAM-3PGA-Co-Ni (.).Error bars 
correspond to the DPI values for the relevant structures as given in Table 6.2.1. 
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6.8. Comparison of metal-ligand binding geometry at the active site of 
Lm iPGAM 
An intermediate stage of the catalytic reaction of Lm iPGAM can be trapped 
effectively when the 'wrong' metals, such as manganese and zinc, are present in the 
assay solution and cause inhibitory effects on the protein activity. Compositions of 
the active site architecture and conformations of amino acid residues near the active 
site of the protein limit specificity of metal to be essential for the catalytic activity of 
the protein. Because the chemical natures of each metal are different, cobalt, 
manganese and zinc bound Lm iPGAM in the active site can lead to slightly different 
environments and metal geometries. Cobalt-bound protein represents an early, and a 
final stage of the catalytic reaction, whereas manganese- and zinc-bound proteins 
represent an intermediate stage (Figure 7.8.1.). It can be seen that metal geometries 
are essential during catalysis. At an early step during catalysis, metal site Ml 
coordinates strongly with 02P of the substrate while metal site Ml locates away 
from 02P. Both metal sites are in tetrahedral geometry. In the intermediate stage, 
metal site Ml makes more interaction with 01P and releases 02P of the substrate to 
metal site M2 creating trigonal bipyramidal geometry at metal site M2. Stronger 
interactions between M2 and OG of Ser75, and a monodentate oxygen of Asp23 in 
the intermediate stage are important factors for phosphoserine creation at Ser75. 
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Figure 6.8.1. Comparison of cobalt, manganese and zinc geometries at metal site Ml and metal site M2 in the structures of Lm 1PGAM-3PGA-Co, Lm 
1PGAM-3PGA-Co-Mn and Lm iPGAM-3PGA-Co-Zn, respectively. Black lines show more strongly interaction bonds, cyan lines represent less strong 
bonds. Metal-ligand bonds in metal geometry drawing are not in scale. 
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6.9. X-ray fluorescence spectroscopy (XRF) experiments to identify 
metal bound at the active site 
Crystals of Lm iPGAM-3PGA-Co (10tM CoC12), Lm iPGAM-3PGA-Co-Mn (10pM 
CoC12 and 6mM MnC12, named CoMn6) and Lm iPGAM-3PGA-Co-Zn (10pM 
CoC12 and 2mM ZnC12, named CoZn2) were obtained in 0.40M ammonium acetate, 
0.20M tn-sodium citrate dihydrate pH 6.0-6.2 and 24-26%(w/v) PEG4000 by the 
hanging drop technique as described previously. Crystals of Lm iPGAM-3PGA-Co 
(10j.iM CoC12), named CoAc, were also obtained from crystallising conditions 
without citrate (0.30M ammonium acetate, pH 6.0 and 24%(w/v) PEG4000). The 
high energy X-ray source available at ESRF, Grenoble, provided an opportunity to 
measure X-ray emission from metals present in crystal samples which was done prior 
to data collection at each metal absorption edge. The station 1D29 can scan from 35-
6keV (0.35-2.4A) and X-ray fluorescence spectra were collected by a Rontec Silicon 
drift diode (http://www.esrffr/UsersAndScience/Experiments/MX/lID290 . Crystals 
in their mother liquor were frozen in mounting loops. The X-ray fluorescence spectra 
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Figure 6.9.1. XRF spectra show metal content in Lm iPGAM crystals prior to data 
collections for anomalous experiments. Black, green and red spectra were from 
crystals of Lm iPGAM-3PGA-Co-Mn (CoMn6), and Lm IPGAM-3PGA-Co-Zn (CoZn2) 
and Lm 1PGAM-3PGA-Co (CoAc), respectively. There is no significant fluorescence of 
contaminated metal in the buffer used in crystallising solution (data not shown). 
The expected values of each metal emission spectrum can he obtained from the 
literature (www.xray.uu.se/,  2005) as shown in Table 6.8.1. XRF spectra of Lin 
iPGAM crystals co-crystallised with different metals (Figure 6.9.1.) show the 
presence of MnK(XI and MnK(x2 emission peaks which are close to each other at 
5.85keV. The CoK1i and CoKp i  emission peaks are at 6.87keV and 7.58keV, the 
ZnKUI and ZnK(L 2 emission peaks are at 8.56keV, and the ZnK 1 emission peak is at 
9.49keV. 
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Table 6.8.1. List of X-ray emission lines in the range of 4 to 1 OkeV 
Atomic No. Element 	Ka i 	Kczi 	Kp j 	L a i 
22 Ti 4.51084 4.50486 4.93181 0.4522 0.4522 0.4584 
23 V 4.95220 4.94464 5.42729 0.5113 0.5113 0.5192 
24 Cr 5.41472 5.405509 5.94671 0.5728 0.5728 0.5828 
25 Mn 5.89875 5.88765 6.49045 0.6374 0.6374 0.6488 
26 Fe 6.40384 6.39084 7.05798 0.7050 0.7050 0.7185 
27 Co 6.93032 6.91530 7.64943 0.7762 0.7762 0.7914 
28 Ni 7.47815 7.46089 8.26466 0.8515 0.8515 0.8688 
29 Cu 8.04778 8.02783 8.90529 0.9297 0.9297 0.9498 
30 Zn 8.63886 8.61578 9.5720 1.0117 1.0117 1.0347 
31 Ga 9.25174 9.22482 10.2642 1.09792 1.09792 1.1248 
32 Ge 9.88642 9.85532 10.9821 1.18800 1.18800 1.2185 
Values are from J. A. Bearden, "X-Ray Wavelengths", Review of Modern Physics, (January 
1967) pp. 86-99. 
A Liii iPGAm-3PGA crystal co-crystallised in the presence of 101LM CoCl2 and 
0.30M acetate buffer but not citrate was obtained at the same concentration of 
precipitating agent and pH as previously. It was used to determine the relative metal 
content by XRF (Figure 6.8.1. CoAc red line). The crystal was mounted in a loop 
with its mother liquor as cryo-protecting agent and was exposed to X-rays. The 
emission spectrum was collected between 2 and 1 3keV. The CoAc spectrum (red 
line) shows a high presence of cobalt and some contamination of Fe, copper and 
zinc. Since the protein in solution may act as a chelator, especially the residues in the 
active site, trace metals such as iron, copper and zinc in solution used in protein 
production, purification and crystallisation may bind to the protein. This spectrum 
revealed that cobalt accumulated in the protein crystal is much higher than that in 
crystals grown with citrate ion in the crystallising solution, indicating citrate chelated 
some metal ions competitively from the active site during the crystallisation process. 
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Because affinity of citrate-transition metals is much higher than that of acetate (Bell, 
1977; Fraásto da Silva and Williams, 2001), this suggests a metal chelation effect by 
the citrate buffer which may remove metal from the metal site M2. Unfortunately, 
the CoAc crystal died during data collection and it was not possible to determine the 
occupancy of cobalt in the metal binding site. 
A crystal of Lm iPGAM-3PGA-Co-Mn (CoMn6) mounted in a loop with its mother 
liquor as cryo-protecting agent was exposed to X-rays, and the emission spectrum 
was collected between 4 and 12keV. Manganese emission peaks in the CoMn6 
spectra (black line) are larger than those in the CoMni spectrum (data not shown), 
and indicated that these peaks are proportional to amount of additional Mn 2 ions in 
crystallising solution. As expected, the peak of manganese is much larger than that of 
the cobalt peak. As in the previous spectrum of CoAc, there is contamination by 
iron, copper and zinc. 
A crystal of Lm iPGAM-3PGA-Co-Zn (CoZn2, green line) was also analysed 
previously. The CoZn2 spectrum shows major peaks of cobalt and zinc but none of 
manganese, and also some of iron. The Kai and K 1  of zinc peaks are relatively larger 
than the K1 and K1 peaks of cobalt because zinc amount is 200 times much more 
than cobalt in the crystal. 
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6.10. Anomalous dispersion experiments to identify metal bound at the 
active site 
Anomalous dispersion experiments were used to identify metals at the active site of 
Lm iPGAM. Anomalous differences can be obtained from X-ray data collection at, or 
higher than, the energy of the absorption edge of the metal of interest. The 
experiments were started by growing the protein crystals in the presence of 3PGA. 
cobalt and other metals, manganese or zinc. X-ray fluorescence for each crystal was 
measured using synchrotron radiation to ascertain the metal content in the sample 
(Section 6.9.). The ionisation energy of each metal was then optimised prior to data 
collection in order to obtain anomalous differences as large as possible from the data 
set collected at a specific wavelength. Theoretical anomalous signals (number of 
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Figure 6.10.1. Theoretical anomalous signals (number of electrons) of manganese, 
cobalt and zinc. 
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X-ray diffraction of each crystal at the specific absorption edge of the metal of 
interest was collected at ESRF, station 1D29 with the ADSC Q210 2D detector. Data 
sets were processed and scaled preserving the anomalous signal by MOSFLM and 
the CCP4 program suite (Collaborative Computational Project Number 4, 1994). All 
crystals belong to the same space group and have the same unit cell dimensions as 
reported in Table 6.10.1. A single MTZ reflection file of the well-defined crystal 
structure of Lm iPGAM-3PGA-Co-Mfl solved at 1.90A resolution containing phase 
information was merged to an individual MTZ reflection file of each data set using 
the CAD program of the CCP4 program suite for the production of the file 
containing anomalous differences and phases of the solved crystal structure. An 
anomalous map of each data set was then calculated individually using the FFT 
program. Anomalous differences of each data set collected at the metal absorption 
edge of interest provided signals identifying the metal in the crystal structure. The 
peak height of each anomalous map represents metal occupation in the crystal 
structure. Results and parameter statistics are shown in Table 6.10.1. 
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Table 6.10.1. Multi-wavelength anomalous dispersion (MAD) statistics and results (ns is not detectable signal at 3o level) 
ESRF: 1D29 ESRF: 1D29 ESRF: 1D29 ESRF: 1D29 
ESRF: 1D29 
X-ray source 
Crystal complexes 3PGA-CoMn 
3PGA-CoMn 3PGA-CoZn 3PGA-Co 3PGA-Co 
(CO 1OM, Mn 1mM) (Co 1OiM, Mn 6mM) (Co lOM, Zn 2mM) 
(Co lOiM) (Co 1mM) 
Mn low peak Mn peak Co peak Mn peak Co peak Zn peak Co peak 
Co peak Co peak 
Data collection at wavelength (A) 1.8958 1.8924 1.6052 1.8925 1.6042 1.2772 
1.6048 1.6046 1.6046 
Space group P2 1 2 1 2 1 P2 1 2 1 2 1 P2 1 2 1 2 1 P2 1 2 1 2 1 
P2 1 2 1 2, P2 1 2 1 2 1 P2 1 2 1 2 1 P2 1 2 1 2 1 P2 1 2 1 2 1 
Unit cell a 62.48 62.43 62.41 62.37 
62.23 62.77 62.68 62.47 62.49 
b 72.32 72.24 72.01 72.82 
72.84 73.03 72.82 72.28 72.45 
C 129.80 129.67 129.55 129.53 
129.32 131.03 130.69 129.79 130.56 
Resolution (A) 2.30 2.30 2.30 2.70 2.90 4.00 
2.75 2.85 2.70 
No. of reflections 80,348 80,384 74,582 61,776 
49,929 16,633 51,909 81,878 91,193 
No. of unique reflections 26,312 26,276 25,374 15,914 
12,549 5,445 16,156 14,298 16,894 
Rg. 15.4 18.6 14.5 14.4 
13.7 18.1 21.5 8.4 9.7 
1.5 3.8 4.7 4.4 5.0 6.1 (2.3) 5.9 (2.3) 
5.2 (4.8) 5.8 (3.2) 
Redundancy 3.2 3.2 3.1 4.0 
4.1 3.4 2.6 5.2 5.4 
Completeness (%) 97.0 97.5 94.0 95.0 
92.7 96.6 97.4 98.0 99.8 
Metal anomalous peak height, a 
M (1) ns 10.2 7.9 11.1 6.5 
6.3 4.5 21.9 20.0 
M(2) ns ns ns ns 
ns 5.6 ns ns ns 
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The resolutions of these data sets are around 2.30 to 2.90A except the data set of 
Co/Zn collected at the cobalt absorption edge which only diffracted to 4.OA 
resolution. cobalt is found in metal site Ml at every concentration of manganese and 
zinc, but is not found at metal site M2. This has been confirmed using crystals grown 
in 101tM and 1mM CoC12. The crystal diffracted X-rays at the cobalt absorption 
edge. The results are in agreement with the previous result that any cobalt at the 
metal site M2 is below the limits of detection. Manganese with concentrations at 1.0 
and 6mM (i.e. 100 and 600 times higher than cobalt) in the crystal samples are also 
detected only at metal site Ml (Figure 6.10.2.(a) and (b), respectively), and shows 
the possibility for manganese to be bound to the protein competitively with cobalt. 
However, the anomalous signal from the data set collected at the cobalt absorption 
edge can be a combination of both cobalt and manganese, see Figure 6.10.1., and it is 
therefore possible to quantify the relative amounts (Table 6.2.1.). On the other hand, 
Co/Zn crystals provide unambiguous results. Zinc occupancy can be detected at both 
metal sites of the Co/Zn (1 0.tM / 2mM) crystal with data collected at the zinc 
absorption edge as shown in Figure 6.10.2(c). Moreover, a Co/Zn crystal grown in 
the presence of 0.5mM ZnC12 with data collected at 0.9790A (full details shown in 
Section 6.6.) also showed significant zinc occupancy at metal site M2. The statistics 
are shown in Table 6.2.1. Although 0.9790A is not ideal for the zinc absorption edge, 
it is however close enough to retrieve anomalous differences from the zinc. These 
results show that the metal site Ml is occupied fully by cobalt, even if manganese or 
zinc is present at high concentrations, and only zinc may be detected at metal site 
M2. This perhaps suggests that binding constant of zinc with the enzyme is higher 
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Figure 6.10.2. Anomalous maps show relative metal occupancies in Lm iPGAM-
31PGA crystal structures. Each anomalous map was obtained from data collected at 
the wavelength of the absorption edge of each metal. The maps in the left hand side 
show electron density peaks contoured at 3cr, calculated using the phases of the 
refined protein structure and with coefficients IF +  - Fl at X = 1.8924A (for manganese) 
and X = 1.2772A (for zinc). The picture on the right hand side is the electron density 
map calculated for data collected from the same crystal but with X at the absorption 
edge of cobalt, the Fourier map coefficient was IF+ - El at X = 1.6048A. 
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6.11. Summary and discussion 
Crystal structures of L. mexicana iPGAM-3PGA and L. mexicana iPGAM-2PGA 
complexes have been solved at 1.90A and 2.05A resolution and have two metals 
bound in the active site. Metal site Ml shows tight binding with cobalt, whereas the 
metal site M2 is only partially occupied. Occupancy of metal site M2 varies with 
cobalt concentration. Crystal structures of the protein grown in different 
concentrations of cobalt have been refined between 2.00 and 2.25A, and the 
occupancy at metal site M2 in each structure was then refined by the program 
SHELX97. The cobalt concentration versus cobalt occupancy plot was made to 
determine a binding constant which was revealed to be 0.28mM. This value may be 
an overestimate as a high concentration (200mM) of citrate (a competitive metal 
chelator), was present in the crystallising solution. 
The identity of the metal at M2 is unclear since the metal-ligand distances and 
geometries of biologically relevant metals (Co 
2+, Mn2 , Mg2 and Zn2 ) are similar. 
Lm iPGAM is inactivated by EDTA and is reactivated fully by Co 
2+ with Kd 
9.1±2.2tM, but not by other metals. Mg 
2+  present in the normal activity assay 
(without cobalt) was not able to reactivate the protein, whereas Mn 2 retains of about 
10% activity of the enzyme. Zn 2  is unclear in effect on the protein activity because it 
inhibits the coupling enzymes. This binding constant is considered to be relevant for 
metal site M2 only since the dissociation constant of metal site Ml is presumably 
much lower as can be seen by remaining fully occupied after a crystal was soaked in 
the presence of 2mM EDTA for 70h. This dissociation constant is likely to be an 
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over-estimated value since the protein still has an uncleavable 6-His tag at C-
terminus which is also a good cobalt chelator. 
In this work Co-Mn and Co-Zn complexes have been studied along with the only 
cobalt crystal structure of Lm iPGAM-3PGA. Substitution of manganese or zinc 
instead of cobalt in the crystal structures of Lm iPGAM-3PGA cause differences in 
metal coordination geometries and protein—ligand binding at the active site, which 
leads to the loss of protein activity. With reference to the structure of Lm iPGAM-
3PGA-Co, metal site Ml of the Co-Zn structure binds more strongly to 01P from the 
phospho group of the 3PGA molecule, and releases 02P toward metal site M2 and 
Ser75. Metal coordination at M2 is changed from tetrahedral (by four tight bonds in 
the cobalt structure) to trigonal bipyramidal form, which is similar to that of the Co-
Mn structure. The distortion of the active site when complexed with manganese and 
zinc may therefore explain the inhibitory of these metals and may imitate the 
formation of phosphoserine intermediate in phosphorylation. This result shows that 
the specificity of metal coordination at the active site is a very important factor for 
the catalytic activity of the protein. 
Attempts have been made to identify the metal at the metal site M2 of Lm iPGAM 
using X-ray fluorescence and anomalous dispersion experiments, as well as activity 
assays of the protein in the presence of a mixture of cobalt and manganese, and a 
mixture of cobalt and zinc. XRF results indicated that zinc contaminated all samples, 
and anomalous dispersion experiments showed that the metal site Ml is occupied 
partially by cobalt, even if manganese or zinc is present at high concentrations. Only 
zinc may occupy the metal site M2. Although zinc is the most strongly bound metal 
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to the protein at site M2 as shown in XRF result, it is unclear if it is required for 
protein activity because zinc inhibits the coupling enzymes in the activity assay. 
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CHAPTER 7 
IDENTIFICATION OF NOVEL INHIBITORS 
FOR Lm iPGAM 
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7. IDENTIFICATION OF NOVEL INHIBITORS FOR Liii iPGAM 
7.1. The first screening of small coinpo u iids from DOCK 
The crystal structure of Lin iPGAM-3PGA-Co refined at 1.90A was used as a 
template for docking and database mining in order to design specific inhibitors. The 
active site of the enzyme was defined by residues involved in the substrate (3PGA) 
binding as shown in Figure 7.1.1. 
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Figure 7.1.1. Crystal structure of Lm iPGAM-3PGA-Co refined at 1.90A with the 
active site showing H-bonds from the substrate (3PGA) and surrounding residues. 
This figure was made by MOLSCRIPT (Kraulis, 1991) and RASTER31D (Merritt and 
Bacon, 1997). 
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It can he seen that the active site of the enzyme is very small and buried in between 
two domains, and therefore the water accessible path of the channel to that active site 
(Figure 7.1.2.) was considered as a docking site for database mining. This strategy 
presented the possibility of ligands being bound into the channel to the active site of 
the enzyme and preventing the substrate from reaching the active site, thereby 
causing 'plug-like' inhibition of the enzyme as shown in Figure 7.1.3. 
Water accessible path of the channel to the 
active site 
The active site with 3PGA and Co 2 ions 
Figure 7.1.2. 	Slab view showing charge details of channel (blue=positive, 
red=negative, white=non-polar). This is the region considered as a docking site to 
which a putative plug-like inhibitor would bind. Oxygen atoms of 3PGA are shown in 
yellow at the active site making direct contact with positively charged residues (two 
CO2* ions are in magenta). This figure was made by PYMOL (DeLano, 2005). 
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(a) 	 (b) 	 (C) 
Figure 7.1.3. Schematic drawing of (a) the active site of Lm IPGAM, a substrate 
accesses and binds to the active site, (b) an inhibitor-like compound accesses and 
binds to active site, and/or channel, and (c) binding of an effective 'plug' molecule 
with residues in the channel which prevents substrate access and causes inhibition 
of the enzyme. This figure was provided by Catherine McDonnell. 
The docking site was generated by the program DOCK 3.5 (Ewing et al.. 2001) with 
a 12.5A radius sphere. The centre of the sphere was defined as the centre of the 
substrate. The docking site was filled with water accessible sphere clusters (Figure 
7.1.4.) and included both the active site of the protein and also the pathway the 
substrate takes to gain entry to the active site. Docking against the Available 
Chemicals Database (ACD) (Allen, 2002), a list of approximately 250,000 3D ligand 
structures yielded the top 200 compounds (by score). These compounds were looked 
at more closely, and shown to correspond to 42 different compounds that were often 
found in several orientations. Further analysis showed that these 42 compounds 
could he grouped into three main types. These are sugar phosphates, nucleotides and 
carboxylic acids, along with their derivatives. However, nucleotides would be 
difficult to develop into potent drugs for Lin IPGAM because they are freely 
available in all organisms and are involved in many enzyme reactions. 
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Water accessible path of the channel to 
the active site 
I 1ci i \ c ltc 
Figure 7.1.4. Water accessible sphere clusters within 12.5A radius of the active site 
(in magenta dots) located in the docking site. The structure of Lm iPGAM is shown in 
carbon backbone style with temperature factors (B). Temperature factor shown is 
ascending order from violet, blue green, yellow to red. This figure was made by 
SYBYL. 
To search for inhibitor-like compounds from the program ISIS-base, each of the 35 
compounds was re-drawn as a template by the program ISIS-draw for individual 
similarity searching, and was assessed against other available compounds that were 
comparable by shape and chemistry to the relevant compound. The search yielded 53 
compounds which were grouped into families and looked at for viable testing. Again 
the similarities between nucleotides pulled out compounds such as ATP and ADP 
which are obviously not possible inhibitors, due to their presence in glycolysis and 
many other biochemical systems. The seven nucleotide compounds and analogues 
were therefore not used for testing. 
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A total of 15 of the available commercial compounds (Appendix 1) were used for 
5mM inhibitory screening. The activity of Lm iPGAM is normally measured by 
coupling its reaction to those catalysed by enolase, pyruvate kinase and lactate 
dehydrogenase in the presence of ADP and NADH, together with Mg 
 2+  (for enolase 
and pyruvate kinase activity) and W (for pyruvate kinase activity) (Figure 7.1.5. The 
production of 2PGA from the substrate 3PGA by iPGAM can thus be detected 
readily by monitoring NADH oxidation rate at 340nm. Unfortunately there is no 
convenient method to quantify the iPGAM reaction directly, as neither the substrate 
nor product is readily detected. Thus, inhibiting compounds were tested against 
coupling enzymes by the above reaction excluding Lm iPGAM and 3PGA, with 
2PGA or PEP to start the reaction instead. The results are shown in Figure 7.1.6. 
3-phosphoglycerate (3-PGA) 
1[ Phosphoglycerate mutase (PGAM) 0.1 units 
2-phosphoglycerate (2-PGA) 
1[ Enolase (ENO) 2 units 
Phosphoenolpyruvate (PEP) 
ADP 	-... I 
Pyruvate kinase (PYK) 4 units 
ATP 
Pyruvate 
NADH~)~  Lactate dehydrogenase (LDH) 6 units 
NAD 
Lactate 
Figure 7.1.5. Schematic reaction of Lm iPGAM activity by coupling assays. Activity 
of Lm iPGAM was measured by following the oxidation of NADH at 340nm. Inhibiting 
compounds were tested against coupling enzymes by the above reaction excluding 
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Figure 7.1.6. A 5mM inhibitory screening of 'DOCK' compounds. Either 3PGA 
(blue) or 2PGA (white) were used as the starting reagent of the coupling assays. 
This screening was done by Jonathan Korgaonkar during a short training program of 
the Biochemistry Honours Project 2003, Edinburgh University. 
It can he seen from Figure 7.1.6. that most of the inhibitory compounds had similar 
effect, with and without Lin iPGAM and suggests that the coupling enzymes are 
inhibited. Although ribose-5-phosphate (R-5-P) seemed to have some inhibition on 
the mutase in this screening with 65% activity remaining, and the predicted binding 
site of this compound is shown in Figure 7.1.7.; this result proved to be non-
reproducible (see next Section, B 1 compound). Oxalic acid and citrate are metal 
chelators and probably removed Co 2,,  Mg2 and K. They were not considered 
suitable for development as iPGAM specific inhibitors. 
R-5-P 
3PGA 
Figure 7.1.7. Predicted binding site of ribose-5-phosphate (R-5-P) (by the program 
DOCK) showed the water accessible path channel to the active site of Lm iPGAM 
was blocked. This therefore may cause inhibition of the enzyme. This figure was 
made by SYBYL. 
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7.2. L-isoleucine is identified as the first inhibitor-like compound 
A 65C/(  similarity searching based on the substrate (3PGA) structure was carried out 
using the program ISIS-base. A total of 22 compounds from database mining were 
screened at 5mM by the standard assay. Specific names and structures of these 
compounds are provided in Appendix 2. The results are shown in Figure 7.2. 1. The 
top five inhibitors in order of efficacy were 138 (DL-isoleucine). 133 (ethacrynic 
acid). 137 (lactic acid). 139 (3-methoxy-1.2-propanediol) and 136 (sodium-4-
hydroxybenzoate). Activity remaining at 247c was observed in the presence of B20 
(citrate) as observed previously. D- (1323) and L-isoleucine (1324) were tested 
individually, and only L-isoleucine inhibited the enzyme, see next Section. 
0 • • • 	.. 	- --,-- - 
- 	C)Lfl 	r- 	C) 	- 	C) 	U) 	N- 	0) 	- 	C') 	U)  
0) 0) 	0) CO CO - C.'J C\J ('4 	C' 	('4 	C') 
	
0) 	0) 	0) 	0) 	0) 	0) 	0) 	0) CO 0) 0) 	CO 
compound 
Figure 7.2.1. 5mM screening of 3PGA-based compounds (first 1-22 bars), citrate 
(B20) in a dark blue, top 5 potential inhibitors in pink, D- (B23) and L-isoleucine 
(B24) in red, B8-based compounds in green, and B9-based compounds in purple 
bars. This inhibitor screening was done by Catherine McDonnell during a short 
training program of the Biochemistry Honours Project 2004, Edinburgh University. 
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Only two compounds of these were shown to inhibit Lin iPGAM specifically when 
assayed for effect on auxiliary enzymes as shown in Figure 7.2.2. The inhibitory 
effect of B8 (DL-isoleucine) and B9 (3-methoxy-1,2-propanediol) on Lin iPGAM 
was apparent in the higher levels of activity seen in the assays started by adding 
2PGA (to check an effect on ENO. PYK and LDH) and PEP (to check an effect on 
PYK and LDH) when compared to that of the complete assays. By contrast. B3. B6 
and B7 did not show specific inhibition of Lin iPGAM. 
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Figure 7.2.2. Effects of top five initial inhibitors on Lm iPGAM and auxiliary 
enzymes. The activity assay started by 2PGA was referred to as the activity of ENO, 


















Figure 7.2.3. Comparison of structural similarity of (a) 3PGA, the substrate of Lm 
IPGAM with (b) DL-isoleucine and(c) 3-methoxy-1 ,2-propanediol. 
Comparison of structures of 3PGA, DL-isoleucine and 3-methoxy-1,2-propanediol 
(Figure 7.2.3.) indicated that the inhibitory action of both compounds may involve 
mimicking of the carboxylate and hydroxy groups of the substrate to bind the protein 
at the active site. Both compounds were then used as individual templates for further 
65% similarity searching on the program ISIS-base. Although some commercially 
available compounds were screened, no promising inhibitory compound was found 
as shown in Figure 7.2.1. (DL-isoleucine based compounds in green, and 3-methoxy-
1 ,2-propanediol based compounds in purple). Specific names and structures of these 
compounds are also provided in Appendix 2. 
Although the first screening of DL-isoleucine gave less than 20% activity remaining 
from the mutase assay, this was not a reproducible result in further testing of 
individual isoleucine stereoisomers. This may be caused by an experimental error. 
However, it was intriguing and surprising to realise that the DL-isoleucine tested, 
actually contained all four stereoisomers of isoleucine as indicated by the 
manufacturer (Acros) (Table 7.2.1.). A mixture of DL-isoleucine from Acros 
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contains 45% (SS) L-isoleucine, 45% (RR) D-isoleucine, 5% (SR) L-allo-isoleucine, 
and 5% (RS) D-allo-isoleucine. As shown in the second generation result (Figure 
7.2.1.), D- and L-isoleucine were tested individually against Lm iPGAM 
individually, D- gave 98% and L- gave 68% activity remaining. 
Table 7.2.1. 	StereoisomeriC compositions of the isoleucine inhibitors from 
different 
suppliers. 
Supplier (SS) (RR) (SR) (RS) 
L-isoleucine D- L-allo- D-allo- 
isoleucine isoleucine isoleucine 
ACROS DL-isoleucine 45% 45% 5% 5% 
D-isoleucine - 85% 7.5% 7.5% 
L-isoleucine 99% - - - 
SIGMA D-allo- - - - 100% 
isoleucine 
L-allo- - - 100% - 
isoleucine 
FLUKA DL-isoleucine 49.5% 49.5% 0.5% 0.5% 
L-isoleucine 99.5% - - - 
L-allo- - - 99% 1% 
isoleucine 
D-allo- - 0.5 0.5% 99% 
isoleucine 
Comparison of stereoisomeric compositions of isoleucine from different suppliers 
showed that most of them are supplied as mixtures, except D-allo-isoleucine and L-
allo-isoleucine form Sigma. However, L-isoleucine from Acros and Fluka seem to 
have the highest purity (>99% purity). Structural comparison of all four 
stereoisomers of isoleucine with two chiral centers is shown in Figure 7.2.4. 
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Figure 7.2.4. Comparison of structural stereoisomer of isoleucine. 
All forms of isoleucine from different suppliers were then tested against Lm iPGAM 
activity individually as shown in Figure 7.2.5. The result showed that only L-
isoleucine is implicated in the inhibition of Lm iPGAM. It is consistent that L-
isoleucine from Acros and Fluka lowered Lm iPGAM activity, whereas DL-
isoleucine from Acros and Fluka had only slight effect on the protein activity. This 
means that only L-isoleucine (45%) in the mixture caused a stereo specific inhibition 
of Lm iPGAM. Although D-allo- and L-allo-isoleucine from Fluka showed 
unexpected activity stimulation of Lm iPGAM, D-allo- and L-allo-isoleucine from 
both suppliers (Sigma and Fluka) exhibited no inhibitory effect on the enzyme. The 
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Figure 7.2.5. A 5mM screening of isoleucine stereoisomers from different suppliers 
resulted in only L-isoleucine inhibiting the mutase. 
The inhibitory characteristics of L-isoleucine were then further analysed by a 
competitive activity assay using different concentrations of isoleucine in the presence 
of 3PGA to generate saturation curves as shown in Figure 7.2.6. Non-competitive or 
uncompetitive inhibition of L-isoleucine are the most likely since the V niax of the 
reaction is obviously altered with increasing of L-isoleucine concentration, whereas 
the K 1  of 3PGA is only slightly affected. 
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• L-isoleucine 0mM 
• L-isoleucine 1mM 
L-isoleuc;rie 2mM 
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Figure 7.2.6. Competition of Lm ROAM activity assays with L-isoleucine. 
The ICso value of L-isoleucine was then determined to be 7.5mM. The result is 
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Figure 7.2.7. IC 50  determination of L-isoleucine is 7.5mM. 
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7.3. Kd characterisation of L-isoleucine bound Lin iPGAM by 
fluoroin etric titration 
There are three tryptophan residues present in the L. inexicana iPGAM. that would 
potentially be useful for fluorometric titration since fluorescence of tryptophan 
excited at 295rn can he detected specifically at 325nm (Ross et al., 1997). Locations 
of tryptophan residues in the structure of Lin iPGAM are shown in Figure 7.3.1. It 
can be seen that Trp221 and Trp365 are buried in the water inaccessible helical cores 
of the structure, whereas Trp214 is located near the active site and exposed to 
solvent. 
r 
Figure 7.3.1. Locations of three tryptophan residues in the structure of Lm iPGAM 
indicated in ball-and-stick fashion and green labels. This figure was made by 
MOLSCRIPT and RASTER3D. 
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Determination the Kd of L-isoleucine binding to Lin iPGAM. The enzyme at a 
concentration of 3iM was titrated by L-isoleucine (0-2.0mM range) at room 
temperature. The fluorometric titration curve was generated by plotting ck quenching 
(the percentage of relative amount of decreasing of fluorescence yield to the total of 
fluorescence yield) against L-isoleucine concentration (Figure 7.3.2.). The graph 
looks like a saturated curve with the highest %quenching of about 12, which can be 
used for evaluation of the dissociation constant. 
12  1 
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Figure 7.3.2. Fluorometric titration curves of Lm iPGAM with L-isoleucine (black) 
and a control experiment of the titration of Lm iPGAM with buffer used in the L- 
isoleucine solution preparation (red). 
However, a control experiment was done using buffer solution instead (same 
volumes as L-isoleucine solution as mentioned above). The titration curve of the 
control gave the highest quenching of about lOc which was similar to that of the 
ligand. Both titration curves were created in a similar manner including correction 
for dilution. The dilution factor of this titration was not allowed more than 3%. The 
similarity of both titration curves indicated that the protein and/or L-isoleucine in the 
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reacting solution may absorb emitting fluorescence at the same time and caused the 
decreasing of fluorescence yields. 
To check the protein and L-isoleucine absorption effects on the fluorometric titration, 
the absorption of solutions with different compositions used in the fluorometric 
titration were measured between 300-700nm (Figure 7.3.3.). A 20mM TEA pH 7.4 
solution containing 50mM NaCl with (green) and without L-isoleucine (yellow) had 
a feature in the absorption curve between 280-340nm, which showed dominating 
absorption bands of both TEA buffer and L-isoleucine. The buffer of 20mM TEA pH 
7.4 solution containing 50mM NaCl with added cobalt did not absorb' energy 
between 300-700nm, but absorbed slightly between 280-300nm (pink). Red spectra 
showed a combination of absorption of TEA buffer, L-isoleucine and cobalt between 
280-340nm. Lm iPGAM in buffer (containing cobalt) solutions, with (blue) and 
without L-isoleucine (magenta) absorbed energy more efficiently than that of the 
others in this region (280-340nm). As mentioned previously (Section 1.6.), electronic 
absorption bands of tetrahedral and octahedral geometries of Co 
2+  protein complexes 
are readily interpreted in the near-ultraviolet (Maret and Vallee, 1993), and this 
agrees well with above results. These results indicated that both protein and L-
isoleucine absorb energy in the same region (325nm) at which fluorescence yields 
were collected (Figure 7.3.4.). This was a major factor that decreases fluorescence 
yield during the fluorometric titration. The fluorescence yields from the titration thus 
were a combination of absorption by L-isoleucine and the cobalt bound Lm iPGAM 
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Figure 7.3.3. Absorption spectra of 20mM TEA buffer pH 7.4 plus 50mM NaCl 
containing mentioned compounds (co: cobalt 10pM; iso: L-isoleucine 2.06mM; Im: 
Lm iPGAM 3pM). See text for details. 
Absorption spectra of L-isoleucine in 20 mM TEA buffer pH 7.4, 50 mM NaCI. 
10 uM CoCl2 
Figure 7.3.4. Absorption spectra of L-isoleucine in TEA buffer measured at the 
same concentrations (mM) used in the fluorometric titration as mentioned above. 
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To check the effect of absorption on fluorescence data collection as mentioned 
previously, the peak height of the fluorescence yields at different wavelengths (320, 
330, 340, 350 and 360nm) from the emission spectra were measured to create 
titration curves of %quenching against L-isoluecine concentration, including dilution 
effect correction (graphs not shown). All titration curves are straight lines with the 
same slope, which indicated that the overlapping of the absorbance onto fluorescence 
wavelengths was over the observed quenching. Because the amount of quenching of 
Lm iPGAM by L-isoleucine is too low (-42% quenching), the Kd determination of 
protein-ligand binding by fluorometric titration may not be suitable for Lm iPGAM. 
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7.4. Preliminary attempts to identify the L-isoluecine bound 
Lm iPGAM complex structure 
Soaking of a Lm iPGAM-3PGA-Co crystal in the same crystallising solution used to 
produce the crystals, but also containing 100mM L-isoleucine at 17°C for 24hr, was 
used as a preliminary study of L-isoleucine binding mode on Lm iPGAM. The crystal 
diffracted X-rays to beyond 2.9A with a total of 12,276 unique reflections and 89.6% 
completeness. Relatively poor resolution may be caused by too high concentration of 
L-isoleucine in the soaking solution. The crystal structure was fully refined using the 
well defined structure of the 3PGA complex as a model. R and R-free factors were 
refined to 16.95% and 26.20%. Data quality was not very good (Table 7.4.1.), and no 
L-isoleucine ligand could be identified. 
However, co-crystallisation of Lm iPGAM with L-isoleucine is in progress to obtain 
a crystal structure of the ligand bound to the protein. This crystal structure will be 
used to identify the L-isoleucine binding mode onto the protein for further inhibitor 
design. 
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Table 7.4.1. Data collection details and statistics, and crystal structure parameters of 
Lm 






Unit cell (A) 	a 
b 
16 








No. of reflections 65,736 
Unique reflections 12,276 
Multiplicity 5.3 (5.3) 
Completeness (%) 89.6 (89.6) 





R-free (%) 26.20 
Mean temperature factor B (A) 
Protein (overall) 20.4 
Col 	 29.6 (100% occupancy) 
3PGA 	 19.7 (100% occupancy) 
Sodium 	 31.6 
All atoms used in refinement 	 4,255 
7.5. Summary and discussion 
The crystal structure of Lm iPGAM complexed with the substrate 3PGA has been 
solved and refined at 1.90A, and the binding site of the protein has been also 
identified. Virtual screening of the structure against the ACD database of 250,000 
structurally defined small compounds by the program DOCK 3.5 yielded compounds 
that could bind the protein. The docking area was defined as a 12.5A radius sphere 
away from the centre of the active site, which included the water accessible path of 
the substrate to the entrance the active site. The first 5mM screening of compounds 
with Lm iPGAM was not successful in identifying potential inhibitor-like compounds 
since the active site of the protein is too small, and limits the numbers of compounds 
that could bind the protein. Further database mining based on the structure of 3PGA 
was done using the program ISIS-base. 5mM screening of a library of 3PGA-derived 
compounds against Lm iPGAM gave L-isoleucine as the first inhibitory compound 
with IC50 7.5mM. L-isoleucine shows stereo specific binding to the protein because 
the other stereoisomers gave no inhibition. 
Dissociation constant (Kd) determination of L-isoleucine by fluorometric titration 
was unsuccessful because the measured quenching by the ligand is too low (12%). 
Both ligand and the protein absorb energy strongly at the emitting fluorescence 
wavelengths, thereby causing a decrease of the fluorescence yields. Thus this 
technique is not suitable for Kd determination of Lm iPGAM. 
The first crystal structure of Lm iPGAM-3PGA-CO soaked in 100mM L-isoleucine at 
2.9A showed no detectable bound L-isoleucine. Higher resolution of the L-isoleucine 
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bound protein crystal structure is required for identification of the binding mode of 
the ligand onto the protein, which will be used for further inhibitor design. To obtain 
the crystal structure as mentioned above, co-crystallisation of the protein with L- 
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8. GENRAL DISCUSSION AND CONCLUDING REMARKS 
8. 1. General summary 
Leishmania mexicana iPGAM is a member of the divalent metal-dependent 
phosphatase superfamily and catalyses the interconversion of 3- and 2-
phosphoglycerates in the glycolytic pathway via a phosphoserine intermediate. It is a 
particularly favorable drug target for leishmaniasis because the parasite and human 
enzymes are not homologous. L. mexicana iPGAM shares 74% sequence identity 
with a valid drug target Trypanosoma brucei iPGAM, and recent RNAi experiments 
with reduced levels of iPGAM in T. brucei caused the death of cultured bloodstream-
form parasites (Albert et al., 2005). Therefore iPGAMs from both parasites are 
potential drug targets. 
Crystal structures of Lm iPGAM show a mixture of substrate and product in the 
active sites which occupy essentially the same position. It was shown that higher 
relative amounts of each ligand in the crystal structures depend on the starting ligand 
in the co-crystallising conditions. Lm iPGAM requires Co 
2+ ions as cofactors, but not 
Mn2 or Zn2t Comparison of Lm iPGAM and the well-defined structure of Bacillus 
stearothermophilus iPGAM that requires Mn 2  shows that the metal requirement of 
iPGAMs can be discriminated by the existence of an extra residue at Tyr210 (Lm) 
that causes His360 to adopt a position where it can form a H-bond with the phospho 
group of the substrate/product, together with local conformational differences of 
residues 422-424 (corresponding to residues 401-403 of Bs iPGAM). These changes 
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in active site structure cause differences in the active site preferences of each of the 
iPGAMs from both organisms for particular metals. Metal reactivation experiments 
show that manganese inhibits Lm iPGAM, whereas the zinc inhibitory effect is 
unclear because zinc lowers the activity of the coupling enzymes used in the assays. 
Manganese or zinc substitutions in both metal sites cause changes in metal geometry 
leading to loss of enzyme activity. It is apparent that metal-ligand binding geometries 
of the two metal sites are important during catalysis. 
Purified L. mexicana iPGAM with a 6His-tag fused at the C-terminus is stabilised 
successfully in TEA buffer pH 7.4 containing CoC12 lOjiM and NaCl 50mM. 
Inspction of the Lm iPGAM crystal structure shows that both metal ions (Co 2+ and 
Nat) are likely to be necessary for protein folding. Col and Co2 at the active site 
coordinate oxygen and nitrogen ligands from the substrate (or product) molecule and 
amino acid residues involved in the active site. Sodium coordination is far away from 
the active site and is not involved in catalysis. The dissociation constant of Col 
bound to Lm iPGAM is much lower than that of Co2. The Kd of Co2 determined by 
activity assays is 9.1j.M, whereas a crystallographic titration by adding cobalt into 
the crystallising solutions gave a value of 0.28mM. The higher Kd from the 
crystallographic titration is probably affected by the presence of citrate in the 
crystallising solution (200mM). In addition, the un-cleavable His-tag at the C-
terminus can also be a competitive cobalt chelator albeit less strong. 
An activity assay of L. mexicana iPGAM used a reaction with three coupling 
enzymes (enolase, pyruvate kinase and lactate dehydrogenase) to monitor the NADH 
oxidation rate at 340nm. Unfortunately there is no convenient method to quantify the 
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iPGAM reaction directly, as neither the substrate nor product is readily detected. The 
metal requirements of the coupling enzymes must therefore be considered in 
reactivation experiments. Therefore inhibiting compounds were tested against 
coupling enzymes by the above reaction, excluding Lm iPGAM and 3PGA, but using 
2PGA or PEP to start the reaction instead. 5-10% DMSO is recommended as a non-
polar solvent for water insoluble ligands because it does not affect the activity of L. 
mexicana iPGAM or the coupling enzymes. Unfortunately, development of enzyme-
ligand binding measurements by fluorescence (quenching) titration was not 
successful because cobalt-bound L. mexicana iPGAM absorbs energy in the near 
ultraviolet strongly, at which the quenching yields of trytophan residues present in 
the protein are collected. 
Ligand inhibition studies using 'DOCK' and 3PGA-based compounds yielded L-
isoleucine as the first inhibitor-like compound for L. mexicana iPGAM, with an 1050 
of 7.5mM. Stereo-specific inhibition is probably required for this enzyme. 
Preliminary attempts to determine the mode of L-isoleucine binding by L. mexicana 
iPGAM by crystallographic have not yet been successful because the quality of the 
data were not good enough (23A). To obtain a higher resolution data, co-
crystallisation of the ligand with the enzyme is in progress. In addition, an inhibitory 
screening of the enzyme with small compounds which mimic the two carboxylate 
groups of the substrate or the product structure are being carried out. 
Trypanosoma brucei iPGAM has also been a drug target for sleeping sickness. Two- 
step purified T brucei iPGAM with a 6His-tag fused at the N-terminus was stabilised 
in TEA buffer pH 7.4 containing 3PGA (substrate) 0.3mM and KC1 150mM. This 
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gives a monodisperse solution with an estimated Mr 64kDa by dynamic light 
scattering. An initial crystallising condition for T. brucei iPGAM has been 
determined and required cobalt in the crystallising solution as well as 3PGA to obtain 
quality crystals. In addition, fresh purified protein is required to obtain quality 
crystals. 
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8.2. Significant  discoveries 
The overall aims of the project were to understand the properties and functions of 
iPGAM from Leishmania mexicana and Trypanosoma brucei, and yielded new 
information that can be categorised as shown below; 
Sequence phylogeny of divalent metal dependent-iPGAMS can give clues about 
metal specificity: 
L. mexicana iPGAM has only 33% sequence identity with Bacillus 
stearothermophilus iPGAM, the first crystallographically well-characterised iPGAM 
(Jedrzejas et al., 2000a; Jedrzejas et al., 2000b; Rigden et al., 2002). The bacillus 
enzyme requires manganese for catalysis. The sequence alignment of a total of 134 
iPGAMs from various sources shows that iPGAMs from L. mexicana and T brucei 
are grouped close to plant iPGAM5. Although the metal requirement of plant iPGAM 
is not clear yet, both trypanosomatid parasite iPGAMs and plant iPGAMs seem to 
require metals with smaller ionic radii (Christianson, 1997) such as CO2 (0.72A) or 
Mg2  (0.65A) rather than Mn2  (0.80A) as found in bacterial iPGAMs. Structural 
inspection of Lm and Bs iPGAMs shows an inserted residue at Tyr210 of Lm iPGAM 
that makes a strong H-bond with His360 which has a direct H-bond to an oxygen 
atom of the phospho group of the substrate (or product). This is absent in Bs iPGAM 
and may cause the active site volume in Lm iPGAM to be smaller than that of Bs 
iPGAM. 
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Metal discrimination by Lm iPGAM, a cobalt-dependent enzyme: 
As mentioned previously, the differences of the active site volumes of Lm and Bs 
iPGAMs are specific to the particular metals used by each enzyme. Metal 
reactivation results show that Lm iPGAM can be reactivated fully only by cobalt. 
This result suggests that Lm iPGAM is a cobalt-dependent enzyme. Manganese 
inhibits Lm iPGAM, because the ionic radius of manganese is larger that of cobalt. 
On the other hand, cobalt can function in bacterial iPGAMs such as from 
Escherichia coli and Clostidium perfringens, in which the native metal is manganese 
as shown in Figure 1.3.1. 
Crystal structures of Lm iPGAM complexed with a substrate (3PGA) or a 
product (2PGA) are very similar but are distinguishable: 
Crystal structures of Lm iPGAM-3PGA-CO and Lm iPGAM-2PGA-CO have been 
solved at 1.90A and 2.05A, respectively. These two structures show a mixture of the 
substrate and the product bound to essentially the same location in the active site. 
Differences of temperature factors of each ligand in each structure together with 
partial occupancies of each ligand can be used to distinguish these two structures. 
Substrate and metals at the active site are essential for protein folding: 
The high resolution crystal structures of the protein complexed with the substrate and 
metal suggest that these ligands are essential for protein folding and for 
crystallisation. Without cobalt, it was not possible to obtain quality crystals of Th 
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iPGAM, although the substrate was present in the crystallising solution. Cobalt at 
metal site Ml of Lm iPGAM shows tight binding with the protein and substrate in the 
active site. This metal was unable to be removed by soaking the crystal in high 
concentration of EDTA. On the other hand, cobalt at site M2 can be removed by the 
presence of citrate in the crystallising solution. 
Metal coordination geometries play a major role during catalysis: 
Cobalt substitution by manganese causes the metal geometry in the active site of Lm 
iPGAM to change, with a consequent loss of activity. Inspection of the manganese-
bound enzyme structure shows that coordination of the two metal sites has changed 
compared to the native structure with cobalt (Figure 6.5.3.). Mn2 at site Ml pulls a 
mono-ester oxygen atom more closely, whereas an oxygen atom of the phospho 
group that used to bind strongly to Ml is released to M2. In addition, Ser75 has 
changed its conformation to coordinate the phospho group and is trapped in an 
intermediate stage (Figure 6.5.4.). This result suggests that Lm iPGAM catalysis 
proceeds via a phosphoserine intermediate. 
Techniques to study metals in protein: 
Different analytical techniques were used in this project to study metals in proteins as 
follows: 
(a) metal geometries can be studied using protein crystal structures. 
PON 
crystallographic titration by adding a metal at different concentrations into 
crystallising solutions, can be used to determine a dissociation constant of a 
particular metal bound to the enzyme 
a combination of metal removal from protein using EDTA treatment, and 
size exclusion chromatography can be used to prepare metal-'free' protein 
metal reactivation of a metal-'free' enzyme by can be used to measure the 
dissociation constant of metal-bound protein. The presence of other metal 
chelators in the assay solution may affect results. 
X-ray fluorescence spectrometry with a wavelength scan-able light source 
can be used to identify relative amounts of metals in a sample 
anomalous dispersion experiments can be used to identify metals bound to 
protein. This technique is suitable for metals with atomic weight higher than 
magnesium. 
atomic emission spectroscopy can be used to quantify the relative amounts of 
metal in specimens that have to be digested and stored in acidic solution. 
However, for determination of metals at low concentration, a metal pre-
concentration and/or large amount of sample are required. 
mass spectrometry can be used to reveal a strong metals strongly bound to 
proteins, however, this thechnique is non-quantitative. 
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Drug discovery: 
L-isoleucine, the first inhibitor-like compound with an 10 50 of 7.5mM of Lm iPGAM, 
was identified by preliminiary screening with 'DOCK' and 3PGA-based compounds. 
Attempts to obtain the high resolution crystal structures of the ligand co-crystallised 
with the enzyme is in progress to reveal the mode of ligand binding. Because Lm 
iPGAM and Th iPGAIVI are very similar (74% sequence identity and they require 
cobalt for catalysis), any potential inhibitor of Lm iPGAM would also likely have a 
similar effect on Th iPGAM. 
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8.3. Future work 
An understanding of the structure and the functions of iPGAMs from L. mexicana 
and T. brucei are crucial for further rational drug design. The following strategies 
could be used to achieve this goal. 
To study the catalytic mechanism of L. mexicana iPGAM effectively, crystal 
structures at high resolution (<1.90A) are necessary because the binding sites of 
the substrate and the product of the enzyme are overlapping. 
The crystal structure of L. mexicana iPGAM apoenzyme is required for studying 
conformational changes during the catalysis of the enzyme. 
The determination of the crystal structure of L. mexicana iPGAM near atomic 
resolution (-1 .4A) has not been successful. This may be caused by the disordered 
6His-tag at the C-terminus that is located on the surface and exposed to solvent. 
The tag could reduce the packing quality of protein molecules in a crystal, and 
limit diffraction of the crystal. A cleavable 6His-tag at the C-terminus of L. 
mexicana iPGAM will be used for this. 
There is promising evidence by cobalt substituted by manganese or zinc crystal 
structures to suggest that the enzyme catalysis proceeds via a phosphoserine 
intermediate. To obtain a crystal structure of Lm iPGAM with a phosphoserine 
intermediate, a mutant enzyme at a residue contributing to metal coordination at 
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the active site may lead to an enzyme with lower activity, and may enable a 
phosphoserine to be trapped. 
The crystal structures of site-directed mutants of Lm iPGAM at Tyr210 may 
cause the active site to lose a binding residue at His360. The consequent 
expansion volume of the active site could be more suitable for a larger metal ion 
to be functioned. Therefore, it will be helpful to explain the relevance of 
particular metals on the volume of the active site. 
Obtaining crystal structures at high resolution of T. brucei iPGAM is required to 
understand the nature and the functions of the protein. The strategy to obtain 
good quality crystals will be carried out in the same way as for Lm iPGAM. 
Novel inhibitor identification for L. mexicana iPGAM by using 'DOCK' and 
3PGA-based compounds yielded L-isoleucine as the first inhibitor-like 
compound with an 1050 of 7.5mM. A high resolution structure of L-isoleucine-
bound protein structure will be used to study the mode of ligand binding and to 
develop tighter bound ligands. In addition, the screening of small compounds 
which mimic the two carboxylate groups of the substrate or the product structures 
is in progress. Inhibitors identified in the way will be optimised by iterative 
cycles of structure-activity analysis and combinatorial chemistry. 
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CRYSTALLOGRAPHIC DATA SETS 
All crystallographic data sets are available in the CD in the pocket inside the back 
cover of the thesis. The list of data sets and coordinates of PDB deposited structures 
(1-5) and non-PDB deposited structures (6-11) is shown below (ent files can be read 
as .pdb files): 





with CoCl2 10pM (1.90A) lm3pga_co10um_SheIX5.eflt 
lm3pga _col Oum_mtz_refmac2.cif.gz 
lm3pga3. coloum_scalal.log 
2 LmiGAM-2PGA complexed 
2 AC1 
lm2pga_col Oum_scalal .mtz 
with CoCl2 10PM (2.05A) lm2pga_co1oum_ShelX4.eflt 
lm2pga _col Oum_mtz_refmac2.cif.gz 
Im2pga_col Oum_scalal .Iog 
3 LmiPGAM-3PGA complexed lm3pga_mnl mm_scalal .mtz 
with CoCl2 10pM and MnCl2 1mM 2ijCC. lm3pga_mnlmm_ShelX3.ent 
(1 .90A) lm3pga_mnl mm_mtz_refmac8.cif.gz 
lm3pga_mnl mm_scalal .log 
4 LmiPGAM-3PGA complexed 1m3pga_zn05mm_SCa1a1 .mtz 
with CoCl2 10PM and ZnCl2 0.5mM 2,JCB 1m3pga_zn05mm_She1X2.ent 
(2.00A) lm3pga_zno5mm_mtz_refmaCl 5.cif.gz 
lm3pga_zno5mm_SCaIal .log 
5 LmiPGAM-3PGA complexed lm3pga_co4mm.mtz 
with CoCl2 4mM (2.00A) 2/iCp 1m3pga_Co4mm_She1X4.eflt 
1 m3pga_co4mm_mtz_refmac6.Cif.gZ 
lm3pga_co4mm_SCalePaCk.IOg 
6 LmiPGAM-3PGA complexed - 1m3pga_c02mm.mtz 
with CoCl2 2mM (2.25A) lm3pga_co2mm_laStrefmaC5_refmac2.Pdb 
7 LmiPGAM-3PGA complexed - lm3pga_coO5mm.mtZ 
with CoCl2 0.5mM (2.00A) lm3pga_coo5mm_IaStrefmaC5_refmac2.Pdb 
8 LmIPGAM-3PGA complexed - Im3pga_co01 mm.mtz 
with CoO12 0.1mM (2.10A) lm3pga_coOl mm_1astrefmac5_refmaC1 .pdb 
9 Lm1PGAM-3PGA complexed - Im3pga_ni4mm.mtZ 
with CoCl2 10pM and NiCl2 4mM 1m3pga_ni4mm_She1X1.eflt 
(2.20A) 
10 LmiPGAM-3PGA complexed - 1m3pga_edta2mm70h.mtZ 
with CoCl2 I OpM soaked in EDTA Im3pga_ edta2mm7oh_refmaC7.Pdb 
2mM 70h (2.25A) 
11 LmiPGAM-3PGA complexed - 1m3pga_Ii100mm24h_sCa1a1.mtz 
with CoCl2 10PM soaked in 1m3pga_1i100mm24h_refmaC5.Pdb 
L-isoleucine 100mM 24h (2.90A)  
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Expression, purification, crystallization and 
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Bacterially expressed 2,3bisphosphogIycerate-indePendent phos-
phoglycerate mutase (iPGAM) from Leishmania mexicana with a 
six-His tag fused at its C-terminus was expressed from plasmid 
pET28a after IPTG induction in Escherichia coli cells and gave a 
yield of 20 mg of highly purified iPGAM per litre of cell culture. 
Crystals of the protein complexed with 3-phosphoglycerate were 
obtained by the hanging-drop method of vapour diffusion with PEG 
4000 as the precipitating agent in the presence of cobalt chloride and 
diffracted synchrotron radiation to beyond 1.90 A. The crystals 
belong to the orthorhombic space group P2 1 2 1 2 1 , with unit-cell 
parameters a = 62.46, b = 72.27, c = 129.68 A. A model of Bacillus 
stearoihermophilus iPGAM (33% identity) was used to provide an 
initial molecular-replacement solution. X-ray data to 2.05 A for the 
structure of L. mexicana iPGAM complexed with 2-phosphoglycerate 
have also been collected. 
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1. Introduction 
Phosphoglycerate mutase (PGAM) is an 
enzyme of the glycolytic pathway that catalyses 
the interconversion of 2- and 3-phospho-
glycerates. There are two types of PGAM: one 
is dependent on the cofactor 2,3-bisphos-
phoglycerate (dPGAM) and the other is 
cofactor-independent (iPGAM). All verte-
brates contain only dPGAM, whereas PGAM 
from the parasitic protozoan Leishmania 
mexicana belongs to the iPGAM class. The 
chain length of IPGAM is much larger than 
that of dPGAM and there is no sequence 
similarity between iPGAM and dPGAM 
(Chevalier ci al., 2000). 
There is significantly more information 
available for the dPGAM family compared 
with the iPGAM family. dPGAMs from a 
variety of organisms have been well studied 
and the enzyme is present in all vertebrates, 
most invertebrates and some fungi and 
bacteria. It is found in monomeric, dimeric 
and tetrameric combinations of identical 
subunits of about M, = 30000 (Fothergill-
Gilmore & Watson, 1989; Graña ci al., 1995). 
The catalytic mechanism of dPGAM involves 
the formation and hydrolysis of a phospho-
histidine intermediate (Fothergill-Gilmore & 
Michels, 1993). A potent inhibitor of dPGAM 
is vanadate, which has no effect on iPGAM 
(Chevalier ci al., 2000; Fraser ci al., 1999). 
X-ray crystal structures of the yeast Sacchar-
ornyces cerevisae dPGAM at 2.3 and 2.12 A 
resolution (Rigden ci al., 1998, 1999) and 
complexed with 3-phosphoglycerate (3PGA)  
at 1.7 A (Crowhurst ci al., 1999) have been 
reported. 
In contrast, information on iPGAM is rather 
sparse. The enzyme is a member of the alkaline 
phosphatase (AlkP) superfamily, which is 
composed of a wide range of enzymes that 
catalyse the intramolecular transfer of 
phospho or sulfo groups (Fraser ci al., 1999). 
All characterized iPGAMs are monomers of 
M, = 55 000-75 000 (Fothergill-Gilmore & 
Michels, 1993) with sequences that are not 
apparently homologous with dPGAM. An 
X-ray structure of Bacillus stearothennophilus 
iPGAM complexed with 3PGA and two MnZ* 
cations has been solved at 1.9 A resolution 
(Chander ci al., 1999; Jedrzejas et al., 2000a) 
and the structure of a complex with 2-phos-
phoglycerate (2PGA) and two Mn 2 cations 
has been solved at 1.7 and 1.4 A resolution 
(Jedrzejas ci al., 2000b; Rigden ci al., 2003). The 
catalytic mechanism of this enzyme appears to 
involve a phosphoserine intermediate (Jedr-
zejas et al., 2000a; Rigden ci al., 2002). iPGAMs 
from bacteria require Mn 2 for activity and are 
also very sensitive to pH (Chander ci al., 1998). 
It has been noted that when iPGAM from 
the trypanosomatid parasite Trypanosoma 
brucci is inactivated by EDTA, it can only be 
fully reactivated by 2* In contrast, Mn2 
only restored activity to about 10% (Collet ci 
al., 2001; Guerra ci al., 2003). Moreover, Collet 
et al. (2001) conclude from kinetic results that 
the mutase reaction is unlikely to proceed via a 
phosphoserine, but that a metaphosphate 
intermediate is more likely. T. brucci iPGAM 
shares 74% sequence identity with L. mexicana 
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Figure 1 
Sequence alignment of L. mexicana and B. stearothermophilus iPGAMs. Residue numbering is according to the 
L. mexicana iPGAM (accession No. AJ544274) and secondary structure is presented for the 
B. 
stearothermophilus iPGAM. The box indicates a putative phosphoserine residue and circles and squares show 
metal-coordinating residues for Miii and Mn2 of PDB entry lejj, respectively. The figure was prepared with 
ALSCRIPT (Barton, 1993). 
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SDS—PAGE analysis of purified fractions from the 
Talon column. A 12% gel was used and marker 
proteins (lanes 1,5 and 7) were from a low-molecular-
weight calibration kit (Amersham Pharmacia 
Biotech). Lanes 2, 3 and 4, proteins not bound by 
TALON; lane 6, pre-eluted fraction with 10 mM 
imidazole; lane 8, crude extract; lanes 9-15, purified 
protein fractions eluted with 50 mM imidazole. 
IPGAM (Lm iPGMA; Chevalier et al., 2000; 
Guerra et al., 2003). 
In this report, the expression, purification, 
crystallization and preliminary crystal-
lographic analysis of iPGAM from L. mexi-
cana are described. 
2. Methods and results 
2.1. OverexpreSsion 
The recombinant plasmid pET28a-Lm 
jPGAM carried by Esclzerichia coli strain 
BL21 (pDLmPGAM)pZLm37 encodes 
iPGAM with a six-His tag at the C-terminus. 
The expressed iPGAM contains 561 amino-
acid residues (Fig. 1), with a calculated Mr  of 
61 623 (excluding the initiator methionine 
and including the His tag LEHHHHHH) 
and a theoretical p1 of. 5.26 (http://www. 
expasy.ch). Cells harbouring the recombi-
nant plasmid were grown at 310 K in Luria-
Bertani (LB) medium containing 30 Vg ml- 1 
kanamycin and expression was induced by 
the addition of isopropyl thio-fi-o-galacto- 
side (IPTG) when the cell culture reached 
an OD600 of approximately 0.6. Cell growth 
was continued at 290 K for 20 h. Cell pellets 
were collected by centrifugation at 4200g for 
30 min and then stored at 253 K. 
2.2. Purification of bacterially expressed 
Lm iPGAM 
Frozen pellets from 11 cell cultures were 
defrosted and completely resuspended in 
20 ml lysis buffer consisting of 100 mM 
triethanolamine-HCI (TEA) buffer pH 8.0 
containing 10% glycerol, 500 m NaCl, 
10 tM CoCl2  and two tablets of 'Complete, 
Mini, EDTA-free' (Roche) protease-
inhibitor mixture. Cobalt was included at 
10 i.IM throughout the purification and 
crystallization because it is essential for 
optimal activity and stability (data not 
shown). 40 mg of lysozyme (Sigma) was 
added to the cell culture, which was incu-
bated at room temperature for 10 mm, 
sonicated and centrifuged at 11 000g for 
30 min at 277 K. 200 mg prolamine sulfate 
(Sigma) was added to the soluble fraction, 
which was then mixed gently on a circular 
rotor at 277 K for 30 min and centrifuged as 
before. The supernatant was collected and 
filtered through a 0.45 gm membrane. 
A metal-affinity Talon (Clontech) column 
was used with 50 mM imidazole in 100 mM 
TEA buffer pH 8.0 containing 10% glycerol, 
500 mM NaC1 and 10 iM CoC12 as eluting 
solution. The column was washed exten-
sively with the same buffer lacking imidazole 
prior to elution. Lm iPGAM was prepared 
for crystallization trials by removal of 
glycerol and imidazole salts using a PD-1 0  
pre-packed size-exclusion column (Amer-
sham Pharmacia Biotech) which was eluted 
with 20 mM TEA buffer pH 7.4 containing  
50 mM NaCl and 10 iM CoC12. The sample 
was then concentrated with a 20 ml Vivaspin 
centrifugal concentrator tube (Vivasciences) 
with a molecular-weight cutoff of 30 000. 
The purified protein was shown to be 
homogeneous by SDS-PAGE (Fig. 2), with a 
recovery of 20 mg per litre of culture. The 
M7  of the purified Lm iPGAM was found to 
be 61 698 by MALDI-TOF mass spectro-
metry, compared with the calculated M, 
from the sequence (61 623) plus the mass of 
one cobalt to give a total of mass of 61682. 
No attempt was made to remove the His tag 
prior to crystallization. 
2.3. Crystallization, data collection and 
preliminary structure analysis 
Well formed orthorhombic crystals of Lm 
iPGAM complexed with 3PGA and cobalt 
were grown in 24-well Limbro plates by 
vapour diffusion using the hanging-drop 
method (Ducruix & Giegé, 1992) at 290 K. 
Crystallization drops contained equal 
volumes (1.5 tl) of reservoir and enzyme 
solutions (5 mg mV' Lm iPGAM, 1.5 mM 
3PGA, 50 mM NaCl and 10 tM CoC12 in 
20 mM TEA buffer pH 7.4). Crystals were 
initially obtained from a preliminary screen 
using the Structure Screen I kit from Mole-
cular Dimensions: 0.20 M ammonium 
acetate, 0.10 M trisodium citrate dihydrate 
pH 5.6 with 30%(w/v) PEG 4000 as the 
precipitating agent. In the optimized crys-
tallization condition, the well solution 
consisted of 0.08 M ammonium acetate, 
0.04 M trisodium citrate dihydrate pH 6.0 
and 24%(wlv) PEG 4000. Streak-seeding 
with a cat's whisker was necessary to obtain 
well formed crystals suitable for X-ray 
diffraction (Fig. 3) (Ducruix & Giegé, 1992). 
The crystals were cryoprotected using crys-
tallizing solution and flash-frozen. X-ray 
data were collected at 100 K in a nitrogen 
flow using a Cryostream Cooler (Oxford 
Cryosystems, Oxford, England), using a 
Cu Ka rotating-anode source mounted on a 
Nonius FR591 generator operating at 40 kV 
and 110 mA connected to a MAR 345 area 
detector. 1.00 oscillation images were 
exposed for about 30 min each. Under these 
conditions, the crystal diffracted X-rays to 
beyond 2.3 A. Analysis of diffraction data 
using the autoindexing procedure of 
DENZO (Otwinowski & Minor, 1997) indi-
cated that the crystal belongs to the ortho-
rhombic space group P2 3 2121 , with unit-cell 
parameters a = 62.75, b = 72.23, c = 129.74 A. 
A total of 28 496 unique reflections were 
processed with 99.3% completeness 
(Table 1). The relative molecular volume, 
VM, is 2.4 A3 Da- 1 and is consistent with one 




Data-collection details and statistics. 
Values in parentheses are for the highest resolution shell. 
Lm iPGAM-
3PGA-Co 
X-ray source Rotating anode 
Wavelength (A) 1.5418 
Resolution (A) 2.25 
Unit-cell parameters 
a (A) 62.75 
b (A) 72.23 
c (A) 129.74 
90.00 
No. of total reflections 257597 
No. of unique reflections 28496 
Multiplicity 9.2 
R,,,,,t (%) 10.2 (45.8) 
Completeness (%) 99.3 (99.5) 
i/o(T) 21.9 (3.9) 
t 
Figure 3 
Crystals of Lm iPGAM complexed with 3PGA and 
cobalt. See text for details. 
molecule of protein in the asymmetric unit 
and a solvent content of 48%. 
A model of B. stearothermophilus 
iPGAM (PDB code lejj; Berman et al., 
2000) was used to provide an initial solution 
using MOLREP (Vagin & Teplyakov, 1997). 
However, the solution was of relatively poor 
quality because the sequence identity of the 
model and Lm iPGAM is low (33% identity, 
Fig. 1) and the connectivity of the electron-
density map was also not always apparent. 
An improved search model was generated 
by threading the Lm iPGAM sequence onto 
the published B. stearothermophilus iPGAM 
structure using 3DPSSM ( Kelley et al., 
2000). After removal of poorly defined 
loops in the structure, the model gave a 
molecular-replacement solution with an R 
value of 56.7% (Collaborative Computa-
tional Project, Number 4, 1994). 
X-ray data were also collected at the 
Daresbury SRS (station 14.2, A = 0.979 A) 
with an ADSC Q4 CCD detector using a 
scan with a step size of 0.5° and 60 s expo-
sures. The crystal-to-detector distance was 
140 mm and the crystal diffracted to beyond 
1.90 A. The data were processed with 
MOSFLM (Leslie, 1992). 
High-quality crystals of Lm iPGAM-
2PGA-Co were also obtained in 0.04 M 
Lm iPGAM- 	 Lm iPGAM- 
3PGA-Co 2PGA-Co 
SRS station 14.2 	SRS station 14.2 









8.9 (25.9) 10.1 (26.6) 
98.7 (98.7) 97.0 (97.0) 
5.7 (11.4) 4.4 (10.2) 
ammonium acetate, 0.02 M trisodium citrate 
dihydrate pH 6.2 with 30%(wlv) PEG 4000 
as the precipitating agent. Data were 
collected at the Daresbury SRS (station 14.2, 
), = 0.979 A) to 2.05 A resolution. Details of 
synchrotron data collection and statistics are 
shown in Table 1. 
3. Discussion 
Leishmaniasis, one of the diseases caused by 
trypanosomatid protozoan parasites, affects 
about 12 million people worldwide and 
efficacious drugs and vaccines are not 
currently available. The parasites are trans-
mitted by the bite of an insect vector, the 
phlebotomine sandfiy. In humans, the 
disease occurs in at least four major forms; 
cutaneous, diffuse cutaneous, mucocuta-
neous and visceral (World Health Organi-
zation, 2002). Current treatments include 
meglumine antimonate, sodium stibogluco-
nate and amphotericine B, which can cause 
severe toxic side effects and can even be 
fatal. Our work is part of an effort to provide 
three-dimensional crystal structures of vali-
dated target proteins. 
In trypanosomes, Leishmania species and 
other kinetoplastid organisms, part of the 
glycolytic pathway is compartmentalized in 
specialized peroxisomes, called glycosomes, 
which are not present in other eukaryotic 
organisms. Bloodstream forms of trypano-
somes exclusively obtain energy through 
glycolysis and the inhibition of any of the 
glycolytic enzymes thus provides a potential 
therapeutic approach. Phosphoglycerate 
mutase is a particularly attractive target for 
the design of selective inhibitors because the 
parasite and human enzymes are not 
homologous (Verlinde et al., 2001). 
In this study, L. mexicana iPGAM 
expression has been optimized and the  
protein purified, characterized and crystal- 
lized. The crystal structure of an Lm 
1PGAM-3PGA complex is being analysed. 
Crystal structures will be used as templates 
for database mining to identify ligands/ 
inhibitors. Combinatorial chemistry and in 
vitro assays will be used to produce tight- 
binding drug-like molecules. Any drugs thus 
produced are also likely to be effective 
against diseases caused by trypanosomes 
because of the high structural similarity of 
their iPGAMs. 
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